Professional Documents
Culture Documents
ISSUU PDF Downloader-2
ISSUU PDF Downloader-2
(178 Remaining.)
fr
Shah TC
www.shahtc.com
READY STOCK
Packing
50gm Aluminium Tin
&
+9183770 00044
info@shahtc.com
Head Office Address: Factory Address:
ROH Syrohchem Laboratories Pvt Ltd. Syrohchem Laboratories Pvt Ltd
111/112, 1st Floor, Subhalaxmi Complex, #26, Survey No. 230/A-1 & 230/A-2B,
SYRO [4 Cc ui E M Link Road, Vasant Nagri, Vasai East— 401 208 DOMS Industrial Complex,
Website: www.syrohchem .com Gokhivare, Vasai East- 401 208
BURT ESR EVs, ESS GST No. 27ABEC56527L1ZV
Ronietie fet Tes Bett (AN ISO 9001:2015 & GMP CERTIFIED Manufacturing COMPANY)
BULK SOLVENTS LR/AR/PHARMA GRADE IN 25 LTR / 200 LTRS PACK SIZE (DISTILLED AT SPECIFIC PARAMETERS)
Contact Details : (+91) 9028240944 I Email : sales@syrohchem.com | Website: www.syrohchem.com
PRODUCT LIST
e 2-MERCAPTO BENZOTHIOZOLE(MBT) e CUPROUS CYANIDE e NICKEL NITRATE
e 3 HYDROXY BENZOIC ACID e CUPROUS OXIDE RED e NICOTINE (EP)
e 3 METHOXY BENZOIC ACID e DI AMMONIIUM PHOSPHATE e NICOTINE ALKALOID - 99%
e 4 CHLORO 1 BUTANOL e EDTA ACID e NICOTINE BENZOATE
e 5 SULFOSALICYLIC ACID e EDTA COPPER e NICOTINE POLACRILEX - 20%
eGBA e EDTA DI SODIUM e NICOTINE SOLUTION (USP)
e ALPHA NAPTHTHALENE ACETIC ACID- e EDTA FERROUS e PYRIDINE - 2°
(NAA) e EDTA TETRA SODIUM e PENICILLIN G
e AMMONIUM ACETATE e EDTA ZINC e PHENYL ACETIC ACID
e AMMONIUM CARBONATE e FERRIC CHLORIDE ANHYDROUS e PHOSPHOROUS ACID CRYSTAL
e AMMONIUM CHLORIDE e FERROUS SULPHATE e PHOSPHOROUS OXY CHLORIDE
e AMMONIUM META VANADATE e GUANIDINE NITRATE e POTASSIUM ACETATE
e AMMONIUM MOLYBDATE e HALQUINOL - 12.5% e POTASSIUM SULPHATE
e AMMONIUM PARA TUNGSTATE e HALQUINOL - 60% e POTASSIUM BI CARBONATE
e AMOXYCILLIN e HALQUINOL - 80% e POTASSIUM BROMATE
e AMPICILLIN e HALQUINOL - 90% e POTASSIUM BROMIDE
e BARIUM HYDROXIDE OCTAHYDRATE e HOMOPHTHALIC ACID e POTASSIUM CHLORIDE
e BARIUM PEROXIDE e INDOLE e POTASSIUM IODATE
e BROMINE LIQUID e INDOLE 3 BUTYRIC ACID e POTASSIUM NITRATE
e BRONOPOL e INDOLE-3-ACETIC ACID e POTASSIUM NITRITE
e CALCIUM ALUMINO SILICATE e IODINE e POTASSIUM PERMANGANATE CRYSTAL
e CALCIUM CHLORIDE e ISO PROPYL ALCOHOL e POTASSIUM PERMANGANATE POWDER
e CALCIUM D PANTOTHENATE e LEAD CARBONATE e POTASSSIUM IODIDE
e CALCIUM NITRATE e LEAD CHLORIDE e SODIUM MOLYBDATE
e CAMPHORQUINONE e LEAD TETRA ACETATE e SILVER NITRATE
e CARNAUBA WAX e MAGNESIUM CHLORIDE e SODIUM BI SULPHITE
e CHROMIUM CHLORIDE e MAGNESIUM OXIDE - LIGHT (IP) e SODIUM BROMATE
e CITRIC ACID e MAGNESIUM OXIDE - LIGHT (USP) e SODIUM BROMIDE 99%
e COBALT CARBONATE e MAGNESIUM SULPHATE e SODIUM BROMIDE 45%
e COBALT CHLORIDE e MANGANESE CARBONATE e SODIUM CITRATE
e COBALT NITRATE e@ MANGANESE SULPHATE (98%) e SODIUM IODIDE
e COBALT OXIDE e MERCURIC ACETATE e SODIUM META BI SULPHITE
e COBALT SULPHATE e MERCURIC CHLORIDE e SODIUM SELENITE
e COPPER ACETATE e MERCURIC IODIDE e SODIUM THIO SULPHATE — ANHY
e COPPER CARBONATE (PHARMA) e MERCURIC NITRATE e SODIUM TUNGSTATE
e COPPER CARBONATE (TECH) e MERCURIC OXIDE (RED) e SULPHUR POWDER
e COPPER NITRATE e MERCURIC OXIDE (YELLOW) e TUNGSTIC ACID
e COPPER OXIDE (BLACK) e MERCURIC SULPHATE e VANADIUM PENTOXIDE
e COPPER OXY CHLORIDE e MERCUROUS NITRATE e ZEOLITE
e COPPER SULPHATE e MONO AMMONIUM PHOSPHATE e ZINC CARBONATE
e CUPRIC CHLORIDE - ANHYDROUS e MOLYBDENUM TRIOXIDE e ZINC CHLORIDE ANHYDROUS
e CUPRIC CHLORIDE - DIHYDRATE e MOLYBDIC ACID e ZINC SULPHATE HEPTAHYDRATE
e CUPROUS CHLORIDE e N-BROMO SUCCINAMIDE e ZINC SULPHATE MONOHYDRATE
Add: 507, Business Park, Tilak Road, Ghatkopar (E), Mumbai-400 077, Maharashtra, India.
Ph: 91-22-4243 4243 (30 Lines) / 2102 4041 | Fax: 91-22-4243 4200 / 2102 8777
Email: info@forbespharma.in / forbespharma@hotmail.com
OFF ADD: Office No. 0-304, 3rd Floor, TOWER | at "RUNWAL R SQUARE".
Old Gabriel Factory, L.B.S Road, Opp. Veena Nagar, Mulund (West), Mumbai - 400 O80,
TEL NO: 0022-49246 101/02/03/04 * MOB: 9223432969
Email Id: mivon(@mivonchemicals.com
13
AGR Extopin
© IMPORT ¢ EXPORT ¢ TRADING ™
AGR ENTERPRISES is an India based distribution company established in 1991. Ever since our
inception, we are performing consistently and offering standard quality products to our clients.
We have evolved as one of the leading suppliers of organic and inorganic chemicals catering to a
number of domestic and international clients. The company currently serves clients across broad
spectrum of industries ranging from pharmaceutical, agrochemicals, coatings, paint, dyes, printing
ink, cosmetics, plastic & several other industrial verticals.
19
Iso 9001:2015, Iso 14001:2015 & Iso 18001:2007 Certified Company
CR
Chemi Pharma Ltd.
2
Formerly known as Mody Chemi Pharma Pvt Ltd.
Your Reliable Partner in Brominated and Lithtum Compounds
=
© ¥
.
s \
PRODUCT LIST
e¢ INORGANIC BROMO COMPOUNDS tae Fa
PRODUCT AT A GLANCE
Neuroleptic Products NASAID & Antimigrane
Injection Napox — D
Helorise Naproxen Sodium 500mg + Domperidon 10 mg
Heloperidol 5mg/ml Megarise 5
Anxiolytics & Hypnotics Inj. Flunarizine 5mg
Lorise
Lorazepam 2mg/ml Megarise LS
Tablet Flunarizine .5mg + Propranolol 40mg
Fluxol MT Gabarise NT
Fluphenthixol 0.5mg + Melitracen 10mg Gabapentin 100/400 mg + Nortriptyline 10mg
Extended Coverage in
Etorise 0.5 Recurrent Infection
Etizolam o.S5mg
Etorise Plus
Etizolam 0.5mg + Proponalol 20mg
Etorise ES
Escitalopram 5mg + Etizolam .Smg
22
PE AAAI Ts) Gls MANUFACTURERS OF ORGANIC HALIDES
CHEMICALS LTD
e Ammonium Bi Carbonate e 1,3 Dibromopropane e@ Bromo OTBN
(ABC) @ 1,4 Dibromobenzene @ Cetylchloride
e Acetonitrile
e Di Methyl Acetamide @ 1,4 Dibromobutane e Ethyl,4-bromobutyrate
e Butyl Amines
@ Di Metyl Amine @ 1,6 Dibromohexane e Ethylene dibromide
@ Di Ethyl Amine (DEA)
e Di Methyl Formamide e 2 Bromoethylbenzene @ HBr 33% in acetic acid
e Di Methyl Amine
e Formic Acid e 2 Bromosuccinamide e Lauroylchloride
(DMA) e 2 Bromo-4-fluroacetanilide @ Meta Bromoaniline
e@ Methanol
e Di Methyl Amine HCL
@ Mono Methyl Amine @ 2 Bromo-2- @ Meta Bromoanisole
@ Mono Ethyl Amine 70% e@ Methoxyacetylchloride
e Sodium Nitrate methylpropionylbromide
@ Mono Isopropyl Amine e 2 Bromo-4-fluoroaniline e N-Butylchloride
e Sodium Nitrite
70% e 3 Bromonitrobenzene e N-Hexylchloride/bromide
e Tri Methyl Amine
@ Mono Methyl Amine @ 4 Bromoanisoe e N-Octylchloride/bromide
(MMA) e 4 Fluoroanisole e N-Pentylchloride/bromide
e Tri Ethyl Amine (TEA) e Benzoylchloride e N-Propylbromide
e Tri Methyl Amine (TMA) SHREE SULPHURICS e Benzylchloride e Phenylacety! chloride
e@ 2 Ethyl Hexyl Amine (2 Ava aD) e Bromoacetic acid e Pivaloylchloride
EHA) e@ Bromoacetonitrile e Tert Butylbromoacetate
e Propyl Amines-Mono e Thionyl Chloride e@ Bromobenzene e Valerylchloride
And Di Propyl Amines e Sulphur Dioxide
@ PMEDA e Sulfuryl Chloride
e Triethyl Amine HCL e Sodium Sulphite
MANUFACTURERS OF INORGANIC HALIDES
e Tertiary Butyl Amines e Sodium Meta bi sulphite
@ Dimethylamino e@ Hydrobromicacid e Potassium bromide
Propylamine (DMAPA) e Phosphorous oxychloride e Sulphuryl chloride
e DBU
ADITYA BIRLA e Phosphorous pentachloride e Thionyl chloride
@ DIPEA e Phosphorous trichloride
@ DIPA
THAILAND
@ Di Sodium Phosphate PRODUCTS:
e@ Mono Sodium Phosphate
DIAMINES AND @ Potassium Meta Bi
e Acetic Acid @ Methylene Di Chloride
Sulphite
CHEMICALS LTD e Sodium Acid Pyro
e Acetyl Acetone @ Monoethylene Glycol (MEG)
e Adipic Acid e@ Morpholine
Phosphate e N Hexanol
e Di Ethylene Tri Amines e Alpha Methyl Styrene
e@ Sodium Hexa Meta e Ascorbic Acid e N Octanol
(DETA)
Phosphate e Chloro Acetyl Chloride e N Pentanol
@ Monoethanolamine
e@ Sodium Meta Bi Sulphite e Chloro Benzenes e N-Methyl-2-Pyrrolidone
(MEA) e Sodium Sulphite
@ Ethylene Diamine (EDA) e@ Citric Acid @ Ortho Phenylene Diamine
e Sodium Tri Poly e Cyclohexane (OPDA)
@ Piperazine 68%
Phosphate e Decanol @ Phosphoric Acid 85%
e Piperazine Anhydrous @ Tri Sodium Phosphate @ Di Acetone Alcohol e Phosphorous Oxy Chloride
e Di Methyl Carbonate e Phosphorous Pentachloride
e Di Methyl Sulfoxide e Phosphorous Trichloride
AAK KAMANI PRIVATE LIMITED @ Do Decanol @ Propionaldehyde
e Ethyl Chloro Formate @ Propylene Glycol
e Soybean Oil e Safflower Oil e Formic Acid (85/99%) @ Pyridine
e Linseed Oil e Heptane e Sodium Benzoate
@ High Oleic Sunflower Oil
e Corn Oil
@ Hexane e Sodium Gluconate
(HOSO) e Hydrazine Hydrate 80% e Sodium Sulphide Yellow
e Sunflower Oil
@ Soybean Lecithin e Hydrogen Peroxide Flakes
e Coconut Oil
@ Medium Chain e Hydroxylamine Sulphate @ Sodium Thiocyanate
e Hydrogenated Vegetable
e Isobutanol e Sodium Tungstate
Oil (HVO) Triglycerides USP (MCTOIl)
e Isophorone e Solvent C-IX
e Isopropyl Alcohol e Sulpholane
e Lactose e@7TGUrea
BROMIDE & CHLORIDE : e@ Methoxy Acetyl Chloride. e Tertiary Butanol
e@ Methyl Chloro Formate e Tetra Hydro Furan
e Allyl Bromide e Pyridine Hydro Bromide e@ Methyl Cyclo Hexane e Tri Ethyl Ortho Formate
@ Cyclohexyl Bromide (PHBR) e Methyl Ethyl Ketone (MEK) e Tri Methyl Ortho Formate
e Cyclopentyl Bromide e Methyl Iso Butyl Ketone @ Tri-N-Butyl Amine
@ HBR 33% in Acetic Acid (MIBK) e Xanthun Gum
e Dectyl Bromide e@ Bromo Benzene
e Lithium Bromide
e Tert Butyl Bromoacetate
e N-Hexyl Bromide
e Chloroacetyl Chloride
e
e@
N- Octyl Bromide
Iso Propyl Bromide @ N-Hexyl Chloride Qs KRISHNA SOLVECHEM LTD.
e N-Propyl Bromide e@ Pivaloyl Chloride Corporate Office: B-503, Sahyog, S. V. Road, Kandivali (West),
e Sodium Bromide @ N- Octy! Chloride Mumbai — 400067. Maharashtra. INDIA. Tel: 9320529869
Email: marketing4@kscl.co.in ® Web: www.kscl.co.in
23
Ab ARIL PHARMACEUTICALS
PRODUCT LIST
Acebrophylline YELPCU msL Ue TLC) Hydrochlorothiazide eaten
PNY ere) Dex Rabeprazole Sodium Hydroxychloroquine Sul. Ofloxacin
Amisulpride ete es EU Males Hydroxyzine Hcl eo) ETirzT
eli
Amitriptyline Diazepam Indapamide Orel cre yell
Amlodipine Besylate Diclofenac Sodium Indion-204/234/214/244/254/ Omeprazole Magnesium
Amoxapine Py eaTol edit em ae PGE] Ondancentron Hcl / Base
Aripiprazole In Diluted Nitro Glycerine [10%] Tey Mace) NEL OIRO Pantoprazole Sodium
Atorvastatin Calcium Diluted-lsosorbide-5 Ketoconazole Paroxetine Hcl
Atropine Sulphate Mononitrate [40/50/80%] Ketorolac Trom [Tab / Inj » Phenobarbitone [Plain/Sod]
Baclofen Domperidone Ip Labetalol Hydrochloride La Cels ered ae
Betahistine Di Hcl Domperidone Maleate Lamotrigine Pregabaline
Chlordiazepoxide Dothiepin Hcl aC) Propranolol Hcl
eer CouE ra male Doxofylline Levocetrazine Di Hcl ere ELEC)
Chlorthalidone gel NELLIS ol ey Cla MUN OLE) Rabeprazole Sodium
Cilnidipine PIN oy Cita ala) Levosulpiride
Ramipril
Cinnarizine Ip Sorta Loratidine
Risperidone
er Coie Cala) Enalapril Maleate Lorazepam
Rosuvastatin Calcium
OE
ey ye m alle SSO Cele mey Cll yr dcr T1
S-Amlodipine Besylate
Citicoline Sodium Ip Etizolam eT CCS)
Serratiopeptidase Granules
Clidinium Bromide Etodolac Wee Mar
Clobazam Etoricoxib WTEC mar Tapentadol Ip
Clomipramine Hcl Lal UD Coss EL Mesalamine (Mesalazine) IEE Ch)
Clonazepam CTL om ne Metaxalone Aenea
Clopidogrel Bisulphate Flavoxate Metformin Hcl #100/80/60 Terbutaline Sulphate
Clozapine Ip Fluconazole Methoxsalen Thiocolchicoside
ONT Coy aU LirAlnt cm Bd Methylcobalamine aT leat)
Desloratadine ale ical Metoprolol Succinate Tolperisone Hcl
Flupentixol Di Hcl Metoprolol Tartrate NO WEL
Fluvoxamine Maleate Minoxidil Tranexamic Acid
Fusidic Acid Were) Trifluperazine Hcl
(Ceres Modafinil Trihexyphenidyl Hcl
Health Glibenclamide
Gliclazide Ip
Montelukast Sodium
Mosapride Citrate
Trioxsalen
Venlafaxine Hcl
Ky
Glimepiride Nella
PATE reli em aCe
Glipizide Nebivolol Hcl
rey Ete)
Haloperidol Nitrazepam Ip
Wealth
765 FLY - EDGE, 808 - 8th FLOOR, OFF. S.V.ROAD, NEAR KORA KENDRA FLY OVER,
BORIVALI - WEST, MUMBAI - 400092.
Tel.: 022-28019252, 28059252 @ Mob.: 9869060346 / 9869825228
Email: logistics@aril-pharmaceuticals.com | Website: www.arilpharmaceuticals.com
25
Vinipul Inorganics Pvt. Ltd.
uni
(Formerly known as Akash Purochem Pvt. Ltd)
ISO 9001:2015 & 14001:2015 Certified Company
UN ELECTROPLATING
LEATHER
Manufacturer of
BIO CHEMICAL Inorganic Chemicals TEXTILE
FOOD PAPER
|
PRIVATE LIMITED
@ Potassium lodide
~ stabilized
@ Potassium lodide
oN ea ease
® Calcium Levulinate
NEW PRODUCTS
@ 2-Chloro 5-lodo Benzoic Acid (CIBA) @ L-Selenomethionine
@ 4-lodoaniline @ N-Bromosuccinimide
@ 3,5-Diiodo Salicylic Acid @ N-lodosuccinimide
@ 5-lodo 2-Methyl Benzoic Acid (MIBA) = @ (R)-(-)-3-Carbamoymethyl-5-
® Diiodomethane Methylhexanoic Acid (RCMH)
@ lodobenzene @ Selenious Acid
© it
© as fal
3 + WWW]
SO | os
og
Mumbai Office Address: 3 — A, Shiv Sagar Estate North Wing, Dr. Annie Besant Road, Worli, Mumbai 400 018, India
Factory Address: 907/2 Jhagadia GIDC Estate, Jhagadia, Gujarat - 393110, India.
Tel: +91-22-6622 7575 | Email: eskay@sk1932.com, mkteskay@sk1932.com | Web: www.eskayiodine.com
27
C
RUSKIN CHEMIPHARM
(Your Sourcing Partner)
CONTACT:
Mr. Krishnakumar: +919322226307. Mr. Yash: +919819826611
Tel: +91-22-22059494/22068330.
Email ID: sourcing@ruskinchemipharm.in, sales@ruskinchemipharm.in
Website: www.ruskinchemipharm.in
28
ACTIVE PHARMACEUTICALS INGREDIENTS
* Adapalene * Escitalopram * Paroxetine
* Amisulpride * Gemcitabine * Pioglitazone
* Antazoline HCI/Phosphate * Faropenem * Ponesimod
* Apixaban * Febuxostat ¢ Pregabalin
* Atorvastatin * Fexofenadine * Prucalopride succ.
* Baclofen ¢ Fingolimod Hcl * Rifaximin
* Bempedoic Acid * Flupirtine Maleate * Risperidone
* Bilastine * Hyoscine butyl bromide ¢ Rivaroxaban
* Bortezomib * Imatinib ¢ Rosuvastatin
* Brivaracetam * Imeglimin Hcl * Sertraline Hcl
* Brexipiprazole * Isavuconazonium Sulfate * Sildenafil Citrate
* Cariprazine HCl * Itraconazole /llaprazole * Silodosin
* Candesartan * lvabradine * Sitaglipitin Phosphate
* Canagliflozin * Letrozole * Sodium Valporate
* Cetilistat ¢ Levocetrizine * Solifenacin Succinate
* Cinitapride * Levosulpiride * Sulphamethoxazole/TMP
* Cilostazole * Levodopa/Carbidopa * Sulphadiazine
* Dabigatran * Linagliptin * Tafamidis Meglumine
* Dapoxetine ¢ Lopinavir/Ritonavir * Tamsulosin/Dutasteride
* Dapagliflozin ¢ Lurasidone Hydrochloride IH * Tapentadol
* Desvenalfexine * Metoprolol Suc./ Tart. ¢ Tegoprazan
* Divalproex Sodium * Methotrexate * Telmisartan
* Digoxin * Mirabegron * Ticagrelor
* Domperidone * Mirtazpine * Torsemide
¢ Edoxaban * Montelukast Sodium * Tranexamic Acid
* Elagolix Sodium * Naproxen/ Sodium * Ursodeoxycholic acid
¢ Eltrombopag * Nebivolol ¢ Valproic acid
* Elobixibat Hydrate * Olanzapine ¢ Vigabatrin
* Ertugliflozin * Ozenoxacin * Vortioxetine Hbr
PELLETS
* Pantoprazole + Domeperidone |* Esomeprazole + Levosulpiride ¢ Mebeverine HCL SR
* Rabeprazole + Domperidone |» Atorvastatin + Clopidogrel + Aspirin * Itraconazole 20%
* Pantoprazole + Levosulpiride |+ Rosuvastatin + Clopidogrel + Aspirin * Itraconazole 22%
* Rabeprazole + Levosulpiride |+ Pregabalin + Methylcobalamine * Itraconazole 40%
* Itraconazole 44%
* Pantoprazole + Itopride * Dexlansoprazole DDR Pellets ¢ Venlafaxine HCL
+ Rabeprazole + Itopride (30mg & 60mg)
SR Pellets
¥
* Esomeprazole + Domperidone |. poxcylic + Lactic acid bacillus ¢ MUP’s Pellets Available
30
AVAILABLE REGULARLY FROM READY STOCK
32
f& Balaji Corporation
ETHYNYL ESTRADIOL IP/BP NORETHISTERONE ENANTHATE
ADAPALENE ETIZOLAM NORETHISTRONE IP/BP
ADENOSYL COBALAMINE EVEROLIMUS
ADRENALINE BITARTRATEIP ONDANSETRONE HCL
ADRENOCHROME MONO SEMI CARBAZONE IP FINASTRIDE BP ORLISTAT
ALFACALCIDOL FLUCLOXACILIN MAGNESIUM BP OSELTAMIVIR PHOSPHATE IP
ALFUZOSIN FLUOCINOLONE ACETONIDE OXICONAZOLE
ALLYLESTRENOL FLUOROMETHALONE ACETATE LE
ALPHA BETAARTEETHER IP FLUROMETHOLONE PIMECRLIMUS
AMOROFLINE FLUTICASONE PROPIONATE/ FUROATE PIPRACILLINE + TAZOBACTAM STERILE
ANASTROZOLE FOLLICLE STIMULATING HORMONE (FSH) POSACONAZOLE
ARTEETHER FOSFOMYICIN SODIUM PREDANISOLONE SODIUM PHOSPHATE IP
ARTESUNATE STERILE FUSIDIC ACID PREGABALIN
AZACYTIDINE PRILOCAINE
GRANISETRON HCL »
BEES WAX AR 70
BENIDIPINE HCL HELOBETASOL BP/USP SERRATIOPEPTIDISE ENTRIC COATED
BETAMETHASONE DIAPROPIONATE HUMAN GROWTH HORMONE (HGH) SILODOSIN
BETAMETHASONE SODIUM PHOSPHATE IP HYDROCORTISONE ACETATE SIROLIMUS
BETAMETHASONE VALARATE BP HYDROXOCOBALAMIN ACETATE SITAGLIPTIN PHOSPHATE
BIMATOPROST HYDROXY PROGESTERONE CAPROATE SOD.HYALURONATE( HYALURONIC ACID )
BUSERELIN HYDROXYZINE HCL IP/USP STANAZOLOL
BUTACONAZOLE NITRATE a SUCCINYL CHOLINE CHLORIDE
INDAPAMIDE SULBACTAM SODIUM STERILE
CALCITRIOL IODOCHLOROHYDROXYQUINOLINE IP/BP
CARBOPROST ISOCONAZOLE NITRATE TAMSULOSIN HCL
CASPOFUNGIN ACETATE ISOFLUPREDONE ACETATE TARAZOCINE
CETRIXONE SODIUM STERILE ISOTRETINOIN TAZOBACTAM SODIUM STERILE
CHOLECALCIFEROL (VITAMIN D-3 ) ITRACONAZOLE PELLETS 44% & 22% TERCONAZOLE
CICLOPIROX OLAMINE IVABRADINE TERLIPRESSIN ACETATE
CITICOLIN SODIUM IP IVERMECTINE IP TESTESTERONE BP (AND DEREVETIVE)
CLARITHROMYCIN IP/USP ST a TESTESTERONE CYPIONATE (DMF AVAILABLE)
CLENBUTEROL HCL BP/USP LEBETALOLHCL IP TETRAHYDROCURCUMIN
CLINDAMYCIN PHOSPHATE IP LETROZOLE THIOCOLCHICOSIDE IP
CLINIDIPINE LETROZOLE TIBOLONE
CLOBETASONE PROPIONATE LEVONORGESTREL IP/BP/USP TIGECYCLINE
CLOBETASONE-17-BUTYRATE LEVOTHYROXINE SODIUM TIOCONAZOLE
CO-ENZYME Q10 LIOTHYRONINE SODIUM (T3) TOBRAMYCINE SULPHATE/ STERILE
COLCHICINE LOPERAMIDE HCL USP TORSEMIDE
CYNOCOBALAMIN ( VIT
B -12 LOTEPREDNOL EBONET TRAVOPROST
-DABIGATRAN WAL] LULICONAZOLE TRENBOLONE ACETATE
DANAZOL LUMEFANTRINE TRETINOIN 99%
D-BIOTINE TRIAMCINOLONE ACETONIDE (MICRONIZED
DEFLAZACORT MEROPENAM
DEHYDROEPIANDROSTERONE (MICRONIZED) METHOTREXATE USP URSODEOXYCHOLIC ACID IP (UDCA)
DESMOPRESSIN ACETATE METHYAL PREDANISOLONE
DESOGESTREL METHYL COBALAMIN VANCOMYCINE HCL STERILE
DEXAMETHASONE SODIUM PHOSPHATE METOPROLOL SUCCINATE IP VIGABATRIN
DIAZOXIDE MICAFUGNIN SODIUM VITAMIN C COATED/PLAINE
DICYCLOMINE HCL IP MICROCRYSTALLINE WAX VITAMIN K1 LIQUID ( PHYTOMENADIONE )
DILTIAZEM MIFEPRISTONE VITAMIN K2 ( MK4 )MENATETRENONE
DINOGEST MISOPROSTOL HPMC( 1%) VITAMIN K2-7(MK7)MENAQUINONE
DOMPERIDONE BP MOMETASONE FUROATE VOGLIBOSE
DROSPERINPNE MUPIROCIN VORICONAZOLE
DUTASTERIDE
NANDROLONE DECANOATE (DMF AVIALABLE)
EBASTIN BP NANDROLONE PHENYLPROPIONATE (DMF ZINC MONO METHIONINE
EBERCONAZOLE AVIALABLE)
EFINACNAZOLE NATURAL PROGESTERONE (MICRONISE)
ENTACAVIR NEBIVOLOL HCL ***SELF IMPORT**
ERLOTINIB NEPAFENAC ACYCLOVIR IP
ESTRADIOL VALERATE NORADRENALINE BITARTATE CLINDAMYCIN HCL
ETHISTERONE NORETHISTERONE ACETATE TRANEXAMIC ACID
* All Above Product As Per Latest Pharmacopeia. *We are offering Third Party Manufacturing.
*Printed Products Are Not Offered For Countries Where Patent Is Still Valid It Is The Enquirer's Responsibility To Check Patent Situation BeforeEnquiring
33
VPM VITRO PHARMA MACHINERY 24
Manufacturers & Exporters of:
x / a s a
Gelatin Service tank Gelatin holding tank Vibro Sifter
(With Stirrer & Vacuum)
ee > y
\ Ja \ )
Colloid mill Encapsulation machine Automatic capsule counting Soft gelatin tray
(- \ “aa sy
ee
—=
J. A. )
Polishing pan Mixing Tank Semi automatic
Capsule counting
4 “nn -
i
L Jw — |S )
Blister Packing Chrome Colloid mill Mixing tank with harmonizer Planetary mixer
fe oe
oe che oe
fe
VITAMIN B2 80% FEED GRADE TYLOSIN PHOSPHATE 10% GRANULAR FEED GRADE
eae
ee
fe
ae
See
L-LYSINE SULFATE (FEED GRADE) CYROMAZINE 2% FEED GRADE ® o\-
tee
L-THREONINE 98.5% FEED GRADE Some of our speciality manufactured products atSome of our associated m anufacturers.
BACILLUS LINCHEMIFORMIS FEED GRADE VITAMIN E 50% FOOD/PHARMA GRADE
oe: Bins
oe
eee
eee
VITAMIN C COATED FOOD/ PHARMA GRADE eeeesd * @ 6
ede
SSSSSSNASSASSEEESE OES OG GG
Head Office
: 401, Hiri Heritage, 4th Floor, Off L. 7. Road. Above
T. B. Z, Borivali(West): Mumbai 400092.)INDIA. © & & 6
For Enquiry Contact : info@rosettalifecare.com, rosettalifecare@gmail.com, _ r K _ . S88 anenae Sean :
Contact No. : 022-28945777, Mob. No.: 9821111333, 9324656139 SSS Si = _ SSueeae Vase
i BA Ree Oe cecal ee
|
2-Methyl-10H-thieno [2,3-b][1,5] benzodiazepine-4- (3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-
amine Hydrochloride 1,3(2H)-dione
?.2-Amino-5-methylthiophene-3-carbonitrile ? P-Toluenesulfonylurea
We are well experienced & specialized in carrying out “HYDROGENATION”
of speciality & pharma product by using all types of Catalyst (Raney Ni, Pd/C, Pt/C, RH etc)
39
Mr. Kamlesh Doshi ® 9325352677
9222241417
PRODUCT LIST
@ ACCECLOFENAC @ IVERMECTINE
@ ALBENDAZOLE @ KETOCONAZOLE
@ ALLOPURINOL ® LACTOSE
® AMBROXOL HCL @ LEVOCETRIZINE HCL
PARSHWA
@ ATOMOXETANE HCL @ LISINOPRIL
@ BROMHEXINE HCL @ L-LYSIN
® CLOTRIMAZOLE @ LORATIDINE
®@ CIPROFLOXACIN HCL @ MCCP
® CHLOROQUINE PHOSPHATE @ METHYL COBALAMINE
@ CHLORZOXAZONE @® METHYL FOLATE CALCIUM
é.
e PROV FEB.
Vw Chemicals For Life | Since1991_ | ‘ma) ISO
Cao soot 01s
A
a
~ ¥PHARMALABCHEM EXPO
£5 DEC. 2023 G23 GE) ET) SEPT. 2023
; PHARMA , LAB AND CHEMICAL EXPO PHARMA , LAB AND CHEMICAL EXPO
hh
d
INDORE Messe Global ,Laxmi Lawns Pune
<
PARTICIPATION COST) “INDIA’S ONLY PREMIER EXHIBITION FOR PHARMA, LAB &
Early bird Discount: INR 1000/-
BARE
per sqm.*
SPACE
CHEMICAL INDUSTRIES AT EMERGING MARKETS” \
%9500/ per sqm.
(Minimum 18 sqm) * Pharmaceutical Machinery + Pharmaceutical Formulation *Pharmaceutical Bulk Drugs, Veterinary Drugs, Additives,
Intermediates » Pharmaceutical Printing, Packaging, Lab, Material & Machinery * Pharma Ancillary & Utility Services &
Exhibitors are required to build their own stand,
Maintenance +» Pharmaceutical Engineering » Pharmaceutical Refrigeration + Software for Pharmaceutical industry and
and take additional electricity from a stall
management * Clean Room Technology + Bar Coding + Bio-Pharmaceuticals / Bio Lab Instruments & Equipment
contractor.
* Biotechnology + R&D Instruments & Equipment » Water Management, Water Treatment, Supply & Disposal, Waste
H SHELL SPACE Management + Environment Control Equipment, Pollution Control Products & Services * Contract Manufacturers
=10000/ per sqm. * Contract Research Organizations (CROs) + Ayurvedic/ Herbal Products + Analytical Laboratory Supplies (Instruments,
(Minimum 9 sqm) Glassware, Lab. Reagents - Chemicals) * Analytical Services » Nutraceutical Product / Dietary Supplements Cosmetics
Products + Excipients / Food Additives / Natural Extracts * Flavors & Fragrances * Safety Equipment * Consultants
Inclusion: * Trade Promotion Bodies -Technical Publications/ Trade Associations / Media / Publications
A Standard Octanorm Shell scheme with rear & side walls
VISITOR PROFILE
Company name in English on the fascia and stand number
Wall to wall carpeting + Pharmaceutical Company Purchase / QDA/ QC / R & D/ Engineering » Merchant Exporters * Contract Manufacturers
1 Power Point (5 amps), 1 Standard Table & 2 Standard Chairs + Pharma Distributors / C & F Manufacturers * Generic & OTC Manufacturers & Wholesalers * Govt. Suppliers / Liaison
\3 Spot Lights, 1 Waste Bin Agents + Top Management & CEOs + Indenting Agents * Pharmaceutical Machinery Manufacturers & Traders
* Packaging Material Companies Biotechnology Companies « Regulatory / Research / Educational Institutions « All senior
professionals-CEO level officers- decision makers Financial Institutions » Regulators & Policy Makers + Govt. Organizations
& PSUs « Industry Associations & Key Members * Diplomats, Foreign Dignitaries, Commercial Attaches » VVIPs from the
Central & State Govt. * Members & Associates of Chemical, Pharma, Food, Paints, Agrochemical, Bio Tech & Chemical
THE MAZADA PHARMA GUIDE Industries
Ajeetkumar Shukla [] 9867864333
42
fe
| ASIEL CH EMPHARMA
Se
INTERMEDIATES
Ethyl 1-(4-methoxyphenyl)-7-oxo-6- ame APIXABAN
ASIEL (4-(2-oxopiperidin-1 -yl) phenyl)4,5,6,7-
tetrahydro-1h-pyrazolo[3,4-c]pyridine-
Aas
H VM Ae VCH PHARMACEUTICALS ENZYMES (§ Mie%UOSCUUc
. 3-CHLORO-5,6-DIHYDRO-1- 536760-29-9 | APIXABAN
e Ortho Phthalaldehyde e Veg Pancreatain(Ip/Bp/Usp) (4-NITROPHENYL)-2-(1H)-PYRIDINONE
© Glycolic
y Acid :
e Animal ‘
Pancreatain(|p/Bp/Usp) 2-(2-Hydroxyphenyl)-4H-1,
3 Nana aaaiASGns 1218-69-5 DEFERASIROX
e 4-Chlorothymol @ Lipase (+/-)-3-carbamoylmethyl)-5- 181289-15-6 | Pregabalin
e Cinnamyl Chloride a methylHexanoicAcid
; © Serratiopeptidase 4-Chloro4-HydroxyBenzophenone 4201-78-3 Finofibrate
e Para Chloro Benzoyl Chloride Amylase ParaChloroBenzophenone 134-85-0 Levocetirizine Cetirizine
e Para Chloro Benzyl Cyanide (R)1-[1-(4-chlorophenyl) 130018-88-1 | Levocetirizine
Pare tive B Ideh e Protease phenylmethy|]piperazine
@
alec riyehonypetizalvenye 7 5-NitroSalicylicAcid 96-97-9 Mesalamine/5-Amino
e Ortho Toluic Acid @ Trypsin Salicylic Acid
‘ : | Formamidine Acetate 3473-63-0 Itraconazole
@ Meta Toluic Acid @ Pepsin
; . ; 2-Bromo-3-Chloropropiophenone 34911-51-8 Bupropion
@ Para Toluic Acid @ Bromelain (+)Chloro phenyl glycine methyl ester 141109-14-4 | Clopidogrel Bisulfate
tartarate salt
@ 3,5 Dimethyl Benzoyl Chloride | e Papain
(D-(+)-Methyl-(2-thienylethamino)2- 141109-19-5 | Clopidogrel Bisulfate
@ Sodium Borohydride Powder e Lactase chlorophenyl)acetate hydrochloride
4-BromophenylAceticAcid 1878-68-8 Bilastine/Macitentan
e Chymotrypsin Ethyl 2-Chloroacetoacetate 609-15-4 Apixaban
Pectinase N.O-Dimethylhydroxylamine Hydrochloride | 6638-79-5 Isoniazid
e@ Lipase R-(+)-N-Benzyl-1-phenylethamine 38235-77-7 Chemical Synthesis for
je iProfease e Diastase Pharma compound
, 4-Nitrobenzenesulfonyl chloride 56553-60-7 Foscmprenavir,Darunavir
@ Amylase @ Alpha-Galactosidase and Amprenavir
© Cellulase © Nattokinase N-Buty! Nitril 544-16-1 New Generation nitrating agents
Phthalide 87-41-2 Pharma Intermediates
Address: 211- B Wing ,Crystal Plaza ,Opp Infinity Mall Link Raod,Andheri(W).Mumbai-400054
Phone: +91 9920082277 | Email: sales@asielchempharma.com,asielchempharma@gmail.com | Web: www.asielchempharma.com
CHLORAMPHENICOL LP.
CHLORAMPHENICOL PALMITATE I.P.
100% SOR Pass Material according to I.P. 2022
For Any Requirements, Please Contact on Above Details
45
AMINE! dtouse of Small Packing Chemicals
READY STOCK
Beerot
Small Packing
B-11 Bombay Trakies Compound, Himaanshu Rai Road Off Hotel Treebo Olive Next, Malad West, Mumbai -400064
Sachin Doshi - Mob : 9969655922 / 9323923076 | Email : sachin2483@rediffmail.com
Office : 53, Highway Avenue, Sai Kripa Complex, Kashigoan, Mira Road-401107
Email : info@diptipharma.com, diptifarma@gmail.com @ Mobile No: 8448085663 / 9930305464
Works : 124/15 GIDC Nandesari Vadodara 391340 Gujarat
46
Jyoti 77 Ora
Polymer Personified
We ee ANS
ra 010)Pe PLU ant
V ¢ INDUSTRIAL CHEMICAL
* PHARMACEUTICAL
V - GREASE & LUBRICANTS
¢ ADHESIVE
V - DYE PIGMENTS
; * PESTICIDES
| oe [Are VY COSMETICS
www.jyotiglobalplast.com
ss
[&] Find the complete value chain from the initial research
Aa ie 1
47
| SHRIYA PHARMA & SURGICAL
IMPORTERS & AGENTS: BULK DRUGS / CHEMICALS / SOLVENTS
PRODUCT LIST
@ ACEBROPHYLLINE ® ESCITALOPRAM OXALATE IP @ PANTAPRAZOLE SODIUM IP
@ ACECLOFENAC BPIIP ® ETODOLAC IP @ PARACETAMOL IP
® ALPHA LIPOIC ACID USP 28/30 ® ETORICOXIB IP @ PAROXETINE HYDROCHLORIDE HEMIHYDRATE IP
® AMBROXOL ® FAROPENEM SODIUM @ PREGABALIN LP.
® AMOXYCILLIN TRIHYDRATE BP/IP COMP ® GLICLAZIDE BP/IP @ PROCHLORPERAZINE MALEATE IP
@ ATROVASTATIN CALCIUM IP @ ISOXSUPRINE HCL IP @ QUETIAPINE FUMARATE IP
® AZITHROMYCIN IP/EP/USP ® LEVO SALBUTAMOL SULPHATE IP ® RANOLAZINE
® BACLOFEN IP ® LISINOPRIL USP ® ROSUVASTATIN CALCIUM IP
® BETAHISTINE DI HCL IP ® LOSARTAN POTASSIUM IP/USP ® SALBUTAMOL SULPHATE
® BROMHEXINE HCL BP/IP @ LULICONAZOLE IP ® SALBUTAMOL SULPHATE IP/BP
® CARBIDOPA IP ® MEFENAMIC ACID IP/BP ® SULTAMYCILLIN TOSYLATE
© CEFIXIME TRIHYDRATE IP (COMPACTED) ® METFORMIN HCL IP / BP ® TELMISARTAN IP/EP/USP
® CEFTRIAXONE SODIUM STERILE USP/IP ® METHYL COBALAMINE I.P @ TENELIGLIPTIN
® CEFUROXIME AXETIL AMORPHOUS IP © METOPROLOL SUCCINATE USP/IP @ TERBINAFINE HYDROCHLORIDE EP/ USP/BP
® CHLORZOXAZONE USP © MONTELUKAST SODIUM IP ® TERBUTALINE SULPHATE IP.
® CITICOLINE SODIUM IP © NADIFLOXACIN IP ® TICAGRELOR
® D-BIOTEEN USP/EP © OFLOXACIN IP ® TRANEXAMIC ACID IP
® DEFLAZACORT © ORNIDAZOLE IP ® URSODEOXYCHOLIC ACID IP/EP.
® DICYCLOMINE HCL IP/BP @ OXACEPROL ® VILDAGLIPTIN
43, Hanifabai Manzil, Room No. 18, Ground Floor, Kapad Bazar, Mahim, Mumbai — 400 016
Tel.: 24472816 | Fax: 24472817 | Mobile: 9323766144
Email: shriya97@hotmail.com / shriya@mtnlI.net.in
oes
pur The B Best Quality
i of
» G ‘ is
Safe GIVIP, ISO:900186&14001
1S0 9001 REGISTERED Certified Company” oe eee
VARAHI INTERNATIONAL
BULK DRUGS & CHEMICALS MANUFACTURER & EXPORTER
Nr. Old Rudy Coach & Rly. Crossing, Opp. Naroda Rly. Statio, N.H. No.8, naroda, Ahamedabad - 382330. Gujarat.India
Phone : (+91) 79-22844991,22844992 Fax : (+91) 79-2282 0931, 2755 2222
Email :vickyxx7 @rediffmail.com, info@varahiinternational.com, pratik@varahiinternational.com
Contact : Mr. Vivekanand Raval Mobi : 09879988961, Mr.Pratik Raval Mobi : 09724596079
Visit us at : www.varahiinternational.com
48
0 PROGRESS LIFE SCIENCES PVT. LTD.
Pro ress Landline: +91 22 4978 1414 | Email: marketing@progresslifesciences.com, office@progresslifesciences.com | Web: www.progresslifesciences.com
Corporate Office: Platinum techno park, 225- 2” floor, Bhagwan Mahaveer Road, Plot no. 17,18, Sector 30A, Vashi, Navimumbai-400703
Life sciences Pvt.Ltd. Manufacturing: J-311, MIDC, Bhosari, Pune — 411026 Maharashtra, India
IP/ BP/ EP
Respiratory EP
BP/ USP -
Tech
Anti-Psychotic
INH Tech
Anti-Allergic
USP Tech
Betahistine EP/ USP 2
Canagliflozin INH Tech Commercial
INH DMF available Commercial
Anti-Diabetic INH e Under
INH = Under
Sitagliptin INH/ USP - Under
Anti-Ulcerative USP DMF available Commercial
HCI IP/ USP ba Under
Oleate - IP/BP/USP IP/ BP/ US Tech Commercial
Excipient
Chlorobutanol PEP/ BP/ USP = Under
INH Tech Commercial
Nutrition
Iron Sucrose INH 2
Nitroxinil - BP BP a Under
Anti-Infective Nitazoxanide INH/USP INH/ USP - Under
Oxyclozanide - BP BP - Under Development
Note : All transactions are carried out in conformity with patent laws applicable in the buyer’s country.
Responsibility with respect to third party patent rights in a specific country lies exclusively with the buyer.
HIGH PRESSURE 45000 PSI MICROFLUIDIZATION HOMOGENIZER ULTRA FINE POWDER THE MICRON AIR JETMILL
Application Application
» Emulsion, liposome, preparation of nano suspension > API crushing
> Extraction of intracellular substances (cell disruption) » Suspemnsion solid powder crushing
> mRNA LNP Vaccines > Inhaler crushing
» Dv90<50-200nm@1 pass }> Dv90<2-5micron @1 Pass
> The internal equipment can realize CIP / SIP + This miners dedicated to the production of DPI products
> Transfer chamber/ RTP valve / ct- Valve / optional > Larger impeller surface area increased energy input
> Integrated VHP sterilization systme > Bottom driven impeller, more stable during mixing process
‘> High mixing uniformity Deviations less than 1%
Product Specification > Integrated Class A environment monitoring system
49
Magnesium Stearate IP/BP/USP
jrdc
Sodium Starch Glycollate IP/BP/USP
(Maize, Potato) MANUFACTURER OF
PHARMACEUTICAL
Microcrystalline Cellulose IP/BP/USP & COSMETIC
(101/102/112) RAW MATERIALS
50
HRITIK CHEMICALS PVT. LTD.
Unit No. 1301-1304, 13" Floor, ‘B’ Wing, Dhanashree Heights, Bldg. No. 42, Azad Nagar 2,
Off. Veera Desai Road, Andheri (West), Mumbai- 400053
Tel: 022-67115900 | Email: pharma@hritikchemical.com; enquiry@hritikchemical.com
Contact:
Azeocryst Organics Pvt Ltd.
www.azeocryst.com
1-G, Siddhivinayak Chambers, Opp. M.I.G Club, Gandhinagar, Bandra East, Mumbai-400051
53
(For Your Divet Fuport , Competitive Price,
Assured Quality With Good Service Please Contac Us :
VIURTUIWVAD LJ neanass
4, kS
STRONG API'S
AMPICILLIN COMPACTED CLORTRIMAZOLE
AMOXICILLIN TRIHYDRATE COMPACTED HEPARIN SODIUM
AZITHROMYCIN TRIHYDRATE METAMIZOLE SODIUM
AMOXICILLIN TRIHYDRATE POWDER ORLISTAT
DOXYCYCLINE SPIRAMYCIN
GENTAMYCIN SULPHATE SUCRALFATE
CEPHALEXIN VITAMIN B2 FEED GARDE
ERYTHROMYCIN THIOCYANATE VITAMIN B2 PHARMAM GRADE
CYANOCOBALAMIN [VITAMIN B12] VITAMIN Bo
ENOXAPARIN SODIUM
*WE CAN OFFER MANY OTHER API'S , KINDLY SEND YOUR REQUIRED API'S TO OFFER*
56
HAP ENTERPRISE
DEALING IN : PHARMACEUTICAL RAW MATERIALS, CHEMICAL, INORGANIC CHEMICAL, INTERMEDIATE
WAREHOUSE : GALA NO. 19 & 20, 1ST FLOOR, GHAR NO. 1055, BHATIYA COMPLEX, PURANA VILLAGE, BHIWANDI - 421 302.
Address : SHOP NO.4, GORAI DISHA CHS LTD., L.T. ROAD, GORAI-2, PLOT NO. 50, OPP. SHANTIDHAM ASHRAM, BORIVALI (W), MUMBAI - 400 092.
© Email : info@hapenterprise.com ¢ 022-28677670 / 71 / 72 © Mob. : 9324265877 / 9324517446
57
VISdOOVWYVHd LSALVT SHL Yad SV LSIT LONGOYd AAOV SHL «
ANINOIHLAWONOW ONIZ @ ALVLYVdSV1 SNINIDUV-1 ©
( SNONINOWNAW ) 2-7 NINVLIA @ NIONILAYLOS! @
( 5dVY9S VIYVHd ) %05 3 NINVLIA @ * LOVYLXA / Y4AGMOd ONASNID @
SSYSHdSONOIN / NIONILSYL @ YAGMOd (W719) GOW DINFTONIIVNWVS @
YALSA YSHLO GNV TOYSLSOLAHd @ YAGMOd (Wd3) GIOV DIONAVINAdVSOOIS @
XIW3ud SANOIGVNAWOLAHd @ YAGMOd 9A ( VHC) GIOV DIONYXSHYSO00 @
YAGMOd lov ALLV4 € VOANO @ ALVAINS NILIONGNOHD @
ALVLADV ONOW SANISAI @ TOYSLSVLAd @
Et ho),
Bie he] ie he) a bode Ba)
TAHLSW / SLVONVOSGNN FLVYLYVLIG ANITVNSNGNVHON @ JOIQVYLSS TANIHL3 @
/ AINSHINVNG SNOMEISOISAL @
719-38] VEIN GREINER
SUVONYOS /B1VNOIdOUd
TANSHd SNOTONCNYN @
SUVOZNIR
| SIVNOIdO¥d @
TANSHd / SLVYSTVA / TOIGVYLSS @
TAHLAW / SLVL3OV SNOTOSINGIYd @ TAYLSADYONOAS @ FNONAYAIdSOUC @
FIVLIOV/ SNOMALSIHLYON @ WNIGOS ANIXOUAHI-1 @ JauLSIN0SIC @
TAULSIONON @ FLVLSOV INOSILYODONGAH @ FIVISOV INONSLONdAD @
ANINVLNADYON @ ACIYALSVNIJ @ ALVELYVLIG SINIIVNAYCY @
SdIOUALS 8 SANOWNYOH
SNOILVOISIODAdS YAWOLSND 8 VAdOOVWYVHd LSALV] YAd SV ATEVIIVAV «+
NIOVYLIOVE ONIZ @ SNONGAHNV FCINVLNIS @
JOH SNITOZVLSNOTAX @ / ONOW NIOLNVENIOULIN @ INIdAZVEYVOISS @
L YNINVLIA @ ALVIINS TAHLAW ANIWSILSOAN @ FCIMALSVLNG @
TIWVdVYsA @ FLVYLIN / INMIOZVHdVN @ ALVYUCGAHONOW ANITOADAXOG @
FNAYNALAVINL @ FNIYNdOLdVOUAW @ OH SNINVdOd @
FCINASYOL @ NINOLV1SW @ FNINVLNGOG e@
IOV OINVNASIOL @ WNIGOS SNIXOMNAHL -1 © WVuI-SINsId @
FCINOCMVHL @ JOH NIOVXO143N01 @ WAZVIL 110 @
FLVOATD OWOND WNIGOS @ FLVNOSYVO WNIHLN e@ FCIMVHOOVS
NILNY @ FCIWONN1431 @ / ALVOZN39 WNINOLYNAd @
FCGINONA SNINDILSOGIYAd @ ANIDINLOWY1 @ ACIXOdAZVIGYOTHO @
JIOVENOIHLTAdONd @ NVLUVSASHI @ FNISLSIOONNVO @
TALNVNDIZVud @ FLVOWVd / 10H ANINVYdINI! @ ANIGAZVNVEYVO @
JOH Id SIOXAdINVYd @ JOH SNIZAXOUNGAH @ NVLYVSSCNVO @
JNOGINASUld @ FIWONd) ALVYVINS 1O10NdOSIE @
JNOZVNSHd @ FNOYNSLSADONdAXONGAH @ N3dO10VE @
JNINNGYS WYdOGNIYAd @ JNONINOONCAH @ FNILSXOWOLY @
FNIdAZVEYVOXO @ OH NOULSSINVYD @ FNONVGOIN @
FNOZVYENSOULIN @ NIOVXO141LV9 @ WNIO1V9 SIVSONdNVOV @
LSI LONGOUd IdV
Wwod'plso1ueBojaausyoued
mmm / WOd'solUeHioJ|aaysuoUed
MMM :Ga/\\ @ Ul'solueHJojsaysyoued@pyjod :1ewy
6Z6E90ZZ-ZZ0 “ON XC @ BLZH/ELZP/ZLZr/ELZv/PLZv/ OOTHE9B9-ZZO :Ud
"69000r-!equun| ‘(Jsey) WeYpuy ‘Web WaL"ddoC ‘Bieyw] eypeud’S'N ‘JOld SUB|OS UMO}GNH gE}-ZE) :Ppy
(Auvdwoy) poyn.19D dD O'H’M)
GU. LITT SOINVOYO THHHSHONVd
(¢ OUR SPECIALITY AND SELF IMPORT ITEMS (1KG & 5KG PACKS AVAILABLE) \
NEUTRACEUTICALS PHARMACEUTICALS CHEMICALS
GINKGO BILOBA EXTRACT 24.6 L-GLUTATHIONE REDUCED
SPIRULINA POWDER KOJIC ACID & KOJIC ACID DIPALMITATE
GINSENG EXTRACT & POWDER SOD. HYALURONATE (HYALURONIC ACID)
GRAPE SEED EXTRACT 95% ARBUTIN & CREATININE
GREEN TEA EXTRACT 95% PERMETHRIN LIQUID
SILYMARIN 80% UV DAB BOVINE COLOSTRUM POWDER
OMEGA 3 FATTY ACID (VEG) (11 DHA: 33EPA)
DHA (DOCOSAHEXAENOIC) 10% & 20% VEG. CARBONYL IRON (TAB. /SUSP. GRADE)
EPA (EICOSAPENTAENOIC ACID) VEG SOURCE FERROUS ASCORBATE DC GRADE
LYCOPENE POWD & LIQ (6% & 10% NATURAL) CALCIUM ASPARTATE
LUTEIN POWDER 10% CALCIUM OROTATE
CHLORELLA POWDER CALCIUM CITRATE MALATE
BETA CAROTENE 10% & 20% & 30% NATURAL FRUCTO OLIGO SACCHARIDES (FOS)
RESVERATROL EXTRACT STABILIZED OXYCHLORO COMPLEX
ASTAXANTHIN 10% POWDER
CANTHAXANTHIN (SOC OPHTHALMIC PRESERVATIVE)
CRANBERRY EXTRACT ZEAXANTHIN 10% POWDER
SOY ISOFLAVONE 40% EXTRACT L-ORNITHINE L-ASPARTATE (LOLA)
MILK CALCIUM POWDER
RUTOSIDE TRIHYDRATE 95% PHARMACEUTICALS AND BULK DRUGS
QUERCETIN
COENZYME Q10 99% VITAMIN K1 LIQUID (PHYTOMENADIONE)
TOCOTRIENOLS 50% VITAMIN K2-7(MK7) MENAQUINONE
BLACK CURRENT EXTARCT VITAMIN K2 (MK4) MENATETRENONE
TROXERUTIN DEHYDROEPIANDROSTERONE (DHEA)
ELDERBERRY EXTRACT SODIUM FEREDETATE BP
PIPERINE 95% MONOSULFIRAM
PINE BARK EXTRACT DUTASTERIDE & FINASTRIDE
MULBERRY EXTRACT
BROMELAIN 2400 GDU NIMODIPINE EP
CAPSICUM OLEORESIN 8% LIQUID MELATONIN 99% POWDER
MIXED CAROTENOIDS 10%, 20%, 30% FLOUROMETHOLONE
BLACK RISE EXTRACT DISULFIRAM
GAMMA LINOLENIC ACID (GLA POWDER) CALCIUM DOBESILATE EP
MICROCRYSTALLINE HYDROXYAPATITE COLLAGEN PEPTIDE
COMPLEX (MCHC) COPPER GLUCONATE
BILBERRY EXTRACT CALCITRIOL
IDEBENONE
ACITRETIN 99% (100 MG, 1 GM & 100 GM PACK) ALFACALCIDOL
ALPHA-GPC 50% (5 KG & 25 KG) DEFLAZACORT
NATTOKINASE 20000FU/G D-MANNOSE
.
MTNL SANCHAR HUT, NEAR BHAGWAN MAHAVIR HOSPITAL, PITAMPURA, DELHI-110034
Email id: - northindiapharma@yahoo.com * Website: www.nipindia.in
59
COSMIC CHEMICALS
MANUFACTURERS & EXPORTERS OF
INORGANIC & OTHER METAL SALTS
MUMBAI OFFICE: |2,Veena Apts, Opp. Bhagwati Hospital, S.V.P. Road, Borivli (WW), Mumbai - 400 103, INDIA
Tel no. 0091-22- 28911481 / 28958550 /35525803 Fax No. 091 - 22 - 28934619
E-Mail: costpr@mtnl.net.in / cosmicvjb@hotmail.com Web Site: http://www.cosmicchemicals.com
Tee RY MCCUE Le MC
60
API PRODUCTS API PELLETS
® Bilastine ® Levocetrizine @ Dex Rabeprazole Pellets
® Cinnarazine BP Hydrochloride IP @ Dex Lansoprazole Pellets
@ Cinitapride Hydrogen ® Montelukast IP @ Esomeprazole Magnesium
Tartrate Trihydrate Pellets
@ Omeprazole
® Clopidogrel IP / USP magnesium USP ® Itraconazole Pellets 20%,
® Citicolin 22%, 40%,44%
@ Omeprazole
®@ Dapagliflozin IP/USP/BP @ Lansoprazole IP/ Usp Pellets
@ Diacerin @ Omeprazole Powder IP/ Usp
® Pantoprazole
Pellets
® Domperidone IP Sodium IP/USP/BP
® Dex Rabeprazole IP @ Pantoprazole Sodium Sesq
® Posaconazole IP/USP/BP Pellets
® Dexlansoprazole
®@ Pregablin @ Rabepraz i |
® Esomeprazole 3 Pellets ole Sodium IP
Magnesium @ Rabeprazole
® Famotidine Sodium IP @ Pantoprazole (EC) &
. Febuxostat IP. © Sildenafil IP Domperidone (EC) Pellets
‘ : @ Omeprazole (EC) &
NSHEETAL
\. @ Calcium Carbonate ®@ Thio Phenol
CHEM
= Small eT Ne uevace
KRONO Corporate Office & Works : Block No. 284 | Village: Dabhasa | Padra | Dsit: Vadodara | Gujarat | India.
Mob: + 93132 31074 / 9909966408 | Fax: +91 2662 244088
Email: sales@kronoxlabsciences.com, info@kronoxlabsciences.com
Kronox Lab Sciences Limited Website: www.kronoxlabsciences.com
64
Oxford
Admin Off: Unit No 12, 1 Floor, Neminath Indl Estate No. 6,
Navghar, Vasai East, Dist Palghar- 401210
TEL : 91-250-2390032 / 2390989
Range of Email: sales@oxfordlabchem.com, info@oxfordlabchem.com
Web: www.oxfordlabchem.com / www. oxfordlabfinechem.com
Laboratory Chemicals
MANUFACTURERS OF WIDE RANGE OF LABORATORY CHEMICALS
A www.chemkart.com | info@chemkart.com
oe 501, K.L Accolade, 5th Floor, 6th Road, Near R.K.Hospital,
Above Captain Gym, Santacruz East, Mumbai-400055, India
66
Committed for Quality Services Since 1957
®@ Acetylsalicylic Acid / Asprin @ Methyl Paraben Sodium I.P. @ Papain USP (50000 USP/mg)
1.P./ B.P/ USP ® Methyl Salicylate I.P./ B.P./ USP @ Papain x / 2x/ 4x/ 5x
/ 8x
@ Beta Carotine 20% and 30% ®@ Octyl Salicylate @ Propyl Paraben I.P.
@ Bromelain 2400 GDU @ Papain 1:350 BPC @ Propyl Paraben Sodium I.P.
@ DHA 10% And 20% @ Papain Refined @ Ruthoside
@ Homosalate @ Papain I.P. @ Salicylic Acid I.P. / B.P / USP
@ Lutein Powder 10 % @ Papain LG 200 @ Sodium Salicylate |.P.
@ Lycopene 6% 10% @ Papain USP/NF ®@ Trypsin BP/ USP
@ Methyl Paraben I.P. @ Papain USP 6300 © Trypsin Chymotrypsin Mix (6:1)
S
67
Enterprise
Delivering Quality Products
Import & Trading | Pharmaceutical Raw Material & Chemicals
PRODUCT LIST
“+ Aspartame FCC/USP ¢* Ibupprofen IP / BP
“+ Acesulfame K “+ Levofloxacin Hemihydrate IP
“+ Alpha Lipoic Acid “+ Lumefantrine IH / USP
¢¢ Azithromycin IP / USP ¢* Levoctrizine HCI IP
“* Aceclofenac IP “* Linseed Oil
“+ Artemether INT Ph. / USP «+ Levoctrizine HCI IP
¢ Amoxycillin IP ¢¢ Light Liquid Parafin (LLP)
“¢ Ambroxol HCI IP “+ Methylene Chloride (MDC)
“+ Benfothiamine ¢* Mannitol Ip / BP / USP / Ph.eur
“+ Bees Wax “+ Methylcobalamine IP
“+ Biotin “¢ Niacinamide IP / BP
“+ BHA/ BHT “* Neotame
“+ Cross Povidone ¢* Ornidazole IP
“+ Caustic Soda Flakes “¢ Ofloxacin IP
“+ Caustic Potash Flakes “+ Paracetamol IP / BP
“+ Citric Acid Mono “* PVPK-30
“* Citric Acid Anhydrous “+ PG- Tech
“+ Clotrimazole IP/BP/USP “+ PG-USP
¢¢ Calcium D Pantothenate ¢* Polysorbate 80
“* Ciprofloxacin IP / USP “+ Pantaprazole Sodium IP
“+ Cefixime IP / USP “+ Piracitam IP
“* Cefpodoxime Proxetil IP “+ Quinine Sulphate USP
“+ Cefuroxime Axetil IP “+ Quinine HCI BP
¢¢ Clindamycin Phosphate /HClI ¢* Quinine Di-HCI BP
** Cloxacillin Sodium IP “* Sucralose USP
“+ Clarithromycin IP “+ Sucralfate JP / USP
“+ Colours - Food “* Sorbitol 70 % IP
“+ Colours - Pharma “+ Soda Ash
«+ Di Propylene Glycol (DPG) ¢* Telmisartan IH / IP
«+ Domperidone IP ¢* Vitamin A Palmitate 1.7 Miu
“* Diclofenac Sodium IP/ BP “ Vitamin A Acetate Powder
“+ Diclofenac Potassium IP/ BP ¢ Vitamin AD3
“+ Dextromethorphane Hydrobromide (DMR) «+ Vitamin C Plain IP
«+ DiCalcium Phosphate (DCP) “+ Vitamin C Coated IP
“~ DMF ¢* Vitamin B1 Mono (Thiamine Mononitrate)
“¢ Erythromycin Stearate IP ¢¢ Viramin B1 HCI Thiamine Hydrochloride)
“¢ Fluconazole IP / USP ¢ Vitamin B2 (Riboflavin)
¢¢ Folic Acid IP ¢* Riboflavin 5 Phosphate Sodium IP
“+ Glycerine CP/IP/USP “+ Vitamin B6 (Pyfidoxine HC 1)
“+ HPMC-E-5 ¢* Vitamin B12 (Cyanocobalamine )
“+ HPMC-E-15 “ Vitamin D3
“+ HPMC-K-100M ¢* Vitamin E Liquid (DL-Alpha Tocopherol)
“+ Hyoscine Butyl Bromide IP/ BP “+ Vitamin E Powder 50 %
¢¢ Iso Propyl Alcohol (IPA) ¢* Xanthan Gum (200 Mesh)
C-32 Aditya Villa, Near Prabhuta Hall, B/h SBI Bank, Ramakaka Temple Road, Channi,
Vadodara - 391740, Gujarat (India). M: +91-9426985832 | Email: contactus@malayenterprise.in
68
PRODUCT LIST:
CORE PRODUCTS: ® Methylene Chloride (MDC) @ Paraformaldehyde 96%
® Propylene Glycol (PG) - Technical @ Polyols
@ Hydroquinone (HQ) Grade @ Polypropylene Glycol (PPG)
@ Tert-Butylhydroquinone (TBHQ) ® Tetrahydrofuran (THF) © Polysorbate 80 (Tween 80)
@ Propionic Acid @ Toluene @ Sodium Formate
@ Butylated Hydroxyanisole (BHA) @ mixed-Xylene @ Sodium Propionate - Food Grade
@ Butylated Hydroxytoluene (BHT) ® Ortho-Xylene @ Sodium Selenite
@ Tert-Butylcatechol (TBC) @ Stearic Acid
@ lodine A) 7 el eV ee ® Toluene Diisocyanate (TD!)
® Tolyltriazole
@ Acetophenone @ Vanillin
® Activated Carbon ® Xanthan Gum
@ Acetic Acid @ Amprolium
Contact Details:
69
GA Cry stal Dharma
e ALBENDAZOLE CP / IP e ETHOPABATE BP VET e OXYCLOSANIDE BPV
e AMPROLIUM BP VET e ETHOXYQUINE 66.6% @ OXYTETRACYCLINE BP
e BUTAPHOSPHAN e ENROFLOXACIN BASE e PRAZIQUENTEL USP
e CARPROFEN e FENBENDAZOLE BP / VET @ RAFOXANIDE BPV
e CLOPIDOL B VET e FLUNIXIN MEGLUMIN @ STREPTOMYCIN SULPHATE
e CLOSANTEL BASE e FURAZOLIDONE BP @ SULPHAQUINOXALINE
e COLLISTIN SULPHATE e@ |VERMECTIN EP 2000 SODIUM
e DIAVERIDINE HCL e LEVAMISOLE HCL BP e TOLTRAZURIL
e DL-TETRAMISOLE e NEOMYCINE SULPHATE e VITAMIN ALL
MUMBAI, MAHARASHTRA.
Tel: 022-25927631 / 67107631 Fax: 022-25925874 Mob: 09820141331 / 09322218073
Email: crystalpharma9@gmail.com / hls_crystal10@yahoo.com Website: www.crystalpharma.co.in
/
al FLT: —NLa
PHARMA CHEM
\ I
DEALERS IN PHARMACEUTICAL RAW MATERIALS
ITEM LIST
& CHEMICALS
AO_
x
EXIPIENTS
@ CROSS CARMALLOSE SODIUM IP/BP/US P MAGNESIUM STEARATE IP/BP/USP @ MICRO CRYSTALLINE CELLULOSE &
¢@ SODIUM STARCH GLYCOLATE IP/BP/USP ALL GRADE IP/BP/USP
Shop No. 10, Sanskruti 1, Near P.G. Vora School, Poonam Vihar, Mira Road (E), Dist. Thane -401 107.
Off: 022-35603596 / 9326250363 Mob: 9820777805
Email: hitenpharmachem@gmail.com
1
Contract Manufacturers / Suppliers / Importers of:
hemicals for Life Sciences, Discove Development and customized intermediates and performance materials
INORGANIC SALTS RESEARCH CHEMICALS
* Ammonium Ferrous Sulphate . Nickel Chloride Anhydrous * Acetanilide
* Barium Sulphate ® Nickel Sulphate Hexahydrate * Chlorotrimethylsilane
Cuprous Chloride ° Potassium Dichromate * Diiodomethane 99% - Stabilized with
Cobaltous Nitrate Hexahydrate ° Potassium Permanganate Copper 98%
* 3,5-Dimethylpyridine
Copper Sulphate Pentahydrate . Potassium Metabisulphite
* Ethylenediamine AR
Ferric Chloride (Anhydrous) AR/LR Potassium Chromate * p-Toluenesulphonic Acid Monohydrate 98%
* Ferrous Sulphide Sticks * Sodium Dichromate Dihydrate * Piperidine Hydrochloride 99%
* Lead Nitrate AR/LR * Trisodium Phosphate (Anhydrous) * Pyridine-2-Carboxaldehyde 99%
* Lead Monoxide * Lead Oxide (Red Lead) ¢ Vinyl Bromide Solution-1 M in THF
Recent import / Local Products from Exstocks
* Tri Methyl Orthoformate (TMOF) ¢ Hexylene Glycol * DOM/DBM/DOA/DBP (Phthalates)
* Di Methyl Malonate (DMM) * N-Butyric Acid / Iso Butyric Acid * |IPDA/1,3-BCP/ Benzene Sulphonyl Chloride/
* Benzyl Cyanide * Morpholine Hydroxy Ethyl Piperazine
* Cyanuric Acid * Dj Ethyl Amine / Di Methyl Amine/ « LtTariaric Acid
* Cyanuric Chloride Mono Ethyl Amine * Butylated Hydroxy Toluene (BHT) / Butylated Hydroxy Anisole
* EMME * N-Butyl Methacrylate * Magnesium Turning
* Malonic Acid / Malononitrile * Monoglyme / Diglyme * SLS Powder/ Needles (Sodium Lauryl Sulphate)
* Ethyl Cyano Acetate « Ammonium Per Sulphate/ * AOS L/ XI - 46 (Alfa Olefin Sulfonate)
* DCDA Potassium Per Sulphate ¢ SLES L - 24 230 (Sodium Lauryl Ether Sulfate)
* Piperidine * PEG-200/ 400/600 / 4000 * Glycerine C.P/1.P
* Dilso Propyl Ether (DIPE) (Poly Ethylene Glycol) * Oleic Acid Lubolic Economy Grade
* Di/Mono Cyclohexy! Amine Distilled Coconut Fatty Acid
* Oleic Acid Lubolic 20 Grade
* Perchloro Ethylene Hydrogenated Palm Oil
* Ginol 1618TA (Ceto Stearyl Alcohol)
* Lauric Acid / Myristic Acid / Palmitic Acid Fully Refined Paraffin Wax
* Ginodet 427 EU (Lauryl Alcohol Ethoxylate 7 Mole)
* Stearic Acid / Caproic Acid / Capric Acid Maleic Anhydride
« N-Methyl Benzylamine
. Caprylic Acid / Melamine MTBE (Methyl Tert Buty! Ether)
.
Thiourea / Tertiary Butyl Amine / Propylene Glycol 2-Ethyl Hexyl Acrylate FINE CHEMICALS AND REAGENTS
, Benzaldehyde / Benzophenone / Citric Acid Paraformaldehyde 91% /96%
. Epichloro Hydrine / Lithium Carbonate/ N-Propyl Acetate * Diisobutyl Ketone, Technical Grade
Lithium Hydroxide/ Lithium Aluminium Hydride Para Octyl Phenol * Fluoroboric Acid 48% Aqueous
* Methyl Methacrylate Para Xylene * Indicator Paper (2.0-10.5)
* Butyl Acrylate PTMEG 1000
/ 2000 * |sopropanol 70
* Methacrylic Acid Pentaerythritol * Orthophosphoric Acid 88% - Hipure
* HEMA (Hexa Ethylene Methacrylate) Tri Chloro Ethylene * Potassium Bromide IR
* AEEA (Amino Ethyl Ethanolamine) Thiophenol / Thioglycolic Acid/ * Perchloric Acid 70% AR (For Diamond Industry)
* Butyl Glycol/ Acetate Thioacetic Acid * Silica Gel 100-200 Mesh
* Ethyl Glycol / Acetate * lodine * Silica Gel Self Indicating (Coarse)
* Methyl Glycol (Acetate) * I|midazole * Silica Gel 60-120 Mesh
HPLC SOLVENTS
* Acetone HPLC * Tetra Hydrofuran HPLC * Acetonitrile HPLC * Methanol HPLC * Water HPLC « n-Hexane HPLC
* Methylene Di Chloride HPLC * Vanillin * lsopropanol HPLC * n-Propanol HPLC * CTC HPLC
REGULAR PRODUCTS
Acetonitrile/Acetophenone/Acetyl Acetone/Adipic Acid/Alu, lsopropoxide/Ally| Alcohol/Allyl Amine/Ally| Chloride/Ally! Glycidyl Ether/Amino Guanidine Bicarbonate/
APS/PPS/Anthraquinone/Benzyl Amine/BKC-50%/1 ,3-BCP/Bronopol/Carbon Di Sulphide/Carbon Tetra Chloride/Chloroform/Citric/Cyclohexanol/DBNPA/Diethy| Ether/
DEM/DES/DEG/DMC/DMDAAC/DMF/DMSO/MDI/DIBOC/EAA/ECF/MCF/THF/PCF/EDA/HAS/Glutaraldehyde-50%/Guanidine-HCl/HH-80%/Hydroxylamine-HCl/
ISO Amyl Alcohol/Isophorone/Itaconic Acid/2-MBT/MSA/MSC/Methanol/MAA/Methy! Cellosolve/MEK/MPK/ME G/MMAA/Nitrobenzene/NMP/CMIT-MIT-14%/OT
Liquid/Butyl Acetate/PTSA/Petroleum Ether (40/60/80/100/120)/Pot. Permanganate/Propionic Acid/Propionic Anhydride/Sod. Borohydride/Sod. Chloride/SLS/S. Metal/
SMO/Sod. Pot. Tartarate/Sod, Sulphate/Solvent C9/TBA/TAA/TBC/TEA/TEOF/TDI/Trimelitic Anhydride/Vitride/1 ,2,4-Butanetriol/Dodecylguanidine Monohydrochloride/
Dimethylcarbamic Acid-N-methylmethanamine/2-Ethyl-2-oxazoline
i. = lease Contact Mr. Shr: Pattani:
\ We are just > ye
S betterthan , % ’ . c
< ‘the best | YMUa
rw Importers of Speciality Chemicals
M-003, Panchsheel Garden, JKLMN CHS. Ltd., Mahavir Nagar, Dahanukar Wadi, Kandivali (West), Mumbai - 400 067.
Tel: +91-22-28020221/28020222/28020223 + Mobile: 09223433613 + Fax: +91-22-28087501 + Email: sigmachem9@gmail.com
72
~N 2 yp WPHER ) Hall
\ Ye= fvoeaasad
| 2023 7 A-82
m Shagun
- Pharmaceuticals r“ Zefelabs
APIs & Excipients Mfg. of Virgin Linseed Oil BP
Y www.shagunpharma.com www.oilin.in
AMRUT ENTERPRISES
Dealers in Chemicals & Solvents
DEAL IN FOLLOWING ITEMS:
@ Acetic Acid GNFC Intact
/ Jubilant Intact © GH17 @ Soda Ash Light (Tata / Nirma / GHCL/
Dicyandimide @ Glycerine (Ip / Cp / Bp/ Usp ) Imported )
@ Acetic Acid Glacial 99% @ Hyarogen Peroxide— Gaci / Np!/ @ Sodium Bi Carbonate Technical/
@ Acrylamide Meghman / IP / Imported Refined, Tata / Imported
@ Alum Lumps/ Powder | @ Hydrated Lime Powder (All Grades) @ Sodium Metasilicate (Local / 5h20/
@ Aluminium Sulphate Powder (NonFerric Hydrogen Peroxide 50 % intact NPL/ 9h20)
4/16 , Rajendraprakash Chs Ltd, S.L.Road , Junction Of S.L.Road & R.P Road , Mulund (W) ,
Mumbai- 400 080 , Maharashtra India
73
b Sohyog Lifesciences
501, Sanjar Enclave, Above Mahindra Showroom, Opp. Milap PVR, S. V. Road, Kandivli (W), Mumbai - 67.
Tel: +91 22 4011 3538, 2865 1412, 4005 8604 | Email: sohyoglifesciences@gmail.com
Dhruvil Parekh : +91 99304 61006, +91 9372073783
Product List
74
KAMLESH ENTERPRISE
D/003, Vijay Park Iraniwadi, Kandivali west, Mumbai-400067
Rajesh Goradia- Mob: 9820019738/9223433306
Email:kamlesh_enterprise@yahoo.com / Rajeshgoradia@gmail.com
PRODUCT LIST
® Emulsifier 4.5(Alphox 100) @ Poly Ethylene Glycol (Peg 200)
@ Emulsifier 9.5(Alphox 200) @ Poly Ethylene Glycol (Peg 400)
® Emulsifier 30(Alphox 500) ® Poly Ethylene Glycol (Peg 600)
® Benzoic Acid 99% Tech Grade @ Poly Ethylene Glycol (Peg 4000)
® Butyl Cellosolve @ Poly Ethylene Glycol (Peg 6000)
® Butyl Carbitol @ Poly Ethylene Glycol (Peg 1500)
@ Castor Oil 40 (Castrox-200) @ Polysorbate 80 (Sorbox -80 / Twin-80)
® Cetomacrogol 1000(Cetodet 500) Ethoxylate
@ Ethyl Carbitol (Igtol 12016 E) ® Propylene Glycol
® Ethyl Cellosolve(igsol 12026 E) ® Toluene (Bulk)
® Ethyl Cellosolve Acetate (Igace 6701 E) @ Methyl Ethyl Ketone (Bulk)
® Methyl Cellosolve ® Butyl Acetate (Bulk)
@ Maleic Anhydride @ Acetic Acid (Bulk)
lan
rN asitle
Akshar Chemicals India Pvt Ltd.
F-8, Ground Floor, Avtari Industries, Hatkesh Udhyog Nagar, Mira-Bhayander Road, Miraroad (East), Thane-401107
Mobile: 9833878293 / 9987744529
Website: www.aksharinternational.in
@ Email: aksharchem.mum@gmail.com / info@aksharinternational.in
Product List
@ Acetonitrile (ACN) @ Fromic Acid @ Naphthalene Powder / Balls
@ Acid Slurry (Labsa) @ Sodium Sulphate @ Benzene
© Castor Oil @ Polyvinyl Alcohol (PVA) @ Benzyl Alcohol
@ Tetrahydrofuran(THF) @ Coco Diethanolamie (CDEA) @ Dimethyl Formamide (DMF)
© Caustic Soda Prills & Flakes @ Trisodium Phosphate (TSP) @ Phosphoric Acid
@ Isopropyl Alcohol (IPA)
@ Soda Ash (Sodium Carbonate) @ Acetic Acid
@ Ethyl Acetate
@ Sodium Lauryl Ether Sulfate (SLES) @ Sodium Bicarbonate
@ Acetone
@ Sodium Laureth Sulfate (SLS) @ Potasium Bicarbonate
@ O-xylene
@ Acid Thickner e@ Sodium Benzoate
@ Tri Chloro Benzene
@ Soap Noodles @ Xanthan Gum
@ Silica Gel
@ Tansparent Soap Base @ DEG (Diethylene Glycol) @ Formaldehyde
@ Alpha Olefin Sulfonates (AOS) @ Nitro Benzene @ Para Nitro Chloro Benzene (PNCB)
@ Pine Oil @ O-Di Chloro Benzene @ Ortho Nitro Chloro Benzene (ONCB)
© Cocamidopropy! Betaine (CAPB) @ P-Di Chloro Benzene @ Para Nitro Aniline (PNA)
@ Alphox 200 @ Mono Chloro Benzene @ Gum Rosin (Grade-WW / N/K)
78
2 JKW CHEMICALS PVT. LID. <u
AUTHORISED DISTRIBUTORS & DIRECT IMPORTERS
ADITYA BIRLA THAILAND GIVAUDAN FRAGRANCES
Sodium Metabisulphite-(SMBS-FG) BIRLASULF SM Hair Care, Personal Care ,Lip care
Sodium Sulphite-(SS-FG) BIRLASULF SS Cosmetics, Detergent ,Dish wash
Monosodium Phosphate —FG (MSP-FG) | Disodium Phosphate-FG Toilet Soaps, Floor/Surface Cleaner
Sodium Acid Pyrophosphate -FG Hand wash, Fabric Softener
we Trisodium Phosphate —FG | STPP-FG |TSPP-FG | TKPP-FG Fine Fragrance , Attar
GULJAG INDUSTRIES (Tween) -20/60/80 Designed For Food and Beverage For Liquid Filtration
Sulfamic Acid Lauryl Alcohol Ethoxylate Pharmaceutical & Pharmaceutical Manufacturing
LAE -6/7/9 Other High Purity Applications Clarifying Filtration.
a
Address: 103, Eco House, Vishweshwar Nagar, Off Aarey Road, Goregaon (East) , Mumbai, Mumbai, 400063.
8: For Fragrances/ Teadit /Filter Sheets — 8591918703, - fragrances@jkwchemicals.com
‘8: For Surfactants -9920083658, & -sales@jkwchemicals.com For Others Products -8591918701 /702
2. Geniosil Vinyl Silanes & Genioplast Polymer Additives 2. Binder For Printing Inks 2: . Octyl Phenol Ethoxylates
Polymer Dispersions For Adhesives 3 . Styrenated Phenol Ethoxylates
3. Silicone Greases
1. Binder For Lamination Adhesives / Wood Adhesives 4. Tridecyl Alcohol Ethoxylates
4. Silicone For Car Care & Personal Care 2. Binder For Paper Adhesives / Wood Adhesives
Silicone Defoamers/Antifoams For: 5. Cetostearyl Alcohol Ethoxylates
3. Binder For Wood Adhesives / Pvc To Mdf 6. Cetyl Alcohol Ethoxylates
Paper And Pulp Industry (Pulpsil Series) 4. Binder For Membrane Press Adhesives
E
Etp And Other Low End Applications 1. Barrier Coating For Paper
Metal Working Industry 9. Oleyl Amine Ethoxylates
10. Glycerine Ethoxylates
a OY Ge
Powder And Liquid Defoamer For Detergent Industry AQUAPHARM CHEMICALS PVT.LTD.
Textile Application Phosphonates: THIRUMALAI CHEMICALS LTD
Powder And Liquid Defoamer For Agro Industry 50 & 60% Hedp
1.Malic Acid
Silicone Emulsions: Hedp Powder 2 Na / Hedp Powder 4 Na
2.Fumaric Acid
1. Tyre And Dash Board Polish Atmp & Detmp & Edtmp & Hmdtmp
2. Mould Release Accl-Acetyl Chloride Other Products
A) For Rubber Footwear Pci3—Phosphorous Tri Chloride
Oleo Chemicals
B) For Eva Footwear Chelating Agents For Agro & Aqua Culture 1. Lauryl Alcohols
C) For Polyurethane Release Hedo Based Chelating Agents
2. Cetyl Alcohols
D) Alumininum Dia Casting Release Polymers: 3. Ceto Stearyl Alcohol (30:70/50:50/70:30)
Paints, Coating & Construction: Copolymers
4. Stearyl Alcohols
Silicone Resin For Heat Resistant Paints Polyacrylate Homopolymer
5. Ldma (For Manufacturing BKC)
Fe
7. Perfume Solubilizer
SS
80
48 YEARS | SERVICE TO THE SCIENCE
dress: 2/22, Babu Genu Road, 2nd Floor, Off: Princess Street, Mumbai 400002 (India).
Tel: 2201 9558. 2208 2806, 2208 2813, 2209 8845 e M : +91 98206 77454 / 98200 77454
Email: sales@earthchemicals.in / admin@earthchemical.in
Web: www.earthchemical.in
81
TM GheMm
Cobalt e Nickel Acetate e Chromium Formate
e Cobalt Chloride e Nickel Sulphate Tungsten
e Cobalt Acetate e Nickel Nitrate e Sodium Tungstate
e Cobalt Sulphate e Nickel Carbonate e Tungstic Acid . ;
e Cobalt Nitrate Chromium cli Tungstic Acid
e@ Cobalt Oxide e Chromium Chloride « Stanncus Chloride
e Cobalt Carbonate e Chromium Acetate e Stannous Sulphate
Nickel e Chromium Fluoride e Potassium Stannate
e Nickel Chloride e Chromium Nitrate e Sodium Stannate
103, Savera, off. Shimpoli Road, Borivali-west, Mumbai — 400092, Maharashtra, India
Mobile: 9833 251 567, 9167 551 567
Email: gogri.harsh@gmail.com
Products
Castor Oil — Various Grades Including Pharmaceutical Grades
Castor Oil Fatty Acids
Hydrogenated Castor Oils & Fatty Acids
Dehydrated Castor Oil & Its Fatty Acids
Castor Oil Methyl Esters
Castor Amides
Blown Castor Oils
Sebacic Acid
2-Octanol & 2-Octanone (Methyl Hexyl Ketone)
Glycerine
Regd. Office : 701, Tower ‘A’ Peninsula Business Park, Senapati Bapat Marg, Lower Parel(W) Mumbai 400 013 India
Tel.: +91 22 4027 1300 @ Fax: +91 22 4027 1399 @ Email: info@jayantagro.com ® Website: www.jayantagro.com
82
KEMS RAW PHARMA
DEALER: PHARMACEUTICALS, CHEMICALS RAW MATERIAL, BULK DRUGS, POULTARY SUPPLIMENTS, ETC.
213, ANAND BHAWAN, 17, BABU GENU ROAD, PRINCESS STREET, MUMBAI: 400002, MAHARASHTRA, INDIA.
PHONE: (O) 022-22051952 CELL: 09322233141/ 8850287091 // 8097075305
Email: kemcochem@yahoo.com/ kemsraw@gmail.com
Following Raw Material Bulk Drugs Available From Ready Stock:
@ Acriflavine e@ Emulsifying Wax (lonic/Non-lonic) @ Oil Olive @ Papain Ip / Pure
e Activated Carbon Powder e Extract Belladona Dry Powder @ Papain Usp / Refine /5x/7x
@ Aluminium Hydroxide Paste e Extract Belladona Green Veredis Paste @ Para Amino Benzoic Acid
e@ Aluminium Sterate e Bees Wax e Extract Liver (Paste / Powder) e@ Para Chloro Meta Cresol
e@ Belladona Green Verdis Paste e Extract Malt (Powder/ Paste) @ Pectine @ Peptone - Gelatin / Proteose
e@ Bile Salt @ Caffine Citrate e Extract Stomach (Paste/ Powder) @ Peptone (Bactro/ Pharma)
®@ Calamine Powder e Calcium Carbonate e Extract Yeast (Paste / Powder) @ Proflavine Hemisulphate @ Propyl Gallate
@ Calcium D- Saccharate @ Gama Benzoin Hexa Chloride @ Protin Liquid (20% / 30% /60%)
@ Calcium Hypophosphite @ Gum Accacia @ Gum Guar @ Silver Sulphadiazine
@ Cassin Protin Hydrolystae Powder 60% © Gum Tragacanth e lodoform e@ Simethicon 100%
@ Cassine Protin Hydrolysate Powder 80% @ Isolated Soya Protine Powder 90% e@ Simethicon Emulsion 30%
@ Cellulose Acetate Pthalate @ Lanoline Anhydrous e Soya Lecthin Powder /Paste
e@ Cerebro Protin Powder @ Light Kaoline e Magaldrate @ Soya Protin Hydrolysate Powder 60%
@ Choline Chloride Powder 98%/60%/50% @ Magnesium Aluminium Silicate @ Soya Protin Hydrolysate Powder 80%
@ Choline Chloride Solution 65% @ Magnesium Hydroxide @ Soya Protin Powder Capsulation Grade
@ Collodion Flexable Sol. @ Magnesium Sulphate @ Sugar Pharma Grade e Sulphur Powder
@ Crysobinum Powder @ Magnesium Trisilicate @ Talcum Powder e Tannic Acid
@ Crystal Violet Powder Pure e@ Malt Diastase e Merbromine Powder @ Tolnaftate
@ Dried Aluminium Hydroxide Gel @ Oil Arachies @ Oil Castor Bss @ Vitamin K 3 Feed / Pharma
e Dry Yeast Powder @ Oil Linseed Refine @ Oil Neem Refine @ Zinc Acetate Pure
Besides This We Can Also Supply All Kinds Of: EXTRACT HERBS, OLEROSINE, AROMATIC ESSENTIAL OILS, FOOD & PHARMA COLOUR. /// BISMUTH SALTS (CARBONATE,
OXIDE, SUB-NITRATE, CITRATE, SUB GALLATE ETC.) /// CHLORIDE & BROMIDE SALT (AMMONIUM.CALCIUM, SODIUM, POTASSIUM) /// MATELLIC STEARATE
(ALUMINIUM, BARIUM, CALCIUM, ZINC, MAGNESIUM)
OTHER PRODUCTS:-
@ ETORICOXIB IP @ METHYLCOBALAMIN IP @ AMBROXOL HCL IP
® OXYCLOZANIDE BP VET @ ALBENDAZOLE IP & USP (PLAIN) @ RIFAXIMIN EP
@ LULICONAZOLE IP @ CLOPIDOGREL BISULPHATE IP @ MONTELUKAST SODIUM IP
@ LINEZOLID IP @ LEVOCETIRIZINE HCL IP ® BRIVARACETAM IHS
@ VILDAGLIPTIN IP @ DOMPERIDONE IP @ MEFENAMIC ACID IP/BP
*All Prices are Subject to final confirmation and availability of the stock at the time of order.
83
RELIC
Address: Ajay Industrial Estate, 3" Floor, Office No. 306, Anjirwadi,
Mazgaon, Mumbai-400 010, Maharashtra, India.
Phone: +91-22-23717140
Email: tejas@relicchemicals.com, info@relicechemicals.com
CHEMICALS
Manufacturer| Importer| Exporter Mob: +91-98331 18324, 98701 94496
84
NGL FINE - CHEM LIMITED
ANIMAL HEALTH | HUMAN HEALTH | VET FORMULATIONS
301, E Square, Subhash Road, Vile Parle (E), Mumbai 400 057, India.
(+91 22) 40842222 | info@nglfinechem.com | www.nglfinechem.com
PANCHAMRUT CHEMICALS
Contact Details : 9870795121 / 9825242122
Office No.: 7021778189 / 8591740139
Email: sales@panchamrutchemicals.com / info@panchamrutchemicals.com
PRODUCTS
HYDROQUINONE
TRI BUTYL PHOSPHATE
L ASPARTIC ACID
SODIUM FORMATE
ORTHO CHLORO BENZOIC ACID
SUCRALOSE
ASPARTAME
GLYCERINE
BENZOPHENONE
203, GANGOTRI, HARIDAS NAGAR, SHIMPOLI ROAD BORIVALI (WEST), MUMBAI - 400 092
85
: Import
Our Products Y) @ Acetone @ Melamine
ap © Acetonitrile © Methan Sulfony! Chloride
Gatz) Gujarat Atkaties and Chemicals Limited Rashiriya Chemicals and Fartikzers Limited e Bisphenol-A e Methyl Aceto Acetate
© Potassium Carbonate sicdinsirednaneiaiean toapaball ape © Ethyl Chloro Formate © Sodium Bicardonate
Granular/Powder © Cyclohexane e Formamide e Sodium Metal
© Cyclohexanone @ Formic Acid © Sodium Nitrate
qe @ Glycering @ Sodium Tripoly Phosphate Tertiary Dutanol
TATA s @ Gum Rosin © Sodium Gluconate
BASTA CHEMICALS LIMITED & AND PETROCHEMICALS @ Hydrogen Peroxide 50% @ Tetra Hydrofuran
@ Soda Ash _ @ Hydroxylamine Sulphate @ Titanium Dioxide Anatase/Rutile
© Sodium Bicarbonate © ISO Propyl Alcohol @ L(+) Tartaric Acid @ Triethylene Tetramine
Contact Details:
1101, Bay View Tower,Sector-11, Opp. Dominoz, CBD Belapur, Navi Mumbai-410 209
Ph: 022-6464 0085 / 9223434334 / 9223433883eEmail: rasayan_India@yahoo.In
ZINC OXIDE (White seal 99.5% / Metal Grade 99.8% & 95% Feed Grade & Acti.Z grade)
Authorized distributors: M/s. Rubamin Ltd.
META PARA CRESOL (Mixed Cresol) — (Imported / Intact) (Sealed Packed Barrels)
ORTHO CRESOL - (Imported / Intact) | PARA CRESOL PURE 99% - (China / Atul) | META CRESOL PURE 99% - (Imported / Intact)
Transformer Oil - IS 335 Liquid Paraffin (Heavy & Light) (All Grades)
Authorized distributors: M/S. Apar Industries Ltd.
86
@; JUANA PHARMA
We provide best solutions in:
APIs | Pellets | Excipients | Flavours | Fragrances
Bhavesh Patel
CEO
Dev T: +91
M: +91
9313337209
9106729963
International E: sales@devinternationals.com
512, Vishala Supreme, S.P.Ring Road, Nikol, Ahmedabad — 382 350, Gujarat, India | www.devinternationals.com
® Castor oil / hydrogenated castor oil @ Ethylene glycol distearate (EGDS) ® Caustic Soda Prills ® Belachwin
® Propylene glycol / glycerin ® Polyquaternium 7(pyq-7 ) ® Liquid Chlorine ® Scalewin
® Carbomer 940/971 p all grade ® Polyquaternium 10 (pq-10 ) ® Hydrochloric acid ® Poly aluminum chloride
® Emulsifier all grade ® Guar hydroxyl trimonium chloride (GHTC) Compressed Hydrogen Gas ® Biowin
® Stearic acid ® Poly glycerol Stearate ® Stable bleaching powder
® Sorbitol liquid & powder ® Acid thickener SPECIAL CHLORINE ® GFI Products
® Xanthan gum all grade ® Sodium polyacrylate ® Derivarivatives Group ®@ Caustic soda
@ Menthol/ camphor
/ thymol © Glycerine ® Anyddrous Aluminium Chloride ® Carbon teltrachloride
@ Hpmc all grade ® Triethylamine (TEA) ® Chlorinated paraffin ® Chlorine
® Sodium cme all grade ® Triethanol amine (TEA) ® Benzyl Alcohol ® Methylene di chloride
® Cetosteryl alcohol / cetyl alchohol @ Sodium Gluconate ® Benzaldehyde ® Hydrochloric acid
® Sodium benzoate ® D- biotin ® Benzyl chloride ® Sodium hydrogen sulphate
® Liquid glucose ® D- panthanol ® Sodium Cyanide group ®@ Hydrogen gas
® Polysorbate 80/60/40/20 ® Vitamin K ® Sodium cyanide ® Fluorspar
® Alphox products ® Folic acid ® Sodium Ferrocyanide ® Anhydrous hydrogen chloride
® Liquid paraffin heavy/ light ® Niacinamide ® Sodium Chiorate group ® Core products
® Magnesium oxide ® Ascorbic acid (vit C ) plain/ coated ®@ Hydrogen peroxide ® Denatonium benzoate
® Edta pure acid ® Rizoflavir/ b2 5 phosphate ® Cautic Potash group ® Anthranitic acid
® Edta di sodium salt ® Vitamin B 6 (pyridoxine ) HCL ® Caustic potash lye ® Potassium permanganate
® Edta tetra sodium salt ® Vitamin E Liquid / Dry powder ® Caustic potash flakes ® Carbomer Powder : 980/940/956/
® Propy! paraben @ Vitamin B 1 (Thiamin Mono/ HCL ) ® Potassium Carbonate 934/971/974 Pharma & Cosmetic Grade
@ Methyl paraben ® Methylcobalamin / Hydroxycobalamin ® Chloromethane Group Available
® Sodium propyl paraben ® Vitamin B 12 ® Metylene Chloride ® Glycerin 99.7% ; CP/IP/BP/USP Grade
® Sodium methyl paraben ® Calcium D Panthoemate ® Chloroform ® Propylene Glycol : Technical/IP Grade
® Propyl gallate @ Vitamin D 3 (cholecalcifero! ) ® Carbon tetrachloride ® IPA (Iso Propyl Alcohol) : Dipak Make
® Benzyl alcohol / benzyl benzoate @ Vitamin A Palmitate/ Acetate ® Phosphoric group Available
® Butyl paraben ® Phosphoric acid ® TEA99% (Triethanol Amine) » CP Grade
® Butylated hydroxyanisole (BHA ) GACL PRODUCTS ® Calcium Chloride group ® Phenoxyethanol : Preservative
® Buylated hydroxytoluene (BHT) ® Caustic Soda Group ® Calcium Chloride powder ® Citric Acid Monohydrate : Ensign Food
® Tertiary butyl hydroquinone. (TBHQ) ®@ Caustic Soda Lye ® Liquid carbon dioxide Grade
@ Ethylene glycol monostearate (EGMS) ® Caustic Soda Flakes ® Water treatment group ® Xanthan Gum : Fufang Food Grade
88
AX JEEVAN CHEMICALS AND PHARMACEUTICALS
Plot no: - C-431, T.T.C. Industrial area, Turbhe, Navi Mumbai-400705.
Email: - drchopde.jeevan@gmail.com
Website: - info@jeevanchempharma.org
Phone no: - 9326362295, 9820112971, 9833140986.
% (
* TRIPROLIDINE HCL Narcotics / Psychotropic Substances
ef Synthetic Molecules
INTERMEDIATES
ite) End use
4-(2-Amino Ethyl) Benzene Sulfonamide Glipizide/Glibenclamide
Glimepiride Sulphonamide Glimepiride
4-Hydroxy Pyridine-3-Sulfonic Acid Torsemide
4-(3-Methy! Phenyl)Amino-3-Pyridine Sulfonic Acid Torsemide
Lasamide Furosemide
4-Amino-2-Chloro-6,7-Dimethoxy Quinazoline Prazosin/Doxazosin/Alfuzosin/Terazosin
4-Hydroxy-3-Methoxy-5-Nitro-Methyl Benzophenone Pharma Intermediate
2, 5 Dichloro Thiophene Pharma Intermediate
2-Dibutylamino-1-(2, 7-dichloro -9H-Fluoren -4yl0 Ethanol Lumefantrine Intermediate
91
Nisha Chemicals
D-501, Neelkanth Business Park, Behind Bus Depot, Vidyavihar (W), Mumbai : 400086.
Tele Nos: (+91)(022) - 61271617/ 18 Fax: (+91)(022) - 35100110
Email: Info@nishachemicals.com Web: http://www.nishachemicals.com
Contact: +919892821414 / +91 9223383831 / +919967186874
Distributors For “ Henan Jindan Lactic Acid Technology Co. LTD.” For Lactic Acid, Sodium Lactate, Magnesium Lactate, Calcium Lactate & Buffered Lactic Acid.
@ 2 Ethyl Hexanoic Acid (Octoic) @ Ethyl Acrylate @ Methyl! Metha Acrylate (MMA)
@ 2 Ethyl Hexyl Acrylate (2EHA) @ Ethyl Carbitol (IG) @ MethAcrylic Acid (MAA)
@ 4 Di Methyl AminoPyridine (4DMAP) @ Ethylene Glycol Mono Methyl Ether (Methyl @ Methane Sulphonic Acid (MSA)
@ Acetonitrile Glycol) @ Methane Sulphony! Chloride (MSC)
® Acrylamide @ Formamide @ Methyl Iso Butyl Ketone (MIBK)
® Acrylic Acid @ Formic Acid 99 % & 85 % @ Methyl Tert Butyl Ether (MTBE)
@ Acrylonitrile @ Glyoxal 40% @ N Butyl MethAcrylate (NBMA)
@ Ascorbic Acid @ Glycine @ N-Methyl Pyrrolidone (NMP)
®@ Bronopol @ Hexa Methyl DiSilazane (HMDS) @ N Hexane
© Buffered Lactic Acid @ Hexamine @ Paraformaldehyde 91% & 96%
® Butyl Acetate Intact @ Hydrazine Hydrate 100% @ Para Toulene Sulphonic Acid (PTSA)
® Butyl Carbitol @ Hydroxylamine Sulfate (HAS) @ Pentaarythritol
® Butylated Hydroxy Toluene (BHT) @ |taconic Acid @ Potassium Bi Carbonate
© Butylated Hydroxy Anisole (BHA) @ L(+) Tartaric Acid @ Potassium Bi Sulphate
® Bisphenol A @ Lactic Acid 80%, 88% & 90%
@ Potassium Carbonate Powder
@ Calcium D Panthothenate @ Lactic Acid Liquid
@ Calcium Lactate @ Lactic Acid Powder @ Potassium Sorbate
® Cyclohexane @ Lactose Mono / Anhydrous @ Propylene Glycol
®@ Cyclohexanone @ Lauric Acid @ Propylene Glycol Technical
@ Cyclohexanol @ L Alanine @ Skim Milk Powder
@ Dicyclopentadiene (DCPD) @ L-Arginine @ Sodium BoroHydride Powder
@ Di Iso Propyl Ether (DIPE) @ L Lysine ®@ Sodium Formate
@ Di Methyl Carbonate @ L Glutamic Acid @ Sodium Lactate
@ Di Methyl Formamide @ L-Valine ®@ Sorbic Acid
@ Di Methyl Sulphoxide @ Magnesium Lactate @ Tetrahydrofuran (THF)
@ Di Propylene Glycol (DPG) @ Methyl Aceto Acetate @ Xanthan Gum
NAKSHA Office : 7 Th Floor , Unit No 716, Highway Commercial Center Premises Co-Op Soc Ltd,
|.B. Patel Road Goregaon (E), Mumbai - 400 063
PHARMA NUTRACEUTICAL PVT. LTD. Tel: 91-22-46051578, 9819811703 @ Email: info@nakshapharma.com
Cahily s(t for Ptiddtatet, Heals Web: www. Nakshapharma.com
92
at os, Address: 77/78 Ashok Chambers, 5th Floor,
Sa~ Nikeon Co rp ora tion 56, Devji Ratansey Marg, Masjid - East, Mumbai - 400 009
ei Ewaha £
wae Tel.: 022-66108086/87/88 | What’s App No. 09223433408
SINCE 1985 EMail.: nikeoncorp@gmail.com | URL.: www.nikeon.com
93
BULAT PHARMACEUTICAL PVT. LTD.
A
@ Alogliptin Benzoate
PHARMACEUTICAL INTERMEDIATES
Valsartan /Sacubitril Intermediate
@ Trelagliptin succinate @ Ethyl 2-Sey phe Oe pee CAS:5717-37-3}
@ Linagliptin @ (R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid {CAS: 1012341 A8- -8}
@ Cetilistat @ (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid { CAS:1012341-50-2}
@ Sacubitril/Valsartan @ 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid(AHU-377)
@ Tenofovir Alafenamide Fumarate 1369773-39-6
@ Osimertinib
@ Ibrutinib Alogliptin intermediate -
@ Baloxavir marboxil @ 1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine 853029-57-9
@ Empagliflozin @ 3-Methyl-6-Chlorouracil { CAS: 4318-56-3 }
@ Tianeptine sodium salt e > [(6-Chloro-3,4-dihydro“3-Methyl-2.4-dioxo-1(2h)- pyriMidinyl)Methyl]benzonitrile {CAS:865758-96-9}
@ (R)-3- Aminopiperidine Dihydrochloride (Cas# 334618-23-4)
@ Tofacitinib
@ Veliparib Linaaliptin i : 7s
gliptin intermediate
° oe ee ee @ 3-Methyl-8-bromoxanthine {CAS:93703-24-3}
: ) @ 2-Aminoacetophenone { CAS:551-93-9} rf.
@ Sofosbuvir . @ Quinazoline, 2-(chloromethyl)-4-methyl {CAS: 109113-72-6} -
@ Daclatasvir dihydrochloride © 8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione { CAS: 666816-98-4}
@ Velpatasvir-Co-Povidone (1:1)- @ (R)-3-Boc-Aminopiperidine Cas: 309956-78-3 X
@ Ledipasvir:Copovidone Solid Dis- ‘ , a
persion @ Palbocilib intermediates 1 CAS: 571188-59-5 =
@ Molnupiravir @ Palbocilib intermediates 2 CAS: 1016636-76-2 if
@ Abiraterone @ Pharma intermediate CAS: 1421372-66-8 ° \
@ Methotrexate @ Pharma intermediate CAS: 4076-36-2 5-Methyl-1H-tertazole
@ Sorafenib @ Pharma intermediate CAS: 626-64-2 4-Hydroxypyridine \
Unit No — 411, Tower A, Spaze Edge, Sector 47, Sohna road, Gurugram - 122018, Haryana A x
EMAIL.: info@bulatpharmaceutical.com, formulation@bulatpharmaceutical.com 1 Ja é
MOBILE : +91 8448085662
SERVICES
Chemical and Pharmaceutical testing
Analytical method development and method validation
Impurity synthesis, custom synthesis and product development
REGULATORY AFFAIRS
DMF (API) and Dossier (Formulation) preparation
DMF and Dossier submission to various regulatory authorities
Assist to prepare draft query responses for DMF/Dossier
94
Manufacturer of
Collodiol Flexible
(Passing / Confirming / BP / USP / IP)
GLOBE PRODUCTS
Chemical House, LBS Marg, Gokulnagar, Thane (W)-400601
Tel: +91 9223433889 | Email: infoglobeproducts@gmail.com
“fo “x
+ Di Octyl Phthalate (DOP) + Maleic Anhydride + Tri Ethanol Amine (TEA) Phosphorus Oxchloride
+» Di Butyl Phthalate (DBP) + Phthalic Anhydride *» Tricloroethelene (TCE) Di Ethylene Glycol (DEG)
“fo “x
+» Liquid Paraffin (Heavy/ Light) + Pentaerythritol «+ Ammonium Chloride Mono Ethylene Glycol (MEG)
Petroleum Jelly » Formaldehyde Citric Acid (Mono) Iso Propyl Alcohol (IPA)
“ ° *fo
“fo “x
“x
ye
Rubber Process Oil (RPO) » Caustic Soda / Caustic Potash Boric Acid/ Borax “> TETA
te
9
96
Our Service is Door to Door from China for Chemicals,
Electronics , Appliances, Weighing Scale Etc.
For Your Requirements of
to Anywhere in India
C/A CHEMIMAN
All Kind of Freight Services / Cargo Consolidation / Door To
Door Services / Sourcing Products / Product Development/
R&D Etc
PRODUCTS
PARAS CHEM (INDIA) TRICHOLINE CITRATE
Certified by ISO 9001:2015 50% & 65% & 70% Solution — |IHT
Dealers in Chemicals, Phosphates, Solvents & Minerals.
CHOLINE DIHYDROGEN CITRATE
50% Solution — IHT
Authorized Dealer of GRASIM, RSPL LTD.
CHOLINE BICARBONATE
50% Solution — IHT
Product List CHOLINE BITARTRATE COATED
with 1% Silicon Dioxide — IHT
Caustic Soda Flakes (Grasim / Meghmani / DCM)
CHOLINE SALICYLATE
Soda Ash (TATA/GHCL/RSPL/NIRMA) 50% Solution — |IHT
100
Available in small packing and in Bulk
IN* NEHA ENTERPRISES
Sales Office : 122,Reena Complex, Near Vidyavihar Station, Opp. Neelkanth
Chlorosulphonic Acid
Business Park, Vidyavihar (W), Mumbai - 400086, Maharashtra, India.
101
NOBLE CHEMICAL AGENCY
«+ Ethamsylate Bp + Ebastine Bp Miconazole Nitate
** Phenytion Sodium Ip * Lorazepam “ Clonazepam
Office: 17-8-187, Chowni Nade, Ali Baig, + Melitracine «> Di Valporate Sodium 70-30 & 45-55 & Bp & Usp
Hyderabad-500 023, Telangana, India. “+ Sodium Valporate Ip & Bp + Valporic Acid Ip & Bp
#» Mefenamic Acid Ip # Co Enzyme Q1 ( Nutraceticals Grade )
*» Hydrocortisone Sodium Succinate
We require all types of Spent Bromides “+ Orlisate Ih “> Pitofenone + Chlorthalidone
Specially , Soent Sodium Bromide “> Disulfiram “ Flupenazine Deconate + Flupentixol Hcl
% Procyclodiane Hcl + Trihexyphenydine Hcl Ip & Bp & Usp
Spent Hydrobromic Acid “> Nicorandil # Chlordiazepoxide
+ Clozapine + Ferrous Ascorbate Dc Grade
Spent Bromides Above 20% * Tolperisone # Mirtrazapine + Razitriptan
Distilled / Spent / Crude / Residual Solvent Mixed + Sumatrptan “ Trypsin & Chemotrypsin + Pencreatine
“* Rutin (Rutoside Trihydrate ) <* Valthamate Bromide
Tri Butyl Tin Chloride “¢ Fenpiverium Bromide # Orphenidrine Citrate
% Methyl Predinisolone Sodium Succinate & Base
% Etizolam Bp # Olmesartan # Miconazole Nitrate Ip
SY olen mt TaN MT (eL cd * Chlorpromazine Hcl Ip & Bp # Peliperidone
* Zolmitriptan # Naratriptan Hcl @ Eletriptan Hydrobromide
Contact: Anastrazole Bromolian
SHRADDHA
ANALYTICAL SERVICES G
ISO 9001:2015 CERTIFIED LABORATORY
State of the Art Advanced Instrumentation Centre for All Analytical Requirements
GANDHI CHEMICALS
GC-ALS, GC/MS, GC-HSS, ICP-OES, HPLC,GPC, IC, XRD, XRF, DSC, TGA, FTIR, CHNS, 301, Purva Plaza CHS LTD., Shimpoli road, Opp. Adani Electricity, Borivali(W), Mumbai-92
Particle size, Porosimetry, SEM, SEM-EDAX and Chemical Analysis Landline: 91-22-61276444/45 @ Phone: 7208855010/11
Website : www.gandhichemicals.com @ Email : mktg@gandhichemicals.com
Partner : Mr. Alpesh Doshi - 9223433838 | Mr. Alpesh Gandhi - 9223433034
Services:
All solvent available in bulk and drum packing
Purity of solvents by GLC and KF All other solvents and chemicals as per the need of customer
Metal testing by ICP-OES up to ppb level
PVC aT ag
Anions and Cations by lon
y < », DEEPAK FERTILISERS
Chromatography up to 0.1 ppm
& AND PETROCHEMICALS
Molecular weight determination by GPC CORPORATION LIMITED
102
AVAILABLE PRODUCTS
Ciipharma PARACETAMOL IP / BP/ EP / USP
(Dealers In Active Pharmaceutical Raw Material)
28, Lohar Chawl, Ground Floor, Mahim (West), Mumbai-400016
Contact: 022-24451832 /24457618/9820051832
FOLIC ACID IP / BP / EP / USP
E-Mail: Unipharma81@Gmail.Com
DOMPERIDONE MALEATE IP / BP
e Albendazole @ Griseofulvin
e Aceclofenac e lsoxsuprine Hcl ENELAPRIL MALEATE IP / BP
e@ Alpha Lipoic Acid e Ketoconazole
e Ascorbic Acid e Levo Salbutomal Sulphate
e Azithromycin e Lumifentrine GLIPIZIDE IP / BP
@ Cefalexin Monohydrate e Metronidazole
e Cefixime Trihydrate e Norfloxacin
Compacted @ Ofloxacin FUROSIMIDE IP / BP.
@ Ciprofloxacin Hcl e Paracetamol e Pvpk 30
@ Diclofenac Potassium e Salbutamol Sulphate
e Doxycycline e Sodium Fusidate
Hydrochloride e Teneligliptin
e Enrofloxacin Hydrobromide Hydrate
205, Srishti Plaza, Saki - Vihar Road, Powai, Mumbai 400072
e Fusidic Acid e Terbutaline Sulphate
Ph: +22 - 40151518 / 19 @ Fax: +22 - 40151520
Email: pharma@sripharmacare.com
We Can Provide Any Item Other Than Above
Website: www.sripharmacare.com
As Per Your Valuable Requirement
For Direct Import of the following products Regularly available at competative rates:
Amino Acids
Diethyl Carbonate Benzoic Acid
Beta Cyclo Dextrin
Propylene Carbonate
Sodium BoroHydride (Powder/Granular)
Sodium Citrate
Sucralose
Please contact :
Tetrahydrofuran
Flora Dyechem Thioglycolic Acid 80%
Xanthan Gum (80 Mesh & 200 Mesh)
Flora Pharmachem
Flora Home & Personal Care Contact:
(International Marketing & Sourcing Agent for all kind of
Raw Materials/ Ingredients) JAY CHEM MARKETING
E-MAIL: pc@floradye.com / dyes@floradye.com / floradyechem@gmail.com (Estd : 1988)
Website : http://www. floradye.com ADD: 101, Labh Sarita, opp. Manek Nagar, M.G.Rd, Kandivali (W), Mumbai - 67. INDIA.
TEL. NO.: 0091-22- 28072677 / 78 / 80 / 28020141
TEL: 0091 - 28541307 / 28547508 MOBILE NO.: 0091-9223433781, 9821153754
MOBILE : +91 9152234933 E-MAIL: info@jaychemmarketing.com; sales@jaychemmarketing.com
103
solutions every industry needs.
Primary Bins and Vats Electroplating Pickling Tanks
‘Cylindrical vertical tonks with open top: CV series ae em oe)
Chemical Matrix
2, Geet Krishna, Navghar Road,
Mulund - East, Mumbai - 81
Phone: 8425031410 / 9769681471
Email: ganesh@chemicalmatrix.co.in
Website: http://chemicalmatrix.co.in
|
+ Anti Coagulants + Anti-Biotic PU)
<> Anti Asthmatic ¢ Antiulceratives
+ Anti Inflammatory
+ Veterinary Product
¢ CNS Drugs
¢ Anti Chloinergic
+ Analgesic
¢ Antimalarials
¢ Oncology
¢ Anti Retroviral
¢ Anti Ulcer
+ Anti Epileptic + Anti Osteoporosis
+ Dyslipidaemic ¢ Antidiabetic NITCO WATERTECH AND INDUSTRIAL CONCEPTS
¢ Arthritic ¢ Anti Emitic Shop No. 3, Kaustubh CHS, Sombhji Path, Vishnunagar,
Naupada, Thane (W) — 400602
¢ Anti Histamine ¢ Anti Parkinson Contact: Akshay Desai : 9820070807
NITCO Tel: 022-25424059 / 25414059 / 25404059 / 25401345
¢ Anti Fungal ¢ Nootropic = Email: nitcostone@gmail.com / nitcowatertech@gmail.com
105
India’s one of the largest, Chem XLNC
innovative & industry useful startups Bison
pharmachem
Pharma Pvt. Ltd.
Excellence Redefined
107
IMPORTERS & DEALERS B.Pankaj & Co.
IN PHARMACEUTICAL
RAW MATERIALS FOLIC ACID IP / BP
108
Po __SUBSCRIPTIONFORM
| THE MAZADA PHARMA GUIDE |
Rs.1 500 (24 Issues 1 Year) enh al i Sigutinets Eisen orcaaworcryane OPK eli -scavcccmnces esse
Rs.3000 (72 Issues 3 years) 7!.No.: | Piste Mel SEEM af Be ICN ¢ sean teats
Manufacturer Broker = _ Trader
AIC. 044 50200000909, MUMBAI Towards Above Marked Subscription In Favor of MAZADA PUBLICATIONS
Payable In Mumbai. (Please Pay Rs,30/- Extra In Case Of Outstation Cheques)
SUBSCRIPTION FORM
AIC. 04150200000909, MUMBAI Towards Above Marked Subscription In Favor of MAZADA PUBLICATIONS
Payable In Mumbai. (Please Pay Rs.30/- Extra In Case Of Outstation Cheques)
azada
PUBLICATIONS Signature of Subscriber Date.
a ede Please Send The Complete Form With Cheque / DD To Subscription Department
Gala No. 1 A, Sharma Compund, Old Nagardas Road, Andheri (E), Mumbai -400 069
Mob: 8108049982 / 9860066753 / 9004528972 * E-mail : chemicalsourcingguide@gmail.com + Website : https://joom.ag/ITNa
109
MAZDA PUBLICATIONS Presents
(\ eT >
«e/NDIALABEXPO
4
Rew |2023 ASIA LABEX
| MUMBAI | |MUMBAI |
2} hepci
. e
neon ”PHARMAG
Incr SOUTH
“AMTECH INDIA AMPTECH INDIA CHENNAI
MUMBAI PHARMA GOA PHARMA an analytics Anacon ind
AND LAB EXPO AND LAB EXPO PHARMA: ee ys
COE = PROBIPACK EXPO CURRUEARETO
GUJARAT ZONE
‘ais “. NORTH ZONE
Industrial Industrial at, ‘
13th, . «™ .
a
i)
AHMEDABAD ,
This directory is full of information which will be of ultimate use to manufacturers, traders, brokers
in the Active Pharma Ingredient and Bulk Drug Industry. The Indian pharmaceutical industry is at a
very unique cross-road owing to the expected growth in the overall economy because of the new
central government which is seen to the pro - growth and extremely business friendly.
The AIABDD is our humble attempt at aiding business to business interaction and help growth in
the Pharma Industry. Owing to the huge amount of data this directly is made in three section.
Needless to mention we are sure that the AIABDD will prove to be a business tool parexcellence for
all your information needs in the Active Pharma Ingredient and Bulk Drug Industry.
We have tried our level best in providing you with the very best and updated information.
Users are welcome to sent in their feedback, comments and suggestions so that we can incorpo-
rate then in the next edition of AAABDD.
Lastly, let me take this opportunity to thank our advertisers who have supported us and also team
which has worked very hard for this AIABDD.
Prakash Anjalekar
Publisher
113
[ADVERTISERS INDEX|
Company
AARA PHARMA
name Pg No
97
CITY
114
(ADVERTISERS INDEX |
LUCONIC CHEMICALS 102 | MUMBAI RAJSHI CHEMICAL & PRODUCTS| 104 | GHAZIABAD
MIS. J.J. TRADERS 87 MUMBAI RASAYAN INDIA 86 NAVI MUMBAI
M/S. ALBA ORGANICS 100 | PALGHAR’ | RATE CARD 112
MALAY ENTERPRISES 68 VADODARA RATI PUSHP INTERMEDIATES PVT LTD 45 U.P
MARUTI INDUSTRIES 39 GUJARAT REGAL REMEDIES LIMITED 16 MUMBAI
RELIC CHEMICALS 84 MUMBAI
oe ae —— i MUMBA RESEARCH LAB FINE CHEMINDUSTRIES 31 MUMBAI
MEHTECH ENGINEERING PVT LTD 105 | PALGHAR ROSES LIFE CARE Soar oD 0 WUMBAI
MERU CHEM PVT LTD 76 MUMBAI
ROUTE 99 INTERNATIONAL 100 | MUMBAI
BALSA A ERAICEALSS i THANE RUSKIN CHEMIPHARMA 28 MUMBAI
MODY CHEMI PHARMA LTD 20 MUMBAI BYGE YASH INDIA ao | MCIESAL
NAKSHA PHARMA NUTRACEUTICALPVTLTD] 92 MUMBAI 6 Al. PROOUGTS aa THANE
NALANDA RESEARCH LABORATORIES 98 NAVIMUMBAI | GantaNa ENTERPRISES dd THANE
NANDLAL BANKATLAL PVT LTD 43 | MUMBAI SALICYLATES AND CHEMICALS 34 | MUMBAI
NEHA ENTERPRISES 101 | MUMBAI SANJAY ENTERPRISES 106 | MUMBAI
NEHA PHARMA PVT LTD 90 MUMBAI SDA PRODUCT 42 MUMBAI
116
to physiological events are all made possi- DISSOLUTION GRAPH FOR FORMULATION F1-F3 (DRUG: extremely beneficial in the treatment of
SODIUM ALGINATE); CPR (COMMULATIVE DRUG
ble by surface modifications of nanoparti- RELEASE) % VS TIME IN HOURS cancer as they can boost the accumulation
cles. These developments in nanotechnol- eH eh es of drugs in tumour tissues, resulting in
ogy have the potential to completely alter more potent therapy.
diseases, including cancer, are treat by Understanding drug formulations helps
improving therapeutic effectiveness and to increase patient compliance in addition
lowering systemic side effects of drugs. to increasing drug efficacy and safety.
Harnessing 3D printing technology is Patient compliance is the degree to which
another feasible method of drug formula- patients follow their doctors’ recommended
tion. With the aid of 3D printing, sometimes treatment regimens. Large tablet sizes,
referred to as additive manufacturing, com- undesirable flavours, and complicated dos-
plex drug dosage forms with a variety of long-term administration. Additionally, sen- ing regimens can all have an effect on
features can be precisely created. Using sitive APIs can be shielded by microencap- patient compliance. Researchers can
this method, patient-specific formulations sulation from the harsh gastrointestinal increase patient acceptance and improve
can be made, providing personalized treat- environment, enabling tailored delivery to adherence to treatment strategies by
ment. Scientists can regulate the drug body sites. developing patient-friendly formulations,
release profile, change dosage strengths, Advances’ in biomaterials and such as chewable tablets, oral films, or
and combine multiple drugs into a single biodegradable polymers have also created flavoured liquids. In the end, this results in
dosage form by incorporating drug and new opportunities for drug formulation, in enhanced patient satisfaction and better
excipient components into a 3D printing addition to these methods. Biomaterials treatment outcomes.
system. Drug formulations that can be tai- have special qualities that may replicate The intricacy of the drug development
lored to the demands of specific patients the body's natural environment, enhancing process and the factors that must be taken
can greatly enhance patient compliance biocompatibility and minimizing adverse into consideration can make drug develop-
and treatment success. Additionally, 3D consequences. A regulated release of the ment difficult. Choosing the right excipients
printing has the potential for on-demand medicine can be achieved by designing for the medicine is one of the biggest
manufacturing, which would cut down on biodegradable polymers to break down issues. Excipients are inactive components
both production costs and time while over time. These components can be uti- used in the formulation of drugs to help
enabling quick reaction to new healthcare lized to make scaffolds, injectable depots, keep them stable and improve their effec-
concerns. or implants. Enhancing drug solubility is a tiveness. Since excipients might affect the
Lipid-based drug delivery systems have significant benefit of formulation research. drug's safety and effectiveness, they
attracted a lot of attention lately in the area The solubility problems that many drugs should be cautiously picked. Making sure
of drug development. Lipid-based formula- experience can reduce their potency. the medicine is stable is another difficulty in
tions use lipids or lipid-like substances as Researchers can increase the solubility formulation development. Understanding
medication delivery carriers. Poorly water- and bioavailability of drugs by choosing formulations from a business point of view
soluble medications’ solubility and absorp- suitable solvents, cosolvents, and surfac- is essential for maintaining competitive-
tion can be enhanced by these formula- tants carefully. As a result, the drug can be ness in the pharmaceutical industry. It
tions, increasing the drugs’ bioavailability. administered to the target site at a larger enables companies to stand out from the
Liposomes, solid lipid nanoparticles concentration, enhancing therapeutic effi- competition by providing distinctive formu-
(SLNs), nanostructured lipid carriers cacy. The stability of drug formulations is a lations that meet unmet medical needs.
(NLCs), and self-emulsifying drug delivery further significant consideration. Over the The market may benefit from formulations
systems (SEDDS) are instances of lipid- span of a defined shelf life, formulations that offer increased therapeutic effective-
based systems. Benefits like enhanced must maintain their efficacy and integrity. It ness, fewer side effects, or greater patient
medication stability, controlled release, and is possible for researchers to create formu- convenience. Understanding formulations
targeted distribution are provided by these lations that maintain the drug's potency by also enables businesses to patent new dis-
systems. Lipid-based formulations have understanding the variables that can affect tribution methods or formulations to safe-
proven effective at delivering a range of stability, such as pH, temperature, and light guard their intellectual property, giving
therapeutics, such as anticancer medica- exposure. This assures that the drug main- them a competitive edge and market exclu-
tions, antiviral agents, and difficult-to-solu- tains its therapeutic characteristics sivity. The demand for personalised drugs,
bilize substances. throughout its entire lifecycle, resulting in escalating research and development
The development of microencapsula- consistent and dependable therapeutic efforts, and technological improvements
tion technology has also had a big impact outcomes. are driving a major expansion in the global
on drug formulation. Active pharmaceutical Additionally, an essential field of study market for understanding formulations.
ingredients (APIs) are enclosed in a pro- in drug formulations is the creation of tai- Among the advances reshaping the market
tective shell that is typically formed of poly- lored medication delivery methods. are enhanced excipients, 3D printing, and
mers through the process of microencap- Traditional oral formulations frequently nanotechnology. Additionally, the rise in
sulation. By using this method, drugs’ sta- cause drug waste and non-specific body chronic diseases, the shift towards person-
bility can be boosted they can be kept from distribution. Researchers can improve the alised therapy, and the ageing population
degrading, and their release profiles may targeting of medications to tissues or cells all contribute to the market's expansion. By
be managed. Sustained release formula- by utilizing innovative delivery approaches, maintaining uniform quality across mar-
tions, in which the drug is given gradually such as liposomes, nanoparticles, or kets, regulatory harmonisation and quality
over a long period of time to ensure a con- microencapsulation. By decreasing the standards are also essential in fostering
sistent therapeutic impact, are made possi- drug's interaction with healthy tissues, this market expansion. *
ble via microencapsulation. This method is not only increases its therapeutic index but
especially helpful for medications that have also reduces its risk of side effects. The author is research director,
a limited therapeutic window or call for Targeted drug delivery systems are TechSchi Research
117
(SPECIAL FEATURE |
FUTURE OF INDIAN AP] MARKET
Dr. Vikas Pandey are now being favored for API exports. sion, and the decision-maker is not the one
Table: Number of facilities manufactur- who pays. Additionally, unlike other sec-
ctive Pharmaceutical Ingredients ing active US-approved APIs, by region tors, pharmaceutical products do not
A\ (API) serves as the fundamental become obsolete over time. Medications
building block within the strategic The market experienced a positive like Aspirin, paracetamol, and metformin
framework of the pharmaceutical value influence in 2020 due to the outbreak of remain the gold standards in front-line ther-
chain. An API refers to any substance or COVID-19, with countries and prominent apy. Therefore, the key drivers of growth in
combination of substances utilized in the industry players producing substantial this industry are scale, quality, compliance,
final pharmaceutical product, with the pur-
pose of delivering a pharmacological action Number of facilities with Number of facilities with
and directly influencing the diagnosis, Region more than 30 active US- more than 10 active US-
treatment, alleviation, therapy, or preven-
approved API products approyed API products
tion of diseases. Of significant importance,
APls are responsible for producing the
therapeutic effects of medicines and are India 114 183
consequently the key drivers of innovation
and often the crucial intellectual property European Union 45 83
within the industry.
The market for API is divided into vari-
Other 7 22
ous segments based on different factors.
These include the business mode, which
includes captive API (produced in-house by China 4 35
pharmaceutical companies) and merchant
API (purchased from external suppliers). United States 3 19
Another segmentation factor is the synthe-
sis type, which includes synthetic APls
(chemically produced) and biotech APIs quantities of ingredients to meet the and process excellence. However, despite
(produced using biotechnological process- demand for COVID-19 treatment. The pan- these factors, India must prioritize the cre-
es). The type of drug is also considered, demic prompted pharmaceutical manufac- ation of robust and resilient supply chains
with segments for generic APIs (non- turers to reorient their strategies towards and accelerate infrastructure development
branded) and branded APIs (specific to a catering to a larger patient population. to ensure it actively participates in the
particular brand). Additionally, the market is In 2020, the global API market was val- upcoming phase of growth, rather than
segmented by application, encompassing ued at $180 billion, and it is projected to being a passive observer.By volume, the
various medical fields such as cardiology, exhibit a mid-single-digit compound annual pharmaceutical industry in India ranks as
pulmonology, oncology, ophthalmology, growth rate (CAGR) of around five to six the third-largest global producer of drugs.
neurology, orthopedics, and more. Finally, percent during the period of 2021 to 2026. With more than 250 facilities approved by
the market is further divided geographical- By 2026, the market is expected to reach the US Food and Drug Administration
ly into regions including North America, US $250 billion and surpass US $300 bil- (USFDA) and the UK Medicines and
Europe, Asia-Pacific, Middle East and lion by 2030, with an estimated increase of Healthcare products Regulatory Agency
Africa, and South America. approximately $50 billion every five years. (UKMHRA), India plays a crucial role in
According to IMS 2020 data, the generic supplying affordable generic pharmaceuti-
Market Outline segment holds a significant market share cals to millions of people across the world.
Over the past ten years, the API market on of 94 percent in terms of volume, while the The growth of the API market is being
a global scale has witnessed substantial innovator segment holds a six percent driven by several key factors. These
expansion, primarily driven by the rise in share. This indicates the substantial oppor- include the growing focus on drug research
chronic diseases. This growth can be tunity for penetration into the generic mar- and development for manufacturing, the
attributed to advancements in API manu- ket. Given the immense size of the market, rising significance of generic drugs, and
facturing techniques and the increasing there is a strong possibility of significant the increasing adoption of biopharmaceuti-
prevalence of conditions like cardiovascu- ancillarization, similar to what occurred in cals. However, the market's progress is
lar diseases and cancer. Furthermore, the automobile industry in the 1950s. We expected to face obstacles due to unfavor-
favorable government policies promoting anticipate the emergence of a considerable able drug price control policies implement-
API production and shifts in geopolitical cir- standalone capacity for API intermediates, ed in various countries and the presence of
cumstances have contributed to the mar- which can be seen as a new rising star in high manufacturing costs.According to the
ket's upward trajectory. However, the API the industry. International Diabetes Federation (IDF)
market is currently undergoing significant statistics of 2022, the number of individuals
transformations due to disruptions in the New opportunities for India in global with diabetes in India was approximately
supply chain caused by the COVID-19 API market 74 million in 2021. This figure is projected
pandemic. As a result of geopolitical fac- The pharmaceutical industry possesses a to rise to around 92.9 million by the year
tors and the desire to reduce reliance on unique characteristic wherein the con- 2030. The significant diabetic population in
China for API products, countries like India sumer does not make the ultimate deci- the country has heightened the emphasis
118
placed by pharmaceutical com- particularly noteworthy. While
India has Highest Number of USFDA Approved the global generic API markets
panies on the development of
advanced and safe drugs. This API Plants are predicted to grow at
increased focus necessitates a (%) approximately 6%, the Indian
substantial quantity of active 35 market is expected to demon-
pharmaceutical ingredients 30 = strate an impressive CAGR of
(API), thereby driving the 13.7% within the first four years
growth of the market. 25 alone. Furthermore, significant
The Indian pharmaceutical investments of approximately
20
industry has expressed signifi- US$ 4-5 billion have been
cant concerns regarding its 15 made in the API sector in India
reliance on China for APIs over the past few years.
(Active Pharmaceutical
Ingredients). The proportion of Figure:API Market Size from
API imports from China has 2021 to 2030
:0 aa tal Tt
dramatically increased from 0.5 Currently, majority of API manu-
Latin Canada China Restof facturers is concentrated in
percent in 1987 to approxi- World
Ametica
mately 78 percent in 2020. Source: Industry, Ind-Ra Asia Pacific, primarily India,
Around 55 percent of India's China, and Taiwan. Teva Active
API requirements are imported, chemical compounds and APIs Furthermore, India boasts the Pharmaceutical Ingredients
with the vast majority sourced for medicines, thereby reducing highest number of US (TAPI), Aurobindo, and Sun
from China. China holds a com- the country's dependence on FDAapproved manufacturing Pharma are the leading API
petitive advantage over India imports from China. plants outside of the US and is manufacturers in the region.
due to factors such as scale, Furthermore, in June 2021, the known for consistently meeting
subsidies, access to cheaper Finance Minister of India the rigorous standards set by Conclusions:
capital with lower interest rates announced an additional outlay the US FDA and the European The Indian pharma industry is a
(around four to five percent of INR 197,000 _ crores Directorate for the Quality of sunrise industry in the Indian
compared to 12-15 percent in (US$26,578.3 million) that will Medicines (EDQM). economy.APIs serve as vital
India), lower logistics costs (0.9 be utilized over a period of five components in drug manufac-
percent compared to four per- years for the pharmaceutical The Future Prospects turing, but the global market for
cent in India), and more afford- PLI scheme. This scheme will By the year 2030, the global APIs faces various challenges.
able power sources. As a focus on 13 key sectors, includ- API market is projected to To ensure operational
response to this situation, sev- ing active pharmaceutical reach approximately US$ 328 resilience during unforeseen
eral Indian companies have ingredients, drug intermedi- billion in size. In 2020, the mar- circumstances, the API industry
shifted their API, KSM (Key aries, and key starting materi- ket was valued at US$ 169 bil- must undertake restructuring
Starting Materials), and inter- als, to further support the lion, and it is expected to grow efforts in its production pro-
mediates requirements to growth of the industry. In India, at a compound annual growth cesses. China and India, offer-
domestic manufacturers who API Market leaders include rate (CAGR) of 6.1% from 2021 ing cost advantages, play sig-
have rapidly expanded their AurobindoPharma, Lupin Ltd, to 2030. Among the regions, nificant roles in driving API pro-
production capacity to meet the Viatris Inc., Sun Asia-Pacific exhibits the high- duction. Additionally, the Asia
increased demand. The Pharmaceutical Industries Ltd, est CAGR during the period of Pacific region is expected to
Government of India has also Teva Pharmaceutical Industries 2021 to 2030, positioning it as witness a gradual increase in
taken steps to support self- Ltd. In terms of drug manufac- the region with the most sub- the market for both generic and
reliance (Aatmanirbharta) turing volume, India ranks as stantial growth rate in the API innovative APlIs.While the API
through initiatives like the the second-largest producer market.Under the PLI scheme, industry presents a promising
Production Linked Incentive globally, following China and India initiated domestic manu- opportunity that has already
(PLI) scheme, aiming to Italy. In value terms, India facturing of 35 APIs in 2022, been tapped into, there is an
encourage the industry to stands at the 12th position on a reducing the country's depen- even greater opportunity for
enhance capacity building with- global scale. Projections indi- dency on import activities from India to become a comprehen-
in the country. cate that the Indian pharma- China by 90%.According to sive supplier of medicines.
In addition, the Indian gov- ceutical sector will reach a mar- credible industry sources, the Currently, raw materials for
ernment is implementing initia- ket size of US$75 billion by Indian pharmaceutical market APIs are imported, indicating a
tives to promote the presence 2024 and is expected to grow anticipated US$39 billion in scope for significant backward
of API products in the market, further to US$130-138 billion by 2022. However, the projections integration. By establishing suf-
which will contribute to the 2030. India has played a signif- for the following six years are ficient backward integration,
growth of the industry. For icant role in improving global India can seize the space of
instance, according to the India healthcare outcomes, fulfilling
Active Pharmaceutical Ingredients (API) Market Size 2021 Key Starting Materials (KSMs)
Brand [Equity Foundation approximately 60 percent of the or intermediates and further
(IBEF), in January 2021, the global demand for Anti-retrovi- enhance its position in the
Central government announced ral (ARV) drugs. Over the past pharmaceutical supply chain. @
the establishment of three bulk five years, Indian manufactur-
drug parks with an investment ing sites have accounted for The author is associate
of INR 14,300 crores about 38 percent of the total
professor, Amity Institute of
(US$1,957 million). These Abbreviated New Drug Pharmacy, Amity University
Figure:API Market
Size from 2021 to 2030
parks aim to manufacture Applications (ANDAs) filed.
119
(SPECIAL FEATURE |
FUTURE PROSPECTS OF BULK DRUGS IN INDIA
Dr. S. Mohana Lakshmi in the pharmaceutical sector is weakened Parks. Its objective is to reduce the manu-
by its heavy dependence on China, partic- facturing costs of bulk drugs by creating
Bulk Drug Substance ularly for vitamins and antibiotics, where top-notch shared infrastructure facilities
ulk drug substances, referred to as approximately 70% of the bulk drugs or supported by the Central Government, ulti-
Bx Pharmaceutical Ingredients APIs are sourced. China holds a dominant mately enhancing the competitiveness of
(API) according to the USP-NF defi- position in the production of APIs using fer- the domestic bulk drug industry.
nition, are utilized in the production of drug mentation processes. In the fiscal year The government is dedicated to mini-
products, typically in conjunction with 2021, India imported APIs and drug inter- mizing the country's reliance on imports
excipients. These bulk drug substances mediates worth Rs 28,529 crore, with and bolstering indigenous manufacturing.
can be obtained through chemical synthe- imports from China accounting for 68% (Rs The Bulk Drug Parks developed under this
sis, plant or animal sources, or through bio- 19,402 crore) of the total value. The quan- scheme will offer comprehensive common
logical or recombinant technology. tity of these imports in the same fiscal year infrastructure facilities in one location, fos-
Alongside the API, the drug substance may amounted to 3,90,475.7 metric tonnes. tering a robust ecosystem for bulk drug
contain additional substances or impurities manufacturing within the country. This
related to the product and its manufactur- Indian government’s initiative in the approach will significantly reduce manufac-
ing process. The World Health making of domestic bulk drugs turing costs. The scheme is expected to
Organization defines API as any substance In an effort to enhance self-sufficiency in promote domestic production of bulk drugs,
or combination of substances employed in the pharmaceutical sector, the Indian gov- reducing import dependence and enabling
a finished pharmaceutical product (FPP) to ernment has implemented a scheme worth India to establish a prominent position in
provide pharmacological activity or directly Rs. 3,000 crores to promote the establish- the global market by facilitating access to
impact the diagnosis, cure, mitigation, ment of bulk drug parks. The objective of standardized testing and infrastructure
treatment, or prevention of diseases. this scheme is to address the existing situ- facilities. Additionally, the scheme aims to
Furthermore, they may have an immediate ation. Under this initiative, the government assist the industry in meeting environmen-
effect on restoring, correcting, or modifying is facilitating the establishment of three tal standards at a reduced cost through
physiological functions in human beings. bulk drug parks within the country. The innovative methods of shared waste man-
Drug product (also called the dosage financial support provided by the central agement systems, while optimizing
form or finished product per USP-NF defi- government for each park is capped at a resources and achieving economies of
nition) contains one or more drug sub- maximum limit of Rs. 1000 crore. A total of scale.
stances, usually with excipients, in the final 13 states, including Uttar Pradesh, Tamil The proposed Bulk Drug Parks in
packaging intended for marketing. Nadu, Telangana, Karnataka, Gujarat and Andhra Pradesh will receive
Maharashtra, Gujarat, Madhya Pradesh, financial assistance equivalent to 70% of
Bulk drugs (Active Pharmaceutical Rajasthan, Punjab, Haryana, Himachal the project cost for common infrastructure
Ingredients) The Indian Pharmaceutical Pradesh, Andhra Pradesh, and Odisha, facilities. However, for Himachal Pradesh,
Industry have submitted proposals to _ the being a hilly state, the financial assistance
The Indian pharmaceutical industry has Department of Pharmaceuticals for the will be 90% of the project cost. The maxi-
experienced remarkable growth in recent three parks. The Department, guided by an mum _ assistance provided under this
decades and contributes approximately Advisory Committee led by the CEO of scheme for a single Bulk Drug Park is lim-
1.72 percent to the nation's GDP. It is pro- NITI Aayog, evaluated the proposals using ited to Rs. 1000 crores.
jected to achieve a market value of $65 bil- both quantitative and qualitative method- According to the proposals submitted
lion by 2024 and $130 billion by 2030. This ologies. After careful evaluation, the pro- by these states, the Bulk Drug Parks will be
growth is primarily fueled by the rising posals from Andhra Pradesh, Gujarat, and established on specific land areas. These
demand for affordable and high-quality Himachal Pradesh have received final include 1402.44 acres of land in Tehsil
medicines, both domestically and interna- approval for the development of the bulk Haroli, District Una, Himachal Pradesh;
tionally. Currently, India ranks as the 3rd drug parks. 2015.02 acres of land in Tehsil Jambusar,
largest producer in terms of volume and District Bharuch, Gujarat; and 2000.45
the 14th largest in terms of value on a glob- acres of land in K.P. Puram&Kodhada of
al scale. Indian pharmaceutical exports The Department of Pharmaceuticals —- ThondagiMandal, East Godavari District,
have witnessed an impressive growth rate Government of India: Bulk Drug Parks Andhra Pradesh. Additionally, the
of 103 percent since 2013-14, increasing The Department of Pharmaceuticals has Government of Assam has proposed a
from INR 90,415 Crores to INR granted provisional approval to the propos- Pharmaceutical Park in Chaygaon,
1,83,422Crores in 2021-22. India meets als put forth by three states, namely Kamrup Rural, covering an area of 100
approximately 20% of the global demand Himachal Pradesh, Gujarat, and Andhra acres with an estimated project cost of INR
for generic drugs, earning it the reputation Pradesh, as part of the "Promotion of Bulk 153.64 crores. In the Budget 2023, Union
of being the "Pharmacy of the World." Drug Parks" scheme. This scheme is a sig- Finance Minister NirmalaSitharaman allo-
nificant initiative aimed at supporting the cated Rs 1000 crore for the development of
Bulk drug industry — Indian Scenario manufacturing of bulk drugs in the country. bulk drug parks.
Despite the significant growth, India faces Notified in 2020, the scheme has a finan- This scheme exemplifies the spirit of
a significant reliance on China for the sup- cial allocation of Rs. 3,000 crores and pro- cooperative federalism, where the Central
ply of active pharmaceutical ingredients vides financial assistance to the three Government and State Governments col-
(APIs). The country's competitive position states for the establishment of Bulk Drug laborate to establish Bulk Drug Parks, aim-
120
of which have substantial API businesses,
have greatly benefited from the scheme. It
is projected that Indian API-producing firms
will experience a Compound Annual
Growth Rate (CAGR) of 9-11 percent over
the next five years.
Under the Production Linked Incentive
(PLI) scheme, India has initiated the pro-
duction of 22 active pharmaceutical ingre-
dients (API) or bulk drugs. These include
1,1 cyclohexane diacetic acid (CDA), para
amino phenol (which serves as a raw mate-
rial for paracetamol), sulfadiazine, atorvas-
tatin, carbamazepine, oxcarbazepine, lev-
ofloxacin, and more. These APIs have gen-
erated sales during the current financial
year..
121
(SPECIAL FEATURE |
INDIAN API TO REACH US $130 BN BY 2030
Komal Saini, Vandita Kakkar and China, is home to significant API manu- Improving kinetics, process engineering, sol-
facturers, with over 1,600 operating in these vent recovery, optimal batch sizes, scale, and
ver the past few decades, the phar- two countries. Leading API manufacturers in minimizing changeovers will be critical for cost
Orie industry in India has expe- India include GlaxoSmithKline, Teva Active efficiency. Companies will concentrate on
rienced significant growth, contribut- Pharmaceutical Ingredients (TAPI), Dr. fewer APIs but manufacture them in larger
ing approximately 1.72% to the nation's GDP. Reddy's Laboratories, Aurobindo Pharma, quantities to achieve scale, procurement, and
The industry is expected to reach $65 billion Lupin, Ipca, Cipla, Divi's Laboratories, cost efficiencies.
by 2024 and $130 billion by 2030, driven by Sandoz, Ranbaxy, Matrix, Sun Pharma, The industry's reliance on China for APIs
the rising demand for affordable and high- BASF, and Pfizer. has been a major concern for the Indian phar-
quality medicines both domestically and glob- Ipca has emerged as one of the top maceutical sector. The percentage of API
ally. Currently, India ranks as the 3rd largest exporters of APIs in India, with nearly 25% of imports from China has risen from 0.5% in
producer by volume and 14th largest by value its turnover coming from this segment. 1987 to around 78% in 2020. India imports
in the world. The country's pharmaceutical Around 75% of their API products are export- approximately 55% of its API requirements,
exports have seen remarkable growth, ed to regulated markets such as the USA, with almost all imports coming from China.
increasing by 103% since 2013-14, from INR Canada, Europe, and Australia. Ipca has China enjoys advantages such as scale, sub-
90,415 crores to INR 1,83,422 crores in been a prominent player in the Indian API sidies, access to cheaper capital (with a cost
2021-22. India meets approximately 20% of market for over 20 years, particularly in the of four to five percent compared to 12-15% in
the global demand for generic drugs, earning anti-malarial and anti-hypertensive therapeu- India), lower logistics costs (0.9% versus four
the title of the "Pharmacy of the World." tic segments. Other major domestic players percent in India), and cheaper power.
Active Pharmaceutical Ingredient (API) is a such as Dr. Reddy's Laboratories, Aurobindo Indian API manufacturers are actively
critical segment of the pharmaceutical indus- Pharma, lpca Laboratories, Alembic enhancing their credibility in regulated mar-
try, accounting for around 35% of the market. Pharmaceuticals, Glenmark kets by obtaining approvals for their products,
APIs are the biologically active components Pharmaceuticals, Jubilant Life Sciences, and therapeutic applications, and manufacturing
of drugs that produce the intended medical Shasun Pharmaceuticals have also estab- facilities. These companies, including those
effect. As defined by the World Health lished a strong presence in these markets selling finished dosage forms, continue to out-
Organization, APIs are substances or combi- and are well-positioned to seize future oppor- perform competitors from China, Italy, and
nations of substances used in finished phar- tunities. other countries in terms of Drug Master Files
maceutical products (FPPs) intended to pro- (DMFs), which are seen as a measure of
vide pharmacological activity or have a direct Highlights of API market quality. India's combination of higher quality
effect in the diagnosis, cure, mitigation, treat- There is a misconception that India's patent and cost containment makes it increasingly
ment, or prevention of diseases, or to restore, regime provided it with a structural advan- attractive for API outsourcing. In fact, India
correct, or modify physiological functions in tage. While this may be true for the domestic has been recognized as one of the leading
human beings. India holds the position of the market, where APIs could be produced and global players, with a significant number of
3rd largest API producer globally, with an 8% sold even under patent, it did not necessarily DMF filings and dossier registrations for
share of the global API industry. The country contribute to India becoming a major exporter active pharmaceutical ingredients, along with
manufactures over 500 different APIs and to regulated markets. Additionally, several numerous manufacturing facilities approved
contributes 57% of APIs to the World Health other countries also had a process patent by regulatory authorities in developed coun-
Organization's prequalified list. The Indian regime until they joined TRIPs in 1998. tries.
API market is projected to grow at a As of 2020, the global API market was val-
Compound Annual Growth Rate (CAGR) of ued at $180 billion, and it is projected to grow Conclusion
13.7% in the next four years, which is approx- at a mid-single-digit CAGR (around five to six The API market is being propelled by the cost
imately 8% higher than the generic API indus- percent) from 2021 to 2026, reaching $250 advantages of China and India, which have
try growth rate. The Indian API sector has billion by 2026 and $300 billion by 2030, established themselves as key manufactur-
become an attractive investment opportunity adding approximately $50 billion every five ing hubs. With strong government support,
for various investors and venture capitalists. years. According to IMS 2020, generics hold a advancements in intellectual property (IP)
The industry benefits from India's robust 94% share of the API market by volume, while systems, and improved manufacturing stan-
domestic market, advanced chemical indus- innovators hold a six percent share. This indi- dards, both countries are driving the growth
try, skilled workforce, stringent quality and cates a tremendous opportunity for penetra- of the generic and innovator API markets in
manufacturing standards, and lower costs tion into the generic market. Given the size of the Asia-Pacific region. As a result, the API
(around 40% less than in the West) for estab- the market, ancillary industries, similar to what market in this region is anticipated to experi-
lishing and operating modern plants, giving it happened in the automobile industry in the ence consistent expansion. In the near
a competitive edge. 1950s, are expected to develop, leading to a future, India has the potential to surpass
significant standalone capacity for API inter- China and become a leading player in the
The major players mediates. global API market. e
India holds a crucial position in the global APIs reside at the base of the value pyra-
active pharmaceutical ingredients (API) mar- mid, making them highly susceptible to the Saini is from Chandigarh College of
ket, particularly in the US generic pharma- impact of genericization. Price erosion is also Pharmacy, Chandigarh Group of Colleges
ceutical industry, where it accounts for about most pronounced in this segment. Therefore, and Kakkar is from University Institute of
half of the certified dossiers filed worldwide for mature APIs, the focus will shift from R&D Pharmaceutical Sciences, Panjab
for APIs. The Asian region, specifically India capabilities to excellence in engineering. University
122
(SPECIAL FEATURE |
OPPORTUNITIES AND CHALLENGES FOR INDIAN PHARMA DRUGS
Dr. Vikas Pandey
123
valued at USD 390.57 billion in 2020, tical industry in India, reg-
and it is anticipated to reach approx- ulatory authorities need to
Indian Pharmaceutical Market (USS billion)
imately USD 574.63 billion by 2030, streamline the approval
demonstrating a compound annual process, particularly for
growth rate (CAGR) of 5.59% 140.0 investments in emerging
between 2021 and 2030. 420.0 research and develop-
The Pradhan Mantri Bhartiya ment (R&D) fields that
Janaushadhi Pariyojana (PMBJP) 7280 often require higher
aims to make quality medicines 80.0 investments compared to
accessible to the general public in 60.0 generic drugs.
India at affordable prices. As part of . Collaborating with global
this initiative, PMBJP stores have 40.0 regulatory bodies can also
been established to offer generic 20.0 encourage pharmaceuti-
drugs that are available at lower cal growth in the country.
costs, while ensuring they maintain Generic medicines are
2021 2024 2030
the same level of quality and effec- not only cost-effective but
tiveness as expensive branded med- capabilities and favorable market conditions, also as safe and effective
ications. India has established itself as one of the most as branded medications. Their widespread
lucrative pharmaceutical markets globally. use in India has been further promoted
Challenges In every industry, there are established through initiatives like the PMBJP, which aims
The pharmaceutical industry in India faces processes to benefit society. For instance, to raise awareness among the public.
several policy and regulatory challenges. The third-party manufacturing pharma companies Furthermore, the pharmaceutical industry has
intellectual property rights (IPR) regime in require students who can become future demonstrated remarkable progress and
India is not considered favorable for the researchers and developers. It is crucial for adaptability in response to a changing envi-
Pharma industry. The drugs price control the pharmaceutical industry to provide the ronment, positioning it for greater success in
order puts pressure on prices, and the Goods necessary training to students aligned with the export of generic drugs from India.
and Services Tax (GST) levy based on maxi- their specific needs. Unfortunately, only a few
mum retail price (MRP) imposes additional industries are actively considering this Conclusions:
burdens on companies with higher taxes. approach. Pharmaceutical companies should India has emerged as a significant and
Furthermore, challenges such as inadequate collaborate with Indian academic institutions increasingly influential player in the global
data collection on drugs and insufficient train- to identify qualified candidates who possess pharmaceutical sector. However, there is still
ing for drug inspectors have resulted in the knowledge and skills required by the untapped potential for further growth.
widespread malpractice among drug sellers, industry. Strengthening communication channels
hindering the smooth entry of drugs into the A new era of biopharmaceutical innova- between stakeholders and Indian regulators is
market. tion is on the horizon. As our understanding of crucial to establish a robust platform for the
India heavily relies on China for approxi- genetics improves, so does our ability to tar- Indian Pharmaceutical Industry. Traditional
mately 77% of its active pharmaceutical ingre- get drugs more effectively. This enhanced major pharmaceutical companies are no
dients (APIs), which are imported. This heavy knowledge, coupled with robust and cost- longer offering the same level of service as
dependence on China for APIs poses a risk to effective genetic profiling, will enhance patient before. Recognizing the importance of respon-
the drug supply chain. The quality of drugs outcomes and expedite the speed and reduce sible and human-centric development and Al
has also been affected, leading to availability the cost of clinical trials. These advancements utilization, India has become a founding mem-
and quality issues. Regulatory bodies have signify a significant shift in the pharmaceutical ber of the "Global Partnership on Artificial
imposed bans on certain drugs due to poor landscape and hold great promise for the Intelligence" (GPAI). This demonstrates the
quality. Moreover, pharmaceutical companies future. government's positive approach to supporting
often engage in unethical practices by offering such initiatives. As a developing country, India
freebies and gifts to doctors to promote their The Future Prospects must continue focusing on fostering similar
drugs. This raises concerns about the integri- In order to achieve their objectives, Indian innovative mindsets in the future.
ty of the healthcare system and patient safety. pharmaceutical companies need to adopt The government has also fostered an
Another challenge is the lack of adequate bold strategic measures and venture into environment conducive to the establishment
training for medical representatives, as well unexplored territories. It is essential to estab- of healthcare startup firms. This enables
as the presence of quacks (fake doctors), lish policies that instill confidence in drug pric- patients and companies to coexist harmo-
which increases the risk to patients’ lives. ing and foster a stable regulatory environ- niously without placing excessive burdens on
Additionally, there is a shortage of research ment. A key focus should be on bolstering API one another. With its existing advantage of
and development due to funding constraints, manufacturing capabilities to reduce depen- scale and global reach in the pharmaceutical
resulting in limited academia-industry collabo- dence on imported APIs. This can be accom- space, India now needs to ascend the value
ration. This hampers innovation and the plished through various means, including the chain by scaling up its research and develop-
development of new drugs and therapies. establishment of dedicated zones exclusively ment (R&D) efforts and fostering innovation.
for API production. Positive strides have This will propel the industry forward, transi-
New opportunities for India in global API already been taken by several state govern- tioning from a "Make in India" approach to a
market ments in India to promote industry growth. more comprehensive "Discover and Make in
The Indian pharmaceutical industry is highly Provinces such as Andhra Pradesh and Uttar India" approach.
regarded worldwide and has emerged as one Pradesh have announced plans to develop e
of India's most successful sectors. Its contri- "pharma parks" that will provide a competitive The author is associate professor,
butions to healthcare outcomes and the econ- advantage to the sector. Amity Institute of Pharmacy, Amity
omy have been significant. With world-class To facilitate the growth of the pharmaceu- University
124
(SPECIAL FEATURE |
OVERVIEW OF INDIAN PHARMA MACHINERY
Rajesh Nath quality control. ceutical machinery industry has wit-
With a positive growth trajectory, nessed significant growth in its export
he Indian pharmaceutical increasing domestic demand, a focus market. In recent years, India has
machinery industry plays a cru- on quality compliance, and a proactive become a prominent exporter of phar-
cial role in the manufacturing and approach to innovation, the Indian maceutical machinery to various coun-
packaging processes of pharmaceuti- pharmaceutical machinery industry is tries worldwide. The industry's export
cal products, encompassing a wide poised for further expansion and is revenue reached approximately USD
range of machinery and equipment well-positioned to contribute to the 650 million in 2020, highlighting the
used in areas such as formulation, fill- growth and success of the pharmaceu- industry's competitiveness in the global
ing, packaging, labelling, and quality tical sector in India and abroad. market.
control of pharmaceuticals.
The industry has experienced sig- Statistics and Industry Highlights: * Employment Generation: The phar-
nificant growth over the years, driven The industry's adherence to quality maceutical machinery industry plays a
by the country's robust pharmaceutical standards, government support, and vital role in job creation. It provides
sector. The industry is characterized by focus on research and development employment opportunities to a large
the presence of both domestic and contribute to its competitiveness in the workforce engaged in manufacturing,
multinational players, offering a diverse global market. research and development, quality
range of machinery solutions to meet ¢« Growth Rate: The Indian pharmaceu- control, and maintenance of pharma-
the industry's needs. Indian manufac- tical machinery market has experi- ceutical machinery. The _ industry's
turers cater not only to the domestic enced a robust growth rate of approxi- growth contributes to the overall
market but also export pharmaceutical mately 8% CAGR over the past few employment landscape in India.
machinery to various countries world- years. This growth is fuelled by the
wide. The industry has established increasing demand for pharmaceutical * Government Initiatives: The Indian
manufacturing facilities across various products and the need for advanced government has undertaken several
regions of India, equipped with modern machinery to support production. initiatives to support the pharmaceuti-
technology and a skilled workforce to cal machinery industry. Programs such
meet the growing demand for pharma- * Market Size: The market size of the as "Make in India" and "Pharma Vision
ceutical machinery. Indian pharmaceutical machinery 2020" aim to promote domestic manu-
In recent years, the industry has industry was valued at approximately facturing, research and development,
gained recognition for its ability to pro- USD 2.0 billion in 2021. The industry and technological advancements in the
vide cost-effective machinery solutions has shown consistent growth, driven by pharmaceutical sector. These _initia-
without compromisingon quality. Indian the expanding pharmaceutical sector tives have facilitated the growth of the
pharmaceutical machinery manufactur- and the government's focus on promot- pharmaceutical machinery industry.
ers have made significant strides in ing healthcare and pharmaceutical
complying with international quality manufacturing. * International Recognition: Indian
standards, such as Good pharmaceutical machinery manufactur-
Manufacturing Practices (GMP) and * Domestic Consumption: India's phar- ers have gained international recogni-
various certifications, to ensure that the maceutical market is one of the largest tion for their quality products and com-
machinery meets global regulatory globally in terms of volume, with a high petitive pricing. The industry has wit-
requirements. Furthermore, the indus- demand for pharmaceutical machinery nessed increased demand for its
try has actively expanded its export to support production. The domestic machinery in global markets due to its
market, capitalizing on the growing consumption of pharmaceutical adherence to international quality stan-
demand for pharmaceutical machinery machinery is driven by the need to dards and compliance with regulatory
worldwide. Indian machinery has cater to the growing population's requirements.
gained a reputation for its competitive- healthcare needs and the rising
ness in terms of pricing, adherence to demand for quality pharmaceutical * Collaboration and Partnerships:
quality standards, and the ability to products. Indian pharmaceutical machinery man-
cater to diverse customer require- ufacturers actively collaborate with
ments. ¢ Manufacturing Facilities: India has domestic and international pharmaceu-
As the pharmaceutical industry con- established a strong manufacturing tical companies to develop customized
tinues to evolve, the Indian pharma- infrastructure for pharmaceutical machinery solutions. Such collabora-
ceutical machinery sector is keeping machinery. Several manufacturing tions enhance technology transfer, pro-
pace with the changing needs of phar- facilities are located in key regions mote knowledge exchange, and foster
maceutical manufacturers. The indus- such as Maharashtra, Gujarat, and innovation in the industry.
try is investing in research and devel- Tamil Nadu. These facilities are
opment, embracing automation and equipped with advanced technology * Research and Development: The
digitization, and exploring advanced and employ a skilled workforce to meet industry invests significantly in
technologies such as robotics, artificial the industry's demands. research and development activities to
intelligence, and data analytics to stay at the forefront of technological
enhance productivity, efficiency, and * Export Market: The Indian pharma- advancements. Manufacturers focus
125
(SPECIAL FEATURE |
FUTURE PROSPECTS OF INDIAN PHARMA FORMULATIONS
Dr. Sanjay Agrawal changes, influenced by the current companies increasingly focus on devel-
health priorities and the need to adapt oping complex formulations, biosimi-
he Covid-19 pandemic has had to the "new normal." The focus is shift- lars, and specialty drugs. This _ shift
devastating effects on ing towards prevention rather than towards innovative and niche formula-
economies worldwide and has treatment, and patients are becoming tions is expected to propel the growth
caused a global health crisis. The man- more empowered and involved in their of the Indian pharma industry in global
ufacturing sectors, including the phar- healthcare. The industry is embracing markets.
maceutical industry, have faced signifi- digital health technologies, automation,
cant challenges during this period, and analytics tools to make healthcare Favourable Regulatory
highlighting the urgent need for India to more patient-centric and efficient. Environment: The regulatory environ-
achieve _ self-sufficiency. However, Stable supply chains have become ment in India has undergone significant
despite the initial push towards self- crucial, as the pandemic exposed the improvements in recent years, making
reliance with the "Atmanirbhar Bharat" vulnerabilities of heavily dependent it more conducive for pharmaceutical
narrative, the ongoing pandemic has supply chains. Businesses are consid- companies. Initiatives such as imple-
disrupted self-sufficiency. ering relocating their production and menting the Goods and Services Tax
One of the major revelations of the supply hubs closer to their target con- (GST) and introducing the Drug Price
outbreak was India's reliance on sumers to mitigate risks. Efforts are Control Order (DPCO) have brought
imports for basic medical supplies. being made to ensure a stable supply transparency and standardization in
Export limitations and supply inconsis- of essential medicines and reduce pricing and taxation. Additionally, the
tencies sharply increased domestic reliance on vulnerable areas. government's emphasis on promoting
pricing for essential medications and To thrive in the future, pharmaceuti- ease of doing business and protecting
disrupted international trade. This cal businesses must prioritize patient- intellectual property rights has created
exposed the areas for improvement in centric approaches, embrace digital a favourable ecosystem for the growth
India's pharmaceutical industry, partic- health strategies, and explore innova- of Indian pharma formulations.
ularly the low availability of Key tive technologies. Patients should be Technological Advancements: The
Starting Material (KSM), which is included as equal partners in health- Indian pharmaceutical industry has
essential for formulation development. care decision-making, and the industry embraced technological advancements
The pharmaceutical industry is a should focus on creating more than just to enhance productivity, quality, and
significant revenue generator, with an medications by integrating digital efficiency. Rapid technological
annual revenue of US$1.2 trillion. To health technologies. Digital pills, virtual advancements will shape the future of
thrive in the future, the industry must reality applications, pharmacoge- the pharmaceutical industry. Precision
embrace new technologies, patient- nomics-based precision medicine, and medicine, which includes personalized
centric design, and innovations while Al-driven drug development are some and predictive medicine, will signifi-
prioritizing prevention and _ digital trends shaping the pharma industry's cantly impact access to medicines.
health. The stakes are high, and the future. Artificial intelligence (Al) will revolution-
industry needs to adapt quickly to the ize healthcare by improving medical
fast pace of technological disruption. Some Relevant Sectors for Future research, creating treatment plans,
One of the challenges faced by the Prospects of Indian Pharma accelerating medical imaging, and
Indian pharmaceutical industry is over- Formulations even aiding in developing new drugs.
dependence on China. While Indian Growing Domestic Market: The Indian Al-driven drug development processes
businesses have positioned them- pharmaceutical market has been wit- can significantly reduce the time and
selves as leaders in the global pharma- nessing steady growth due to an aging cost of bringing new medicines to mar-
ceutical industry, the heavy reliance on population, rising disposable incomes, ket.
Chinese imports for fundamental raw and increased access to healthcare. Automation, artificial intelligence
materials, particularly Active The demand for affordable and high- (Al), and data analytics are increasing-
Pharmaceutical Ingredients (APIs), has quality medicines is expected to drive ly integrated into various aspects of the
been a cause for concern. the growth of Indian pharma formula- pharma value chain, including formula-
About 70% of the pharmaceutical tions in the domestic market. The gov- tion development. These advance-
industry's API needs are met through ernment's focus on improving health- ments enable companies to streamline
Chinese imports, which offer lower care infrastructure and increasing processes, improve product quality,
costs than Indian-made APIs. The healthcare spending further enhances and reduce time-to-market for new for-
heavily subsidized pricing of Chinese the opportunities for domestic pharma mulations. Incorporating technology-
APIs led to the shutdown of domestic companies. driven solutions will be crucial in shap-
API production plants in India. The Increasing Global Demand: Indian ing the future of Indian pharma formu-
higher cost of technology and infras- pharma formulations have gained sig- lations.
tructure required for API production in nificant traction in the international mar- Focus on Research and
India further contributed to the decline ket, primarily driven by cost-effective- Development: Indian pharma compa-
in domestic API manufacturing. ness and adherence to stringent quali- nies invest heavily in research and
The pharmaceutical and healthcare ty standards. With a strong emphasis development to develop novel formula-
industries are undergoing significant on research and development, Indian tions and drug delivery systems. The
127
emphasis on innovation and intellectu- Practices: Sustainability has become a normal," ensure stable supply chains,
al property has led to collaborations global key focus for the pharmaceutical prioritize prevention and patient-centric
with global pharmaceutical giants, industry, and Indian companies are no approaches, and embrace innovative
research institutions, and academia. exception. With a greater emphasis on technologies. The prospects of Indian
This focus on R&D has resulted in environmental consciousness and pharma formulations look promising,
development of new formulations and responsible manufacturing practices, driven by a growing domestic market,
enabled companies to file for patents Indian pharma companies are adopting increasing global demand, a
and strengthen their product pipelines. sustainable measures throughout the favourable regulatory environment,
Expansion into Emerging Markets: formulation development process. This technological advancements, and a
Indian pharma companies are expand- includes reducing waste generation, focus on research and development.
ing their presence in emerging mar- optimizing energy consumption, and With the right strategies and invest-
kets, such as Africa, Southeast Asia, implementing eco-friendly packaging ments, Indian pharma companies can
and Latin America. These markets offer solutions. Such sustainable practices continue to play a significant role in
significant growth potential due to ris- contribute to environmental preserva- providing affordable and high-quality
ing healthcare expenditure, an increas- tion and enhance the reputation and formulations to meet the evolving
ing middle-class population, and a competitiveness of Indian pharma for- healthcare needs of the world. Only by
growing demand for _ affordable mulations in the global market. rethinking traditional business models
medicines. By leveraging their exper- In conclusion, The pharmaceutical and putting the patient first can phar-
tise in formulation development and industry is undergoing significant trans- maceutical businesses thrive in an era
cost-effective manufacturing, Indian formations driven by the need for self- focused on prevention, early detection,
pharma companies can tap into these sufficiency, technological advance- and personalized therapies. e
markets and establish a_ strong ments, and changing healthcare priori-
foothold. ties. To succeed in the future, the The author is
Sustainable Manufacturing industry needs to adapt to the "new pharmaceutical consultant
VWV- growing concerns around quality issues of medicines may include doing an analysis and then calculating what the
exported from India and to be audit ready for unan- weight of the sample should be to pass and then fabricating the
nounced audits, experts recommend it is high time to balance data.
adopt Good Documentation Practices (GDP) to avoid warning let- Performing 'chromatographic analysis’ without any physical chro-
ters, product recalls or import alerts with increasing USFDA matographs, merely reintegrating and printing the same sets of
inspections. Experts say that the US Food and Drug data using a chromatography data system is yet another form of
Administration (FDA) have raised concerns over the quality of falsification.
drugs manufactured by some pharmaceutical firms and that has Experts have also pinpointed lack of awareness and effective-
led to a slump in the number of Indian pharmaceutical companies ness of trainings leading to data integrity issues in pharma com-
receiving approvals from the FDA, resulting in loss of business for panies.
them. GDP is a set of rules that are required for the safety and Data integrity refers to maintaining and assuring the accuracy
quality of pharmaceutical products. In the pharmaceutical sector, and consistency of data over the entire data life-cycle to ensure
documentation is required in the areas of manufacturing, distri- data is recorded exactly as intended and upon later retrieval,
bution, laboratory, clinical and documentation. ensure the data is the same as it was when it was originally
Highlighting the role of GDP, Dr Sanjt Singh Lamba, Managing recorded.
Partner, Trillyum Consulting and Advisory and chief executive offi- Dr Lamba further explained, “Employees need to be trained to
cer of Biocuris Pharmaceuticals Private Limited said, “A GDP understand GMPs. Inadequate training causes employees to
record must have only one Official Record. GDP records must consider activities as a chore rather than understanding their rel-
have a defined Record Owner (either function or person). Record evance in light of GMP.”
Owners must be defined in the record management inventory. Besides quality assurance, lack of investment in research and
This inventory must be approved by the corresponding Quality development and disruptions due to Covid-19 pandemic is also a
group and be stored in the Electronic Document Management cause of concern.
System (eDMS).” Experts also voiced the concern that diversion of management
"Senior management, under the European Union (EU) Good and employees’ attention from their daily activities, to focus on
Manufacturing Practices (GMP) Chapter 1 is responsible for the Corrective Action and Preventive Actions (CAPAs) as a part of the
overall quality system and that includes data integrity", added Dr lengthy remediation process tends to cost time, money and often
Lamba. loss of talent. Therefore there is an urgent need towards creating
There are also rampant cases of data falsification and fraud in the awareness and sending a clear message of “Zero tolerance to
pharma industry which include copying a passing result file from data integrity breach (DIB)”.
one batch into a new batch without doing the actual analysis. This - Our Bureau, Mumbai
128
(SPECIAL FEATURE |
THE IMPORT AND EXPORT OF INDIAN APIS :
A GLOBAL PERSPECTIVE
able exporter of pharmaceutical prod- 3. Wide Range of Therapeutic
Dr. Sanjay Agrawal ucts. Options: API imports enable Indian phar-
Overall, India has a robust and rapid- maceutical manufacturers to access a
he pharmaceutical industry is a ly growing API industry, supported by diverse range of APIs, expanding the
| vital component of global factors such as a large skilled workforce, therapeutic options available to health-
healthcare, with Active cost advantages, established manufac- care providers and patients. This facili-
Pharmaceutical Ingredients (APIs) being turing infrastructure, and adherence to tates the production of a wide range of
the crucial building blocks for producing international quality standards. The medications to address various medical
various medicines. India, known as the country is known for producing diverse conditions.
"pharmacy of the world," has emerged APIs, catering to domestic and interna-
as a significant player in the API market, tional markets. Opportunities for API Imports:
both as an importer and exporter. In this The Indian API industry has grown 1. Collaborations and Technology
blog, we will explore the significance of substantially over the years, fuelled by Transfers: Collaborating with internation-
the import and export of Indian APIs, factors like patent expirations, increasing al suppliers and entering into technology
highlighting India's role in the global generic drug production, and rising transfer agreements can enhance India's
pharmaceutical landscape. demand for affordable healthcare solu- capabilities in API manufacturing. This
tions worldwide. India's pharmaceutical collaboration can help build local capac-
Indian API Industry Overview industry holds a critical global position, ities, improve process efficiencies, and
India plays a significant and vital role driven by its extensive production of reduce import dependency.
in the global pharmaceutical and vaccine generic medicines, a wide range of vac- 2. Research and Development:
industry. It holds the distinction of being cine offerings, adherence to quality stan- Increased investment in research and
the largest provider of generic medicines dards, and affordability. Its contributions development (R&D) activities can lead to
worldwide. With a share of 20% in glob- to global healthcare accessibility and the development of innovative and com-
al supply volume, India _ contributes affordability make it a pivotal player in plex APIs within India. Focusing on
approximately 60% of the global vac- the pharmaceutical and vaccine land- indigenous R&D capabilities can help
cines. Regarding volume, India ranks scape. the country reduce its reliance on import-
third globally and holds the fourteenth ed APIs and foster self-sufficiency.
position in terms of value. The Indian Import of APIs in India 3. Export Potential: India's expertise
pharmaceutical industry encompasses While India is a significant exporter of in pharmaceutical manufacturing and its
various segments, including OTC APIs, it also relies on imports to meet cost competitiveness can create oppor-
medicines, generics, APIs, vaccines, domestic pharmaceutical requirements. tunities to export APIs to other countries.
biosimilars, and custom research manu- Several factors contribute to the import By leveraging its manufacturing capabili-
facturing (CRM). of APIs, including the need for special- ties and adhering to global quality stan-
Notably, India is the global leader in ized molecules, technological limitations, dards, India can become a significant
supplying vaccines such as DPT, BCG, and cost considerations. India imports player in the API export market.
and Measles. Moreover, it boasts the APls from various countries, including
highest number of US FDA-approved China, the United States, Germany, Italy, Export of Indian APIs
plants outside the United States. The etc. The import of APIs is crucial in India's prowess in the API sector
Indian Pharmaceutical Industry's unique ensuring a steady supply of essential extends to its role as a significant
selling point (USP) lies in its ability to drugs within the country. exporter. India holds a 5.92% share of
offer medications at affordable prices the global market for pharmaceuticals
without compromising on quality. This Importance of API Imports: and drugs. The central portion of India's
has earned India the well-deserved rep- 1. Meeting Domestic Demand: India exports comprises formulations and bio-
utation of being the "Pharmacy of the is the largest provider of generic logics, accounting for 73.31% of the total
World." medicines globally, and a significant por- share, followed by drug intermediates
One of the remarkable achievements tion of its pharmaceutical production and bulk drugs. In the fiscal year 2021-
of the Indian Pharma Industry is its role depends on imported APIs. Importing 22, the value of India's pharmaceutical
in providing access to affordable HIV APIs helps meet the increasing demand product exports reached US$ 24.62 bil-
drugs. Additionally, India is one of the for affordable and quality drugs in the lion, maintaining a steady performance
largest suppliers of low-cost vaccines country. compared to the previous year.
globally, contributing significantly to glob- 2. Ensuring Drug Quality and Safety:
al healthcare initiatives. APIs imported from reputed international India's pharmaceutical products find
Regarding exports, India primarily suppliers contribute to maintaining the their way to various regions around the
focuses on drug formulations and biolog- quality and efficacy of pharmaceutical world, including North America, Africa,
icals, constituting about 75% of the formulations. It allows Indian pharma- the European Union (EU), the
country's total pharmaceutical exports. ceutical companies to produce drugs Association of Southeast Asian Nations
This highlights the nation's strong pres- that meet stringent quality standards and (ASEAN), Latin America and_ the
ence in the international market as a reli- comply with regulatory requirements. Caribbean (LAC), the Middle East, Asia,
129
the Commonwealth of Independent Pharmaceuticals focuses on developing Continued investment in research and
States (CIS), and other European the pharmaceutical sector within India. innovation is vital for the growth of the
regions. The majority of India's exports, The department's primary functions Indian API industry. By developing novel
nearly two-thirds, are directed towards involve ensuring the availability of drugs APIs and improving manufacturing pro-
NAFTA (North American Free Trade at affordable prices, overseeing the cesses, Indian companies can differenti-
Agreement), Europe, and Africa. In the operations of Central Pharma ate themselves and offer value-added
fiscal year 2021-22, the top five export Undertakings, supporting projects and products to the global market.
destinations for the Indian Pharma revitalizing schemes, ensuring effective
Industry were the United States, the management, developing human e Collaborations and Partnerships:
United Kingdom, South Africa, Russia, resources and infrastructure, formulating Collaborations with international phar-
and Nigeria. schemes and projects, and preparing an maceutical companies and research
annual plan, budget, and monitoring institutions can help Indian API manu-
To summarize, India's presence in expenditure. facturers enhance their capabilities and
the global pharmaceutical market is sub- access new technologies. Partnerships
stantial, with a 5.92% market share. The What are the Challenges and can facilitate knowledge exchange, joint
country's exports predominantly consist Opportunities for the Import and research projects, and market expan-
of formulations and biologics, and in the Export of Indian AP? sion opportunities.
fiscal year 2021-22, the pharmaceutical
product exports were valued at US$ e Increasing Competition: The global e Digital Technologies: Embracing
24.62 billion. India's export destinations API market is highly competitive, with digital technologies such as data analyt-
encompass various’ regions, with several countries vying for market share. ics, artificial intelligence, and blockchain
NAFTA, Europe, and Africa being the key India faces competition from countries can streamline supply chain processes,
recipients of Indian pharmaceutical prod- like China, which has a strong presence improve efficiency, and enhance trace-
ucts. in the API industry. Indian companies ability. Adopting digital solutions can
must continuously innovate and improve help Indian API manufacturers meet
Regulatory Landscape and Quality their manufacturing processes to stay global standards and enhance their
Assurance competitive. competitiveness.
Ensuring the quality, safety, and effi-
cacy of APIs is paramount in the phar- e Dependence on Imports: India is a Conclusion
maceutical industry. Regulatory bodies significant exporter of APIs but still relies The import and export of Indian APIs
such as the US Food and Drug on imports for certain specialized APIs. present challenges and opportunities. To
Administration (FDA) and the European This dependency poses a challenge as it overcome challenges, Indian companies
Medicines Agency (EMA) have stringent makes the country vulnerable to supply must focus on innovation, research and
guidelines for importing and exporting chain disruptions and price fluctuations development, regulatory compliance,
APIs. Indian API manufacturers adhere in the global market. and building solid partnerships. By
to these regulatory standards to maintain e Regulatory Compliance: Meeting leveraging opportunities such as explor-
compliance and enhance their credibility stringent regulatory requirements set by ing new markets and embracing digital
in the global market. Quality assurance various international bodies, such as the technologies, India can strengthen its
practices, including Good Manufacturing US FDA and the EMA, can be a chal- position as a critical player in the global
Practices (GMP), are implemented to lenge. Compliance — with Good API industry. Continued investment and
meet international quality requirements, Manufacturing Practices (GMP) and strategic planning will be crucial for the
thus ensuring the reliability of Indian other quality standards is essential for sustainable growth and success of the
APIs. Indian API manufacturers to gain accep- Indian API sector in the years to come.
tance in the global market. The import and export of Indian APIs
Governing Authority e Research and Development: have played a pivotal role in shaping the
1: Pharmaceutical Export Promotion Investing in research and development country's pharmaceutical industry and
Council of India (Pharmexcil) is crucial for the long-term growth of the contribution to global healthcare. India's
Pharmexcil, established by the API industry. Indian companies must position as a significant exporter reflects
Government of India, is a promotional focus on developing new molecules and its ability to provide cost-effective and
body for the Indian pharmaceutical processes to stay ahead of the competi- high-quality APIs to meet the global
industry. The council's responsibilities tion and meet evolving market demand for affordable medicines.
include: demands. Simultaneously, India's reliance on
e Guiding the government. API imports highlights the need for
e Organizing seminars and meetings Opportunities: strategic planning and investments to
to address export-related matters. eExploring New Markets: Indian API enhance domestic manufacturing capa-
e Arranging domestic and interna- manufacturers have the opportunity to bilities. As the Indian API industry con-
tional business meetings. expand their reach and explore new tinues to evolve, it is imperative to prior-
e Coordinating trade delegations. markets. Emerging economies in Asia, itize research, innovation, regulatory
Pharmexcil also supports its mem- Latin America, and Africa offer potential compliance, and _ collaborations to
bers in securing Market Access Incentive growth opportunities for Indian APIs. By strengthen India's position as a global
(MAI) claims from the Indian govern- understanding the unique requirements API powerhouse. @
ment. of these markets, Indian companies can
establish a strong presence and capture The author is
2: Department of Pharmaceuticals market share. pharmaceutical consultant
Formed in 2008, the Department of e Research and Innovation:
130
(SPECIAL FEATURE |
IMPORT AND EXPORT SCENARIO OF
INDIAN BULK DRUGS
Komal Saini, Vandita Kakkar bulk drugs. As a result, Indian pharmaceu- tates collaborative efforts between the gov-
tical manufacturers, including Alembic, ernment and the private sector to formulate
ndia's pharmaceutical industry is Sarabhai, Indian Drugs & Pharmaceuticals a long-term plan that delineates their
| renowned as one of the most advanced Ltd. (IDPL), Hindustan Antibiotics, JK respective responsibilities and aligns with a
among developing nations. In terms of Torrent, Ranbaxy, and Standard3, have shared vision of revitalizing the industry.
volume, it ranks third globally, and in terms been compelled to shut down their facilities Without a clear plan incorporating defined
of value, it stands as the thirteenth largest. due to the competition posed by low-cost roles, responsibilities, and timelines, the
India plays a significant role in the global Chinese intermediaries like Penicillin-G/V. bulk drugs sector will continue to face chal-
supply of generic medicines, accounting for The COVID-19 pandemic further lenges.
approximately 20% of the world's demand exposed India's vulnerability to disruptions The "Make in India" initiative presents a
in terms of volume. Moreover, India serves in global supply chains and its heavy promising platform for the growth of the
as the primary source for around 60% of dependence on China for pharmaceutical bulk drug industry. However, to fully lever-
the global demand for vaccines and requirements. Lockdown measures caused age the support provided by this initiative, it
HIV/AIDS medicines. The country has scarcity in basic raw materials necessary is crucial to address various business envi-
gained worldwide recognition for providing for drug production. In response to these ronment-related challenges. These chal-
internationally acceptable quality products challenges and to mitigate future risks lenges encompass areas such as land
at affordable prices. Indian pharmaceutical associated with unforeseen events, India acquisition, ease of doing business, taxa-
products are exported to over 200 coun- introduced a production-linked incentive tion, and operational infrastructure.
tries, including developed nations with (PLI) scheme. This initiative aims to Acknowledging and resolving these chal-
stringent regulatory standards. Notably, the strengthen the domestic pharmaceutical lenges require the active participation and
United States serves as the largest market industry, which is valued at $50 billion, and collaboration of all relevant stakeholders.
for India's pharmaceutical formulations. reduce its reliance on China. By doing so,
India's prominence extends to the India seeks to safeguard its pharmaceutical Recent development of bulk drug
export of bulk drugs (active pharmaceutical sector from future black swan events like In the Budget 2023, Union Finance
ingredients - APIs) as well. With 664 manu- the COVID-19 pandemic. Minister Nirmala Sitharaman has allocated
facturing plants approved by the US Food Despite the introduction of the produc- Rs 1,250 crore for the development of bulk
and Drug Administration (USFDA), India tion-linked incentive (PLI) scheme, India's drug parks and the promotion of medical
holds the highest number of such facilities efforts to reduce its reliance on China for device parks in India. The allocation com-
outside the United States. Indian compa- active pharmaceutical ingredients (APIs) prises Rs 1,000 crore for bulk drug parks
nies have filed 4,500 drug master files and other pharmaceutical products have and Rs 200 crore for the promotion of med-
(DMFs) for active pharmaceutical ingredi- not yielded the desired outcomes, at least ical device parks, according to an official
ents as of September 30, 2019, and have not yet. Nearly three years have passed from the Department of Pharmaceutical.
obtained 5,029 abbreviated new drug appli- since the launch of the scheme, but India's This allocation marks a_ significant
cation (ANDA) market authorizations for dependence on China has only intensified. increase of over 1150% compared to the
formulations as of June 30, 2020. However, According to data from the Ministry of previous year. In the previous year, the
despite these accomplishments, India Chemicals and Fertilisers, imports of bulk government had only allocated Rs 100
remains heavily reliant on China for the drugs or APIs and drug intermediates from crore for the development of bulk drug and
supply of bulk drugs and drug intermedi- China increased by 20% in FY22, reaching medical device parks. The Department of
ates. Approximately two-thirds of India's Rs 23,273 crore. This accounted for 66% of Pharmaceuticals is entrusted with the
total pharmaceutical imports originate from India's total imports of medical products implementation of the "Promotion of
China. It is important to note that India's worth Rs 35,249 crore during that fiscal Medical Devices Parks" scheme, aimed at
import dependence on China primarily lies year. Furthermore, data from the com- creating world-class infrastructure to estab-
in bulk drugs and not in formulations. merce ministry reveals that imports of 30 lish the Indian medical device industry as a
India's reliance on China for a signifi- crucial medical devices rose by 25-152% global leader.
cant portion of its active pharmaceutical during April-December 2022 compared to The "Promotion of Bulk Drug Parks"
ingredients (APIs) manufactured through the previous year. scheme, with a financial outlay of Rs 3,000
fermentation, including penicillin, crore from FY 2020-2021 to FY 2024-25,
cephalosporins, and macrolides, is notable. Current industry challenges provides financial assistance to three
In 2016, the Minister of State in the Ministry To unlock its full potential, the bulk drug states for establishing bulk drug parks. The
of Commerce and Industry acknowledged industry must establish a well-defined Minister of State of Chemicals and
the considerable dependence on imports roadmap consisting of actionable steps and Fertilizers, BhagwanthKhuba, had _ previ-
for 12 essential drugs, such as paraceta- milestones. This endeavour requires the ously stated that the "Promotion of Medical
mol, metformin, ranitidine, amoxicillin, support of key stakeholders who must exe- Devices Parks" scheme has a total finan-
ciprofloxacin, cefixime, acetyl salicylic acid, cute the agreed-upon action plan in a coor- cial outlay of Rs 400 crore, with a maximum
ascorbic acid, ofloxacin, ibuprofen, metron- dinated and timely manner. Just like any assistance limit of Rs 100 crore for a med-
idazole, and ampicillin. The influx of other industry, the bulk drugs market ical device park. Additionally, Sitharaman
Chinese imports has gradually eroded thrives when it has a conducive ecosystem announced in her Budget speech the intro-
India's manufacturing capacity for many for growth and sustainability. This necessi- duction of a new program to promote
131
research and innovation in the pharmaceu- tives and subsidies to attract private invest- maceutical industry achieves self-sufficien-
tical sector through centers of excellence in ment. cy in bulk drug manufacturing, reducing
the country. Medium-term establishment reliance on imports.
The government's focus on allocating Infrastructure development: Construct Industry-academia collaboration:
funds for the development of bulk drug essential infrastructure within the park, Foster collaboration between the industry
parks, medical device parks, and research including common effluent treatment plants and academia by establishing colleges or
and innovation in the pharmaceutical sec- (ETPs), testing facilities, captive power educational institutions within the park that
tor demonstrates its commitment to plants, storage facilities, and well-connect- offer specialized courses and training pro-
strengthening the domestic pharmaceutical ed roads. grams in drug production and related
industry and establishing India as a leader Research and development (R&D): fields.
in this field. Establish dedicated R&D centers within the Skill development and _ training:
park to support drug manufacturing activi- Establish training infrastructure and insti-
Future directions ties and foster the development of new tutes focused on providing industry-specif-
Short-term establishment technologies for pollution control and sus- ic training and skill development programs
Location assessment and land acquisi- tainable production. tailored to the needs of the bulk drug man-
tion: Conduct a thorough evaluation to Policy reforms: Introduce policy ufacturing sector.
select an ideal location for bulk drug man- reforms such as promoting the use of Innovation focus: Incentivize bulk drug
ufacturing that ensures easy access to raw domestically manufactured active pharma- manufacturers to prioritize process innova-
materials and proximity to transportation ceutical ingredients (APIs) in formulations tions and adopt key technologies such as
hubs such as airports and ports. Acquire and relaxing price controls to encourage fermentation and bio-catalysis. Recognize
sufficient land for setting up new plants. growth and investment in the bulk drug and reward companies that embrace inno-
Streamlined approval process: industry. vative approaches to enhance efficiency
Implement a single-window clearance sys- Dedicated investment fund: Establish a and sustainability in their operations. e
tem, enabling swift and efficient issuance professionally managed equity fund specif-
of necessary clearances by placing offi- ically dedicated to promoting API manufac-
cials from relevant departments within the turing and developing cluster and individu- Saini is from Chandigarh College of
park. al unit infrastructure. Pharmacy, Chandigarh Group of
Financial support and_ incentives: Long-term establishment Colleges, Kakkar is from University
Provide funding support, facilitate access Achieve self-sufficiency: Create a com- Institute of Pharmaceutical Sciences,
to affordable finance, and offer tax incen- prehensive ecosystem where India's phar- Panjab University.
132
(SPECIAL FEATURE |
FUTURE PROSPECTS OF INDIAN ACTIVE
PHARMA INGREDIENTS MARKET
Raheel Shah
Introduction:
he Indian pharmaceutical industry
has witnessed remarkable growth in
recent years, establishing itself as a
global leader in the production and export
of generic drugs. One crucial factor that
has contributed to this success is the pres-
ence of a robust Active Pharmaceutical
Ingredients (API) manufacturing sector.
APIs are the core components responsible
for the therapeutic effects of drugs, making
them an integral part of the pharmaceutical
supply chain. In this article, we will delve
into the future prospects of the Indian API
market, analyzing the opportunities and
challenges that lie ahead from a pharma-
ceutical perspective.
Rising Global Demand for Generic
Drugs:
The rising global demand for generic
drugs is a significant trend in the pharma-
ceutical industry. Generic drugs are gaining cal industry, particularly the API manufac- also focus on improving process efficien-
popularity due to their affordability and turing sector. The government is aggres- cies, enhancing quality standards, and
accessibility. As healthcare costs continue sively encouraging the expansion and meeting the stringent regulatory require-
to rise, patients and healthcare systems development of local API production ments set by international authorities.
are seeking cost-effective alternatives to through programmes like "Pharma Vision The growing emphasis on R&D holds
brand-name medications. Generic drugs 2020" and the "Make in India" campaign. significant implications for the future of the
offer the same therapeutic benefits as their These initiatives have a twofold objective: Indian API market. By actively engaging in
brand-name counterparts but at a fraction reducing the reliance on imported APIs and research and development, manufacturers
of the cost. This affordability factor is par- positioning India as a global manufacturing can stay at the forefront of innovation,
ticularly important in developing countries hub for APIs. ensuring they remain competitive and meet
where access to essential medications is a The government's efforts are comple- the evolving demands of the global phar-
challenge. mented by policy reforms and incentives maceutical industry. This strategic
Furthermore, the expiration of patents that have been implemented to create a approach enables Indian API manufactur-
on several blockbuster drugs has opened conducive business environment for API ers to gain a competitive edge, foster tech-
the market for generic drug manufacturers, manufacturers. These measures encour- nological advancements, and ultimately
fostering competition and driving down age investments in research and develop- drive growth in the market.
prices. Governments and healthcare orga- ment (R&D) for the development of new Quality Compliance and Regulatory
nizations are also promoting the use of and innovative APIs. By incentivizing R&D Challenges:
generic drugs through policies and incen- activities, the government aims to foster a The Indian active pharmaceutical ingre-
tives, further boosting their demand. culture of innovation within the industry, dient (API) market is a promising sector,
The increasing prevalence of chronic leading to the creation of high-quality APIs offering significant opportunities for growth
diseases and the aging population has also that meet global standards. and expansion. However, it is not without
contributed to the demand for generic Growing Emphasis on Research and its challenges, particularly concerning qual-
drugs. As more individuals require long- Development: ity compliance and regulatory standards.
term medication regimens, generic drugs The Indian API (Active Pharmaceutical International agencies have established
provide an economical solution. Overall, Ingredient) manufacturers are recognizing strict regulations and requirements for API
the rising global demand for generic drugs the importance of research and develop- manufacturers, emphasizing the need for
is expected to continue as they offer a ment (R&D) activities to stay ahead in the adherence to Good Manufacturing
viable option to reduce healthcare costs highly competitive global pharmaceutical Practices (GMP) and stringent quality con-
and improve access to essential medica- market. By investing in R&D, these manu- trol measures at every stage of the manu-
tions worldwide. facturers aim to develop complex and spe- facturing process.
Favorable Government Initiatives: cialized APIs, thereby expanding their To successfully compete in the global
The Indian government has taken sig- product offerings and catering to niche market, Indian API manufacturers must
nificant steps to support the pharmaceuti- therapeutic areas. Moreover, R&D efforts invest in modern infrastructure, adopt
135
greener and more sustainable pharmaceu-
tical industry. By prioritizing environmental
responsibility, these manufacturers play a
vital role in advancing sustainable develop-
ment and promoting a healthier future for
both people and the planet.
In conclusion, the Indian API market
holds promising prospects for the future,
driven by various factors that contribute to
its growth and success. The rising global
demand for generic drugs, driven by afford-
ability and accessibility, presents a signifi-
cant opportunity for Indian API manufactur-
ers to cater to a vast market and provide
cost-effective alternatives to brand-name
medications. Moreover, favorable govern-
~ RD
ment initiatives such as "Pharma Vision
2020" and the "Make in India" campaign,
* . + coupled with policy reforms and incentives,
support the growth and development of the
domestic API manufacturing sector.
Recognizing the importance of
research and development (R&D), Indian
advanced technologies, and cultivate a By embracing this shift towards special- API manufacturers are investing in innova-
highly skilled workforce. These investments ized APIs and biopharmaceuticals, Indian tion to stay ahead in the competitive global
are essential to consistently meet the strin- manufacturers are aligning themselves pharmaceutical market. By expanding their
gent quality standards set by international with the evolving needs of the pharmaceu- product offerings, focusing on specialized
regulatory bodies. By ensuring compliance tical industry. This strategic move allows APIs and biopharmaceuticals, and improv-
with these regulations, Indian API manufac- them to tap into the growing demand for ing process efficiencies, they aim to meet
turers can maintain trust and reliability personalized and targeted therapies, the evolving demands of the industry and
among global partners and customers. ensuring their relevance and sustainability maintain a competitive edge.
The significance of adhering to interna- in the market. However, the Indian API market faces
tional regulations cannot be overstated. It Increasing Focus on Sustainability and challenges related to quality compliance
not only demonstrates a commitment to Green Chemistry: and regulatory standards. Adhering to inter-
producing high-quality APIs but also The pharmaceutical industry is witness- national regulations and ensuring strict
assures global buyers that the products ing a growing emphasis on sustainability quality control measures throughout the
meet safety and efficacy standards. Failure and green chemistry due to the increasing manufacturing process are essential for
to meet these standards can result in repu- global focus on environmental conserva- Indian manufacturers to maintain trust and
tational damage, loss of business opportu- tion. In line with this trend, Indian active reliability among global partners and cus-
nities, and potential legal consequences. pharmaceutical ingredient (API) manufac- tomers. Non-compliance can have signifi-
Shift Towards Specialized APIs and turers are actively adopting sustainable cant consequences, including reputational
Biopharmaceuticals: practices to reduce their environmental damage and loss of business opportunities.
The pharmaceutical industry is current- footprint. One significant aspect of this shift To remain relevant and sustainable,
ly undergoing a significant transformation, is the implementation of green chemistry Indian API manufacturers are also embrac-
with a notable focus on specialized APIs principles, which seek to minimize the ing sustainability and green chemistry prin-
(Active Pharmaceutical Ingredients) and adverse impact of manufacturing process- ciples. By integrating sustainable practices
biopharmaceuticals. This shift is primarily es on the environment. into their operations, such as _ utilizing
propelled by advancements in personal- Indian API manufacturers are integrat- renewable energy sources and adopting
ized medicine, targeted therapies, and the ing sustainable practices into their opera- eco-friendly manufacturing techniques,
field of biotechnology. Recognizing this tions by utilizing renewable energy they contribute to environmental conserva-
trend, Indian API manufacturers have start- sources, reducing waste generation, and tion goals and enhance their reputation in
ed to adapt their operations to meet the ris- adopting eco-friendly manufacturing tech- the international market.
ing demand for specialized APIs and bio- niques. By embracing sustainability, these Overall, the future of the Indian API
logics. manufacturers not only contribute to global market looks promising, with opportunities
To stay competitive in this evolving environmental goals but also enhance their for growth and expansion. By capitalizing
landscape, Indian API manufacturers are reputation and competitiveness in the inter- on the rising global demand for generic
strategically expanding their capabilities. national market. The adoption of sustain- drugs, investing in R&D, ensuring quality
They are actively collaborating with able practices reflects a commitment to compliance, and embracing sustainability,
research institutes, academia, and biotech responsible manufacturing and resonates Indian API manufacturers can solidify their
companies, which not only fosters innova- well with environmentally conscious con- position as global leaders in the pharma-
tion but also provides them with the oppor- sumers. ceutical industry and contribute to a health-
tunity to enter niche market segments. Through their efforts to incorporate ier and more sustainable future for all. @
These partnerships enable Indian manu- green chemistry and sustainable practices,
facturers to diversify their product offerings Indian API manufacturers are actively con- (The author is managing director,
and bolster their position in the market. tributing to the larger goal of creating a BDR Pharmaceuticals)
136
(SPECIAL FEATURE |
HYDERABAD HOSTS STH EDITION OF
PHARMALYTICA EXPO
Our bureau, Mumbai Shankar Gupta said, "Thank you for (FTDC), Dr. Reddy's Laboratories; Anish
inviting me for the event, India is known Agarwal, Global Head of Analytics, Dr.
he 9th edition of the PharmaLytica for its pharma industry. Covid has Reddy's Laboratories. They discussed,
expo, kickstarted on 1st June at brought attention of world towards India, collaborating with partners that meet
HITEX, Hyderabad. In welcome as we supplied vaccines and medicines your business needs; Points to be con-
address, Yogesh Mudras, managing to the world. | must complement organis- sidered by pharma and bio-techs when
director, Informa Markets India said, We ers for their effort to bring such event". choosing the right CMO; assessing if
welcome everyone ata the event and we Harish Jain, "Its being honor to share your current partnerships are effective in
are happy to be back in Hyderabad. stage with such big people. India is 14th achieving the desired output and stan-
Pharma industry in India is growing at largest in terms of value in pharma and dards; understanding the needs, culture
very fast pace and third largest globally. we will be US$130 bn business by 2030. and relationship required to partner suc-
At the event, you can see all the latest Government machineries and players cessfully with CMOs; creating improve-
innovation and we are happy to see the have observed innovations as important ment opportunities with CMOs; creating
strength at the event". He further stated factor. R&D is also key to development. a win-win approach; flexibility in opera-
that Hyderabad has become pharma hub Innovative way to best products is also tions and contractual agreements that
of India. The event was organised by important. We should take help of tech- don’t constrain development.
Informa Markets in India and the last day nology for development of the industry, Yogish HN, AVP -—_ Business
of the event was 3rd June 2023. so that we can give good products to Development, Enerparc Energy gave
“We are thrilled to announce the high- potential”. presentation on solar PV adoption for
ly anticipated 9th edition of the Avinash Talwar, "| would like to tahnk pharmaceutical industry for their opera-
PharmaLytica Expo, which will bring organisers at the event. Pharma industry tional cost savings and sustainability
together the complete pharmaceutical is Us$ 50bn market now and will reach goals. He also spoke about, rooftop and
ecosystem and industry stakeholders. US$ 65 bn dollar by 2024 and to grow at ground mount solar PV solution suitabili-
Then show is supported by key govern- 11% pa. CAGR lab equipment market is ty; OPEX, CAPEX and open access
ment body, Invest Telangana, among oth- also growing. There are many small labs mode of solar PV adoption; case study of
ers, and it is a pleasure to return to in Hyderabad. Events like these help labs solar adoption for a pharmaceutical
Hyderabad and focus on the expanding to showcase their products. Packaging client.
pharmaceutical hub of Southern India in business is increasing. Sustainable pack- Next was panel discussion on latest
addition to the Western market. This also aging is increasing but lot has to be done developments and trends in the pharma
signifying our commitment to the growth in this segment". API industry, Vishwas Sovani, director,
of the Indian pharmaceutical industry. As Jayesh Ranjan IAS _ Principal Pharma Wisdom was the moderator for
a key player in the global pharmaceuti- Secretary to Govt, Industries & the discussion and other panelists
cals industry and the largest supplier of Commerce Dept Government of includes, Nasir Ali, associate vice presi-
generic medications worldwide, India has Telangana, "| congratulate organisers to dent - API R&D, Aurobindo Pharma;
witnessed a significant increase in health bring this event in Hyderabad. Response Krishna Bhavanasi, VP head formulation
sector funding. The Indian government in the event looks good. Pharma industry R&D, Natco Pharma; Narender Rao
has raised the funding from Rs 86,200.65 us keeping their optism. Industry in India Somisetti, vice president, Head-R&D,
Crores to Rs 89,155 crores for the cur- should showcase best technologies. Metrochem API; Tausif Anmed, head-bio-
rent fiscal year 2023-24. As we progress India exports pharma process to more pharmaceutics, Preclin & Clinical
towards becoming a leading pharmaceu- than 150 countries". Rahul Deshpande, Bioanal, global clinical management
tical market, PharmaLytica aims to serve Sr. Group Director, Informa Markets India (VP), Dr. Reddy's Laboratories; Srinivasa
as a comprehensive platform amidst an gave vote of thanks. Rao Sambangi, Sr. General Manager,
increasingly digitized ecosystem, main- The event saw keynote panel discus- Aurobindo Pharma. They discussed
taining a global supply chain in a con- sion — Why the pharmaceutical industry points such as, how to reduce API manu-
strained environment, and new analysis is turning to outsourced manufacturing? facturing costs and get the best value for
methods for optimizing laboratory pro- Vishwas_ Sovani, Director, Pharma your money without cutting back on the
cesses, thereby creating smart pharma Wisdom was the moderator for the ses- importance of safety and containment
technological hubs,” he added. sion and other panelists included, procedures; importance of proper com-
RK Agrawal, National President, Sudeep Srivastava, Senior Vice munication - Information sharing
BDMA said, "Its my pleasure to be here President, Biological E. Limited; Satya between the API manufacturer and the
and i request everyone to take full advan- Babu, Sr. VP and Head - Operations, drug product manufacturer; increasing
tage of the event. India is truly pharma Quality, Regulatory and Scientific Affairs, trend toward more potent therapies and
hub of the world and i thank and congrat- Biological E. Limited; Vimal Kothari, the consequences of the changing face
ulate organisers to bring such event in Associate Director - External of pharma; comply - Must have QR code
Hyderabad". He said that instrumental Manufacturing, Dr. Reddy's Laboratories; in each packing of API and medicine;
technology is increasing in pharma Rajkumar Rajgopal, Head, Fermentation regulatory hurdles and opportunities.
industry. Technology Development Centre Shakthi Nagappan, director (life sci-
137
ences & pharma) & CEO, Telangana Life Padmanabhuni, advisor, BDMA patients; What helps us to have a better
Sciences gave _ presentation on (FormerPolicy Advisor, |Pharmexcil); understanding about data quality and data
Telangana Life Sciences - Overview of Manjeeth Singh Rawat, head of pharma privacy? RWE gives efficient and cost-
the Life Sciences sector in the state of supply chain - CIS & Romania, Dr. Reddy's effective clinical trials? How? What are
Telangana. He also spoke about With a Laboratories; Himal P. Desai, vice president, complications will rise by inserting new
focused approach in incentivizing invest- supply chain management, Virchow data source? And it leads to breakup in
ments, the Life Sciences sector in Biotech; LAKSHMI NARAYANA, Associate data? Obtaining patient-centric using RWE;
Telangana has received over Rs 25,0000 Director, SCM, Aragen. They discussed what kind of changes needed to be place in
crores investments creating over 1.3 points like, innovative strategies implement- RWE? Compelling with regulatory; market
Lakh jobs and 4 Lakh indirect jobs. Some ed from small-midsize pharma to overcome access for innovative medicines in emerg-
of the initiatives like dedicated industrial supply chain issues without incurring signif- ing markets.
parks ,personalised incentive icant costs; pragmatic solutions for over- Next panel dicsussion was — future in
schemes for corporates, skilling and coming supply chain hurdles; transportation manufacturing — roadmap to 2024 — mov-
training programs and BioAsia - Asia's and logistics issues - where are we heading ing forward. Moderator for the discussion
biggest life sciences forum have helped with this problem? Common pitfalls in SCM was Sandhya Pittala, founder and COO,
Telangana Life Sciences position - What are the lookout for facts? How to Crenza Pharmaceuticals and other pan-
Telangana as the "Hub of Life Sciences insulate your risks against supply disruption; elists included Rajendar Burki, associate
in Asia". steps needed to insure supply chain integri- vice president, (R&D), Biological E.
BM Rao, CEO - QDOT Associates ty from the raw material stage through the Limited; K. Suresh Babu, vice president-
gave presentation on scientific approach- end user; role of CFAs in in supply chain quality assurance, Natco Pharma; Rahul
es to analytical procedure development operation for effective drug supply / distri- Mittal, head strategy - emerging markets,
He also spoke about, guidance to the bution to trade. Dr. Reddy's Laboratories; Vivek Jha, head
analytical procedure development and Next panel discussion was on reshaping - strategy and operations, global drug
validation of developed methods, method pharma industry in the way of digital trans- development -India, Novartis. They dis-
performance through system suitability formation. Moderator for the discussion was cussed points such as, lessons learnt from
testing - future expectations from Rithesh P, director, leading technology covid times — making the best from the
USP<621>. Practical challenges and acceleration (digital solutions), Novartis and worst times. Relationshipswt partners —
suggested solutions, key validation other panelists included Dilip Kastala, VP & How should this look by 2024; overcoming
parameters that characterise analytical global head - digital, IT & process excel- challenges — Increasing costs and compe-
procedures, use of analytical testing to lence, Dr. Reddy's Laboratories; Ram tition; RWD and RWE drive in pharma;
support pharmaceutical quality systems, Kumar, director MSTG, Cipla; Kavita electronic quality management system-
discussion of analytical lifecycle manage- Lamror, expert, Real World Investigator & How trackwise, Edms, LMS, LIMs to be
ment. RWD Product Owner, Sanofi; Narendra maintained for successful audit outcome?
There was another keynote panel dis- Kumar, senior general manger (Quality) | Overcoming regulatory constraints.
cussion on pioneering laboratory knowl- site quality head, Viatris. They discussed The last panel discussion for the day
edge- future of lab and moderator was topics such as, looking beyond pharma 4.0: was PPLST— Pharma Packaging Labelling
Pawan Patinge, founder, Academy of future initiatives and advanced manufactur- Serialisation Track & Trace —- Where are we
Analytical Instrumentation and other pan- ing approaches; What’s New? innovation in heading? Which way is the right direction to
elist included, Srinivas Achanta, VP, Dr. pharma industry; ensure the success of improve? Moderator for the discussion was
Reddy's Laboratories; Gnanadev Gudipati, Technology transfer; addressing main chal- Sandhya Pittala, founder and COO, Crenza
vice president ARD & QC Natco Pharma; lenges in implementing digitisation in phar- Pharmaceuticals and other panelists
Balaram Patro, CEO, GRK Research ma; making big data useful: practical included, Gunjan Singh, VP and head
Laboratories; Rajesh Thempadiyil, Head — approaches; How is Al resolving the tech mature markets API (US, EU, Mexico,
Quality Digital Transformation & problems faced by the industry? How will Canada, CIS), Dr. Reddy's Laboratories;
Compliance, Dr. Reddy's Laboratories. They the near future be? Do digital trends really Vinay Singh, associate director — Supply
discussed points like, quality management help in manufacturing? How? Increasing Chain Management, Dr. Reddy's
in the laboratory; sustainability in the labora- agility through digitalisation; technological Laboratories; Chandi Prasad Ravipati,
tory / Lab automation / Lab and tech inte- evolution in drug manufacturing and drug head - packaging development, Aurobindo
gration; future-proofing labs through smart delivery. Pharma; Lokesh Patel, founder director,
technology and innovation; future of lab is Narendra KumarUMAR, senior general URL Aseptic Automation; Sunil
digitalisation, automation and connectivity: manger (Quality) | site quality head, Viatris Chandupatla, AGM, Labelling, COE,
challenges and tools to engage staff; loT in gave presentation on quality culture excel- Freyr Solutions. They discussed points
the lab of medicinal chemistry and the lence. He also discussed points such as to such as, preparing for the future of phar-
simultaneous impact of Al; identify out-of- transform from "Compliance led" to "excel- ma packaging; fightback against coun-
the-box systems and solutions; review out- lence led"; guidance and tools for cultural terfeit online medicine suppliers — How
dated processes, workflows, and tools and assessment and few QMS elements as does the packaging help? How packag-
safety and its journey towards improvement. quality culture enablers. ing requirements for pharmaceuticals are
Second day saw panel discussion on, Kavita Lamror, expert, real world inves- changing in post pandemic? Maintaining
latest trends and developments in your sup- tigator & RWD Product Owner, Sanofi gave quality, traceability and accessibility in
ply chain — moving up the value chain. Other presentation on RWD & RWE - creating labeling; recent trends in serialization
panelist included, P V Raju, senior vice value from next-generation real-world evi- track and trace; new and major problems
president supply chain, Biological E. dence. She also spoke about, how pharma in implementing trace and trace in supply
Limited; Kamaraj Abraham, associate vice will handle complexity of data in RWD? dis- chain; ensuring end to end supply chain
president, head quality assurance, cussing how the RWE helps to get custom- in pharma — How the serialization helps
Aurobindo Pharma; Appaji Venkat made treatments and drug therapies for maintaining dignity of products. e
138
(SPECIAL FEATURE }
el
a ye
.*
139
(SPECIAL FEATURE |
142
Purchase Manager - Pharma Industry
Contact Person : Mr. Arvind Vasudeva Contact Person : Ms. Arshi Mistry
Designation : Chief Operating Officer Designation : Secretary to Chairman & managing
Address : Wing - A Glenmark House, H D O corporate Address : 301 /A, 6th Floor Shreya House perieria hill
building B D sawant marg off western express highway road opp onemagic chakala andheri mumbai
chakala andheri mumbai maharashtra 400099 maharashtra 4000099
Contact Person : Mr. Keyur Kishor Mehta Contact Person : Ms. Katy M Umrigar
Designation : Assistant Manager -commercial Designation : General Manager * commercial
Address : Acme Plaza Andheri - Kurla Road Opp Address : 301 /A, 6th Floor Shreya House perieria hill
sangam cinema andheri mumbai maharashtra road opp onemagic chakala andheri mumbai
maharashtra 4(m99
Contact Person : Mr. Mahesh Kadam Contact Person : Mr. Neeraj Katare
Designation : General Manager -procurment Designation : Vice President - Operational excellence
Address : Plaza Andheri - Kurla Road Opp sangam Address : Ist Floor D + Mart Building Goregaon smulund
cinema andheri ( E) MUMBAI maharashtra 400059 link road opp wockhard hospital mulund (w) mumbai
maharashtra 400cno
Contact Person : Mr. Subhendu Mitra Contact Person : Mr. Supratim Halder
Designation : Administration Manager Designation : Chief Manager - Operational Exellence
Address : Acme Plaza Andheri - Kurla Road Opp Address: Ist floor-or D - Mart Building Goregaon -
sangam cinema andheri (e ) mumbai maharashtra mulund link road opp wockhard hospital mulund (w)
400059 mumbai maharashtra
Contact Person : Mr. Harsh Piramal Contact Person : Mr. Cancherla Ramgopal
Designation : Executive Vice Chairman Designation : Distribution
Address : lOth Floor Nicholas Piramal Tower Address : 54 / AAventis House Sir mathurdas vasanji
Ganpatrao kadam marg peninsula corporate park lower road sanfoi Aventies chakala andheri ( E) mumbai
parel (w) mumbai maharashtra maharashtra
Contact Person : Mr. Sanjeev Naik Contact Person : Mr. Praveen Patel
Designation : Manager - Purchase Designation : Assistant General Manager
Address : AAventis House Sir Mathurdas vasanji road Address : Opp Stock Exchange, Near Sahjanand
sanfoi aventis chakala andheri ( E) mumbai maharashtra Collage Ambawadi Ahmedabad Gujrat 380015
Contact Person : Mr. Ramesh Contact Person : Mr. Shailendra Singh kushwaha
Designation : Manager - Administration Designation : Manager - Research & Devlopment
Address : 711 6th B Cross, 3rd Block koramangala Address : AuresNoB-9/2 MIDC, waluj Industrial Estate
Bengaluru karnataka Aurangabad Maharashtra 431136
Email ID : Email ID :
Contact Person : UMESH KUMAR MODI Contact Person : Mr. Rajesh V. Shah
Designation : Director Designation : Director
Address : 510 - 511, 14cn, 98 Modi Tower No 98 nehru Address : Ghanshyam House 19 Nehru Place new
place new delhi 110019 delhi delhi 110019
Contact Person : Shreekant Dattathray Sawant Contact Person : Mr. Shrikrishna N. Inamdar
Designation : Director Designation : Director
Address : Flot NO -4 Phase -2, International Biotech Address : P - 14 Rajiv Gandhi Infotech Park,phase 1
park hinjewadi pune maharashtra 411057 MIDC Hinjewadi pune maharashtra
Tel.: 022 4030 9000 Mobile : Tel.: 022 4030 9000 Mobile :
Contact Person :MR. AMAN MEHTA Contact Person : MR. AJAY SAHNI
Designation : Independent Director Designation : Managing Directo
Address : 3, 6th Floor, G Block Wockhardt towers Address : 3, 6th Floor, G Block Wockhardt towers
sandra kurla complex sandra mumbai maharashtra sandra kurla complex sandra mumbai maharashtra
400051 400051
Contact Person :Ms. Shweta Munjal Contact Person : Gaurav Pravin Aggarwal
Designation : Vice President & Global Head Designation : Director
Address : C 4th, 5th Floor & 7th Floor, 48 c -25 laxmi Address : 227 New Jagruti No. 8 S V Road Bandra
towers bandra kurla complex bandra MUMBAI MUMBAi maharashtra 400050
maharashtra
Serdia Pharmaceuticals India (P) Ltd AMN Life Science (P) Ltd
Contact Person : Mr. Ravi Kandiah Contact Person : Veena Mishra
Designation : Officer - Administration Designation : General Manager
Address : House Dr S S Rao Road Behind mahatma Address : 811, A-Wing, The Capital, Bandra-Kurla
gandhi road memorial hospital parel mumbai Complex,Bandra (East) — 400 051.Mumbai — INDIA
maharashtra
Bharat Serums & Vaccines Ltd Bharat Serums & Vaccines Ltd
Tel.: 22 6287 1000 / 6879 Mobile : Tel.: 22 6287 1000 / 6879 Mobile :
Contact Person : Dr. Adil D Billimoria Contact Person : Mr. Jayant Rajgopal kamath
Designation : Senior Vice President - Quality Designation : General Manager - Corporate affairs
Address : Assurance & Regulatory Affairs B S devshi Address : 3rd Floor Brady House No 12 + 14 Veer
marg station road govandi mumbai maharashtra nariman road fort mumbai maharashtra
Contact Person : MARIA ANA PAULA MENEZES Contact Person : Mr. Vasant Parikh
Designation : Director Designation : Manager - Admin
Address : 1, 2nd Floor Fortune * 2000, sbandra kurla Address : No 2 Jayprakash Road Goregaon munbai
complex mumbai maharashtra maharashtra
Contact Person : Mr. Brijimohan K Sharma Contact Person : Mr. Rafik Patil
Designation : Deputy General Manager -technicial Designation : Manager
Address : 58-D, Government Industrial Estate, Charkop, Address : 8 Metropolis Laboratory, Shree niketan
Kandivali (West),Mumbai — 400 067 Maharashtra. India kashibai navarange marg grant road (w) mumbai
http://;www.rusanpharma.com maharashtra 4cx)007
Tel.: 0240 - 2554407 Mobile :0240 - 2554299 Tel.: 22 66402323/66402299 Mobile :91 22 6640 2323
Contact Person : Mr. Nitin Wadia Contact Person : Mr. Hemant Goalatkar
Designation : Senior Vice President -oprations Designation : General Manager * purchase
Address : 159 C ST Road Kalina, Santacruz mumbai Address : Plot No « A/2, 8/8 TTC Industrial Area kalwe
maharashtra 400098 blod village midc navi mumbai maharashtra 400708
Tel.: 22 61454U/27402331 Mobile :91-22-22020644/ Tel.: 22 27401066 Mobile :91 22 2646 2313
Contact Person : Mr. Dharmesh P Gandhi Contact Person : Mr. Vipin Shah
Designation : Vice President - Purchase Designation : General Manager « Purchase
Address : seethna 4th floor 55 maharshi karve road Address : 2nd Floor Steel Made industrial estate marol
marine lines mumbai 400 002 maharashtra india village andheri mumabai maharashtra
Tel.: 22 30887777/28204453 Mobile :91 - 22 - 68757575 Tel.: 22 41515151/27781481 Mobile :91-22-4151 5151
Contact Person : Mr. Hemant Golatkar Contact Person : Mr. Abhay Manjrekar
Designation : Senior Deputy General manager Designation : Senior Manager - Purchase
Address : Floor Administrative Building Dr ambedkar Address : D Mart Building Goregaon Mulund Link road
road morajee mills compound parel mumbai mulund (w) mumbai maharashtra
maharashtra
Contact Person : Mr. Tarun Jain Contact Person : Mr. Burzin Shahana
Designation : Assistant Manager - Purchase Designation :
Address : 2nd Floor Administrative Building Dr Address : Mart Building Goregaon Mulund Link road
ambedkar road morarjee mills compound pare mumbai mulund (w) mumbai maharashtra
maharashtra 400012
Contact Person : Sanjiv Navangul Contact Person : Mr. Sarjerao Maruti Yadav
Designation : Managing Director Designation : Designer
Address : 16, 17th Floor Hoechst House Nariman point Address : No - 503 Dalmal House Jamnalal Bajaj road
mumbai maharashtra 400021 narimna point mumbai maharashtra 400021
Contact Person : Mr. Sameer G Chawnekar Contact Person : Mr. Baban Kand
Designation : Senior Manager Designation : Senior Manager -Admistration
Address : Ground 4th Floor, Wing * H, J & K Tex centre Address : A Jyoti Wire House Off Veera desai road
off saki vihar road olandivali andheri MUMBAi shah industrial estate andheri (w) mumbai maharashtra
maharashtra 400072
Shreya Life Sciences (P) Ltd Shreya Life Sciences (P) Ltd
Contact Person : Dr. Arvind M Jha Contact Person : Dr. Sheshadri Nathan
Designation : Senior General Manager -medical Designation : Vice President - Research &
Address : No « 301 /A, 6th Floor Shreya House Address : 301 /A, 6th Floor Shreya House perieria hill
perieperia hill road opp cinemagic andheri mumbai road opp onemagic chakala andheri mumbai
mharashtra 40w99 maharashtra 4000099
Tel.: 022 6693 8222 Mobile : Tel.: +45 91 89 46 73 Mobile :022 6693 8222
Contact Person : Mr. Amar Yadav Contact Person : Mr. Keyur Kishor Mehta
Designation : Manager - Purchase Designation : Assistant Manager -commercial
Address : Glibal Headqurtar mumbai india Gaurav Address : Sun House CTS No 201 B/1 Western
caugh express highway Goregaon east mumbai 40063
Tel.: (+91 22) 4324 4324 Mobile : Tel.: (+91 22) 4324 4324 Mobile :
Shreya Life Sciences (P) Ltd Shreya Life Sdences (p) Ltd
Contact Person : Mr. O P Gupta Contact Person : Ms. Arshi Mistry
Designation : Executive - Administration Designation : Secretary to Chairman & managing
Address : 301 /A, 6th Floor Shreya House perieeia hill Address : 301 /A, 6th Floor Shreya House perieeia hill
road opp cinemagic chakala andheri mumbai road opp cinemagic chakala andheri mumbai
maharashtra maharashtra
Contact Person : Mr. Sanjay Tripathi Contact Person : Mr. Amar Yadav
Designation : General Manager - Finance Designation : Manager - Purchase
Address : A Wing Reheja Plaza L BS Marg opp darga Address : Acme Plaza Andheri - Kurla Road Opp
ghatkopar (w) mumbai maharashtra 400086 sangam cinema andheri mumbai maharashtra
Contact Person : Mr. Shashi Singh Contact Person : Mr. pravin Bhatkulkar
Designation : Manager - Purchase Designation : Quality Assurance
Address : 301 /A, 6th Floor Shreya House perieria hill Address : pennusilia Business park Ganpatrao kadam
road opp onemagic chakala andheri mumbai marg lower parel mumbai 400 013
maharashtra 4000099
Contact Person : Mr. Chirag Kulkami Contact Person : Mr. Sanjay Gilda
Designation : Officer - Purchase Designation : General Manager - Operations
Address : Glibal Headqurtar mumbai india Gaurav Address : Acme Plaza Andheri - Kurla Road Opp
caugh sangam cinema andheri mumbai maharashtra 4w059
Contact Person : Mr. Rajendra Agarwal Contact Person : Mr. Jai Bhaumik
Designation : Vice President * Operations Designation : Manager - Operational excellence
Address : 3 B Pathanwala Compound, Patanwala Address : Floor D - Mart Building Goregaon - mulund
industrial estate LB S marg opp shreyas cinema link road opp wockhard hospital mulund (w) mumbai
ghatkopar (w) mumbai maharashtra maharashtra
Tel.: 91 022 66 888 333 Mobile : Tel.: 91 832 665 5000 Mobile :
Contact Person : Mr. Ajaai Singh Contact Person : Mr. Nilesh Bandekar
Designation : Vice President Designation : Assistant Manager - Quality
Address : 80 A government industrial estate charkop Address : chandivali studio 8 chandivli farm Rd
kandivali (w) mumbai 400067 india chindivali powai mumbai mahrashtra 400072
Tel.: 22 28794667/28794661 Mobile :022 2867 7377 Tel.: 22 28291839/28291839 Mobile :022 4030 9000
Contact Person : Mr. Sumit Jain Contact Person : Mr. Manish Khandelwal
Designation : Manager - Finance & Forex Designation : Director - Controlling & Group Reporting
Address : 80 A government industrial estate charkop Address : 2136 lokmanya Bal Gangadhar tilak road
kandivali (w) mumbai 400067 india vidyanagar colony sadashiv peth pune maharashtra
411030
Contact Person : Dr. Kanchan Naik Contact Person : Mr. Joerg Reinhardt
Designation : Head - Technical Operations Designation : Chief Operating Officer
Address : Floor Sandoz House Dr Annie Besant road Address : 8th Floor Sandoz House Dr Annie Besant
shivsagar estate waroli mumbai maharashtra road shivsagr estate waroli mumbai maharashtra
Contact Person :M.K. Prabhakaran Contact Person : Mr. Jagdish Dhanaji Mokal
Designation : General Manager Designation : Customer Support Engineer
Address : post Box No. 1 kochuveli thiruvananthapurm Address : Floor Sandoz House Dr Annie Besant road
695021 shivsagar estate waroli mumbai maharashtra
Contact Person : Aditi Kare Panandikar Contact Person : Biren Pravinchandra Dave
Designation : Managing Director. Designation : Director
Address : indico house 166 CST road santacruz (E ) Address : Bayer House central Avenue hiranandani
mumbai 400, 098 india estate thane (west)
Tel.: 91 22 6287 1050 Mobile :+91 22 6287 1000 Tel.: 22 24311785/0 Mobile :
Tel.: 91-22-25233085 Mobile :91-22-33107500 Tel.: 91-22-6875 9010-35 Mobile :+91-22-6875 9010
Contact Person : Mr. Sam Rutty Contact Person : Mr. Shashikant P Kurani
Designation : Head - Purchase Designation : Vice President * Regulatory Affairs
Address : 12 S V Road udyog Nagar,Goregaon (w) Address : 12 S V Road udyog Nagar,Goregaon (w)
mumbai maharashtra 400104 mumbai maharashtra 400104
Tel.: 91-22-3802 3000/4000 Mobile :91-22-3802 3084 Tel.: 91 22 24826300 Mobile :91 22 24826000
Tel.: 91 2718 225039 Mobile :91 2718 225001 Tel.: 022 4925 2828 022 Mobile :022 4925 2828
Tel.: 22 25821793/26414516 Mobile :022 4925 2828 Tel.: 91-22-43661111 Mobile :91-22-2495 0363
Tel.: 22 66124199/24952624 Mobile :098195 65196 Tel.: 33 22129700/22129629 Mobile :91 33 2230-2330
Contact Person : Sarath Chandra Reddy Contact Person : Mr. Sekhara Bathina
Designation : Director Designation : Systems Administrator
Address : plot No « 2 Maitri Vihar Ameerpet Hyderabad Address : PlotNo 2 Maitri Vihar Ameerpet Hyderabad
Andhra 500038 Andhra pradesh 500038
Contact Person :Mrs. Mahima Dada Contact Person : Mr. Uday Halankar
Designation : Senior Vice President projects Designation : Assistant General Manager
Address : | & 3 Azamabab, p O BOX NO 1804 Address : 313 Auro House Bachupally, Quthubullapur R
Hyderabad Andhra pradesh 500020 k District Andhra pradesh 5cm90
Tel.: 91-40-7121 6249 Mobile :91-40-7121 6064/ Tel.:91 (40) 6672 1200 Mobile :
Tel.: 40 23547530/23548243 Mobile :040 2354 7532 Tel.: 020 2645 9122 Mobile :
Tel.: +1 (732) 274 - 0037 Mobile :+1 (732) 274 - Tel.:91 40 2373 1946 Mobile :
Contact Person : Mr. Samik Das Contact Person : Sanjay Champalal Vyas
Designation : Senior Manager Designation : Director
Address : 7-1-27 Corporate Administration beside hotel Address : 2520 Meridian Parkway, Research Triangle
green park aeerpet hydrebad andhra pradesh Park, Suite 200, Durham, NC 27713
Tel.: 40 49002900/23456915 Mobile : Tel.: 40 44379999/4(N8406 Mobile :+1 919 544 3170
Tel.: (40)27700363 Mobile :66327722 Tel.: 40 23075816/23720738 Mobile :040 2307 3079
Tel.: 02, 2720 0103 Mobile :91-40-2720 1101 Tel.: 40 23810261/28366579 Mobile :
Tel.: +91 40 23704923 Mobile: Tel.: 40 23079834/23078269 Mobile :040 2307 9081
Contact Person : Mr. Ramam Subba Reddy Contact Person :S Industrial Estate, p O BOX NO
Designation : Senior Manager Designation : www.synthokemlabs.com
Address : F - 405 Flat No 1, 5, 14 15 Keerti Apartments Address : info@synthokemlabs.com
Jetl road industrial devlopment area jeedemetla
hydrebad anhra pradesh
Contact Person : Mr. E Satyanarayana Contact Person :Mr. Ram Subba Rao
Designation : Commercial Executive Designation : General Manager - Domestic marketing
Address : 24 / 2/1 Pipe Line Road jeedimetla Address : 4 Area, uppal hyderabad andhra pradesh
subashnagar andhra pradesh 5cm55 500039
Tel.: 40 44613347/23193295 Mobile :040 4461 3333 Tel.: 40 27201101 Mobile :91-8458 279296
Tel.: 40 27201101 Mobile :022 2820 8025 Tel.: 40 27200343/0 Mobile :+91 44 2499 4585
Contact Person :SINGH BRAR Contact Person :Mrs. PRAGYAN PARAMITA PATRA
Designation : Director Designation : Sr. Executive — Customer Relation
Address : Sai chambers, 101-104, Old Mumbai - Pune Address : Pipe Line Road jeedimetla subashnagar
Hwy, opp. Bajaj Showroom, Wakadewadi,shivajinagr secunderabad andhra pradesh 500055
pune maharashtra 411003
Tel.: 40 669299991669299m Mobile :020 2554 0555 Tel.: 4044613347/27426.cm Mobile :91 40 67605725
Contact Person : Mr. Satya narayana Prasad Contact Person : Mr. Meher Kumar
Designation : General Manager Designation : Assistant Manager - personnel &
Address : PIOt NO 231 -A Road NO 12 M LA colony Address : 2nd Floor, 3rd Block My Home Hub
banjara hills hyderabad andhra pradesh madhapur hi-tech city hyderabad andhra pradesh
500081
Contact Person : Dr. Vikash Kumar Sinha Contact Person : Mr. Rahul Adakmol
Designation : Scientist Designation : Senior Manager -
Address : 2-d, Kaul Building, Shankar Sheth Road, Address : 3-1192/1 / 1, 3rd Block, 5th Floor white house
Guru Nanak Nagar, Pune, Maharashtra 411042 near lifestyle kaundanbagh begurmpet hyderabad
andhra pradesh 5016
Contact Person : Mr. Anil Pradhan Contact Person : Mr. Ravi M Shankar
Designation : Associate Vice president -oprations Designation : Manager - Projects
Address : 151 /1, 4th & 5th Floor Sairam towers Address : 3rd Floor uptown Banjara Road NO - 3 q-
alexander road secundebad andhra pradesh 500003 mart banjara hills hyderabad andhra pradesh 500033
Tel.: 020 2421 0201 Mobile : Tel.: 91-40-2789 9273 Mobile :040 2789 9273
Fourrts India Laboratories (P) Ltd Fourrts India Laboratories (P) Ltd
Contact Person : VEERRAMANI RADHA Contact Person : SEKHARIPURAM VISWANATHAN
Designation : Director Designation : Director
Address : ploat no1 fourts Avenue Annai indira nagar Address : plooat no 1 forts avenue annai indira nagar
okkiyan thoraipakkan chennai tamil nadu okkiyan thoraipakkan chennai tamil nadu
Contact Person :Ketchaani Rajan Makesh, Contact Person : Mr. Sendhi Kumar
Designation : Director Designation : Director
Address : 18 Dr Ambedkar Road Kodambakkam Address : Manali Express Highway Manali chennai
chennai tamil nadu Tamil nadu 60003B
Contact Person : Mr. Samaved Rajshekhar Contact Person : Mr. Abraham Varky
Designation : Assistant Manager Designation : Assistant Manager -Adminstration
Address : No. 9 Senthil Nagar, Chinakodungyur Address : Floor SIDCO Garment complex guindy
chennai Tamil nadu 6001 1B chennai Tamil nadu 600032
Contact Person : Mr. Hetal Shah Contact Person : Mr. Nazir Patel
Designation : Executive - International Designation : Head - Safety
Address : Mdr& :3rd Floor Zydus Tower Sarkhej - Address :Floor Zydus Tower Sarkhej- Gandhinagar
Gandhinagar Highway Satelite crss Road opp fun Highway satelite cross Road opp fun Republic satelite
Republic satelite Ahmedabad Gujrat 38015 Ahemdabad Gujrat
Email ID : Email ID :
Contact Person : Mr. Suketu Vayuuala Contact Person : Mr. Hernal Shah
Designation : Head - Safety & Plant Designation : General Manager
Address : 406 Silver Oak Commercial complex Address : 405, 4th Floor Abhishilp Premchand Nagar
opposite Arun society paldi Anmednagar Gujrat 380007 Road 132ft Ring Road opp keshar Baug party plot
vastrapur Ahmedabad Gujrat
Contact Person : Mr. Mohan Padmanabhan Contact Person : Mr. Sumatheendra kumbhkonam
Designation : Director - Research & Deviopment Designation : Head « Operations
Address : Bellary Road Hebbal, Kirloskar Buisiness Address :Bellary Road Hebbal, Kirloskar Buisiness
park Bengaluru karnataka park Bengaluru karnataka 560024
Contact Person : Mr. Venkata Akella Suresh Contact Person : Mr. Ganes N Achar
Designation : Senior Manager -Admistration Designation : General Manager - Purchase
Address : Bellary Road Hebbal, Kirloskar Business Address : No - 30, 2nd Block 10th Main, Ashoka pillar
park Bengaluru karnataka 560024 Road jaya Nagar Benguluru karnataka
Contact Person : Mr. Kumar Gopinathan Menon Contact Person : Mr. Nandakumar C kangote
Designation : Vice President - Commercial Designation : Vice President - Quality Assurance
Address : Avishkar Off Bellary Road, Hebbal, post no. Address : Strides House Bannerghatta Main Road opp
2483 Bngaluru karnataka 56Q4 11m college Bilekahalli Bengaluru karanataka 560076
Apotex Pharmachem India (P) Ltd Anglo-French Drugs & Industries Ltd
Contact Person : Mr. Vineet Kumar Contact Person : Dr. Kulvinder Singh Saini
Designation : Project Manager Designation : Biotechnology & Bioinformatics
Address : NO - 89 & 90 - 32 Gurgaon Haryana 122001 Address : PIOt NO 20, 77 - B Global Vantage Building
IFFCO road sector 18 udyog vihar industrial Area
Gurgaon Haryana 122015
Contact Person : Mr. Sunil Goyal Contact Person : Ravi Gangal gangal
Designation : Purchase Officer Designation : Director
Address : Mathur Vaish Naar Tone Road sanganer Address : B - 1/1446/10 -B Hambran Road Y Block
jaipur Rajsthan 302011 crossing Lundhina punjab 14100
Contact Person : Juzar Khorakiwala Contact Person : Mr. Sushim Kumar Jain
Designation : Vice President - R&D Designation : Manager - Engineering
Address : 33 MIDC Waluj Aura bad Maharashtra 431136 Address : B - 9/2 MIDC, Waluj Industrial Estate
Aurangabad Maharashtra 431136
Contact Person :PRIYESH GHIYA Contact Person : Mr. Pankaj Kumar shrivastwa
Designation : Senior Manager - Engineering Designation : purchase Officer
Address : B - 9 2 MIDC Waluj Industrial Estate Address : NoD-74/75 MIDC, walunj industrial Estate
Aurangabad Maharashtra 43116 Aurangabad Maharashtra 422010
Tel.: 022 6663 8000 Mobile : Tel.: 260 2242908 Mobile :022 3088 7777
Contact Person : Mr. Ramesh Birari Contact Person : Mr. Dilip Godekar
Designation : Supervisor * Maintenance Department Designation : Head - Safety
Address : G-1 Jhalawar, E S Patanwala complex opp Address : Medley House, D2, Rd Number 16,MIDC
shreyas cinema LBS marg ghatkopar area Andheri East mumbai mharashtra 400093
Tel.: 91 22 25000466 Mobile :+91 22 25003838 Tel.: 260 2242908/4228510 Mobile :022 3088 7777
Contact Person : Mr. Mahesh Dube Contact Person : Mr. Narendra Hegde
Designation : Head - Safety Designation : General Manager - Quality Assurence
Address : plot No 1802-805 3rd phase GIDC vapai Address : 302, Dalamal House, 3rd Floor, J. Bajaj
gujrat396195 Road, Nariman Point, Mumbai - 400 021.india
Contact Person : Mr. Yogesh Patel Contact Person : Mr. N Krishna Mohan
Designation : Head - Safety Designation : General Manager
Address : Plot NO - 221 GID C Industrial Estate vpai Address : 11/12, Udyog Nagar,sv road Goregaon
Gujrat 396195
Tel.: 260 2780080/0 Mobile :260 - 2780459. Tel.: 2612277211/22731364 Mobile :0261 239 7712
Tel.: 0265-2280550 Mobile :0 Tel.: 260 6532701/2424156 Mobile :0260 653 2701
Tel.: 265 2280873/2592094 Mobile : Tel.: (+91 22) 4324 4324 Mobile :
Contact Person : Mr. Bhavin N Upadhyay Contact Person : Mr. Ronak Joshi
Designation : Administration Officer Designation : Designer
Address : 2nd Floor, Sun Plaza-l, Near Vadsar Bridge Address : Ban House Gondal Road (South) Rajkot
makapura GIDC Road makapura vadodara Gujrat Gujrat 360004
Tel.: 265 2363229/2225672 Mobile :0265 264 6914 Tel.: Mobile :+91 8460372121
Tel.: 361 2522265/41509192 Mobile :022 4355 0500 Tel.: 413 2654100/2655154 Mobile :044 4344 6700
Contact Person : Mr. Krishna Das Varier Contact Person :Mr. S N Sathu
Designation : Deputy General Manager -opration Designation : Vice President - Development &
Address : https://www.avpayurveda.com Address : Thiruvananthapuram, India, Kerala
Tel.: 486 2276112/41947068 Mobile :022 2774 4196 Tel.: 413 26541W2655154 Mobile:
Tel.: 7312856368/278027 Mobile :0731 429 4567 Tel.: 824 2408738/2408793 Mobile :
Tel.: 832 2392223/2392225 Mobile :022 6228 8000 Tel.: 832 6614102/0 Mobile :
Tel.: 1 410 576 2221 Mobile :1 410 576 2000 Tel.: 832 2860336/2860368 Mobile :(91) (832) 2441300
Tel.: 836 2350608/2253386 Mobile :0836 225 2007 Tel.: 877 2276118/0 Mobile :022 6610 1024
Contact Person : Mr. Nitin Mehta Contact Person : Mr. Indrasingh Chowdhary
Designation : Supervisor Designation : Head - Maintenance
Address : Village Saidpura, Teshil Derabasi patiala Address : 4-7-11/4/C, Raghavendra Nagar Ncharam
punjab 140507 Hydrebad 500076
Tel.: 1762 308052/23377340 Mobile : Tel.: 1795 271246/271246 Mobile :+91 93471 39904
Tel.: 020 2663 4701 Mobile :+91 20 67649000 Tel.: 1795 245842/245843 Mobile :
Contact Person : Mr. Rudrasingh Verma Contact Person : Dr. Ajay Varshney
Designation : Executive * Purchase Designation : General Manager - Operations
Address : Prabhat Estate, Off S.V.Road, Jogeshwari Address : Industrial Area, Nagrota, 8agwan Kangra
(West), Mumbai — 400 102 Himachal pradesh 17647
Tel.: 1795 246706/367374 Mobile :91 022 66 888 333 Tel.: 1892 252109/253123 Mobile :
Tel.: 1795 2467%/23328479 Mobile :91 022 66 888 333 Tel.: 188127364 1/273304 Mobile :0172 270 6696
Tel.: 1905 287246/287250 Mobile :022 6798 0800 Tel.: 2115 253348/285%740 Mobile :
Tel.: 2192 250018/22621405 Mobile :022 2760 7954 Tel.: 91-22-2495 0363 Mobile :91-22-43661111
Tel.: 2192 660200/22202720 Mobile :91-22-67942111 Tel.: 2192 274335/22836392 Mobile :-43661042
Contact Person : ANIL MORESHWAR SAVE, Contact Person : Mr. Manohar Sonanes
Designation : Engineering Officer Designation : Head - Testing
Address : No H -19MIDC walunj Aurangabad Address : 4 M1DC Industrial Area, ChikhIithana
Maharashtra431133 Aurangabad Maharashtra 431210
Tel.: 5944 250278/26732385 Mobile :91-80-41379500 Tel.: 8532 247924/247924 Mobile :022 2820 1722
Tel.: 91 8532238704 Mobile :+91 94910 6 Tel.: 08819 — 224168 Mobile :08819 — 224075
Contact Person : Mr. M Vinay Kumar Contact Person :Mr. D N Mohan Reddy
Designation : Assitant General Manager Engeeneer Designation : Technical Director
Address : Venkatayapuram, Tanuku West Godawari Address : 5 - 70 floor Near Andhra bank street No. 8
Andhra pradesh 534215 habisiguda Hydrebad telangna
Tel.: 9989233357 Mobile :9989233357 Tel.: 040 2717 9878 Mobile :040-27179878
Tel.: Mobile :099495 72555 Tel.: 0866 247 0127 Mobile :9885780162
Contact Person : vunna Rama krishna Contact Person : Sunil Kumar Annapu
Designation : mechanicial manager Designation : Director
Address : road No 13 commercial Hub jnpc parawada Address : 501-505, Park Plaza, 5th Floor, opp.kamla
vishakapattnm-530021 Andhra pradesh india nehru park ketkar Road pune 411004 maharashtra
Tel.: +43 (0)2236 Mobile :43 (0)2236/48608 Tel.: 040 2354 2802 Mobile :8008444843
Tel.: 094406 10307 Mobile :8555289677 Tel.: 040-32587476. Mobile :098489 12120
Tel.: Mobile :085880 58570 Tel.: 91 11 22485797 Mobile :011 2248 3582
Tel.: 91 484 268 6111 Mobile : Tel.: 098711 99062 Mobile :9871196164
Tel.: 9810924221 Mobile :098109 24221 Tel.: 91 11 43026090 Mobile :096508 18888
Tel.: 91 11 43764376 Mobile :91-120-4505353 Tel.: 9711581282 Mobile :011 2550 4479
Tel.: -9212168677 Mobile :9212168768 Tel.: 011 4153 9602 Mobile :0124-4042977
Tel.: 0261 249 4977 Mobile : Tel.: 11 42430203 Mobile :011 4243 0203
Tel.: +91 9923594002 Mobile :02138 232286-90 Tel.: 085888 55749 Mobile :91-8588855749
Tel.: 011 2696 6333 Mobile : Tel.: +977 11-661855 Mobile :-45615564
Tel.: 0172 264 0018 Mobile :91 11 25881731 Tel.: +91 96501 82840 Mobile:
Contact Person : Mr. Rajesh Narula Contact Person : Ajay Kumar Shukla
Designation : Partner Designation : Director
Address : 2A/75 Ramesh Nagar, New Delhi-110015, Address : B-3, Sector-6 Gautam Budh Nagar, Noida,
Delhi, India Uttar Pradesh -201301, INDIA
Contact Person : Rajender Kumar Tiwari Contact Person : Mr. Karan Bhalla
Designation : Director Designation : Director
Address : Unit No 311 Third Floor Lsc E-Block Vikas Address : 29 Ground Floor Near Hotel Om Palace V &
Puri , New Delhi-110018, Delhi, India Po Mahipalpur , New Delhi-110037, Delhi, India
Email ID : Email ID :
Contact Person : BASANT LAL AGARWAL Contact Person : JASWANT SINGH CHAUHAN
Designation : Director Designation : Director
Address : Dtj 821 DIf Tower B Jasola Plot No-10 & 11 Address : Office No 101/102 Aditya Tower Dist Centre
Dda District Centre South Delhi DI, New Delhi-110044, Laxmi Nagar, New Delhi-110092, Delhi, India
Delhi, India
Email ID : Email ID :
Email ID : Email ID :
Contact Person : Mr. Ashish Goel Contact Person : Sudhir Kumar Jain
Designation : Owner Designation : Proprietor
Address : 161/19 Shop No 37 2nd Floor Mangal Market Address : No 127 Aihant Nagar Punjabi Bagh West ,
Bhagirath Palace, Delhi-110006, Delhi, India New Delhi-110026, Delhi, India
Shrey Nutraceuticas! & Herbals Private Sidhaant Life Sciences Private Limited
Tel.: 11- 26532129 / Mobile :9891296838 Tel.: 11- 43503661 Mobile :9810162031
Contact Person : Mr. Chander Prakash Kukretti Contact Person : Ankur Saini
Designation : Director Designation : Vice President
Address : 88 Fl 367 Cghs Paryatan Vihar Vasundhara Address : B-4 Block 183-A Safdarjung Enclave , New
Enclave , New Delhi-110096, Delhi, India Delhi-110029, Delhi, India
Tel.: 91-120-4351546 Mobile: Tel.: +91 11 416 62 311 Mobile :91 987 358
COR
Fertin India Private Limited Gaja Trade Private Limited
SUBSCRIPTION FORM
THE MAZADA PHARMA GUIDE |
Subscriber's Name : Mr. / MIS..........-.:::s:eseseseseceseeneeseeeeeeeeeseeseeeerensatecesseess ERIS PUIG cscs stem ttt wetter tmpnrstt pecs tse sear abahunssseens Casceaceenncangacad
Rs.1 500 (24 issues 4 Year) plan: ner ene cevanroveseen CAML taenonesioeveonsinass COUNLIY...-.--ccrcrererererennees
MAZADA PUBLICATIONS, PNAHO baa sicscascssacsscsossd DT ONT seo ssesssscascsensscnsassuntscernerrveiad BFA coast assscnsrsvesvesnsiasn
A/C. 041 50200000909, MUMBAI Towards Above Marked Subscription In Favor of MAZADA PUBLICATIONS
Payable In Mumbai. (Please Pay Rs.30/- Extra In Case Of Outstation Cheques)
Mazada
PUBLICATIONS Signature of Subscriber Date.
PI Please Send The Complete Form With Cheque / DD To Subscription Department
Gala No. 1 A, Sharma Compund, Old Nagardas Road, Andheri (E), Mumbai -400 069
Mob; 8108049982 / 9860066753 / 9004528972 - E-mail ;: mazdapharmaguide@gmail.com » Website : http://issuu.com/themazdapharmaguide
Po SUBSCRIPTIONFORM
Chemical Sourcing Guide
THE COMPLETE MONTHLY MAGAZINE FOR CHEMICAL INDUSTRY
Rs.600 (12 Issues 4 Year) CRY: scnecenscrenmanenmoscneatend SAC iwc ccesecemcnrnenecezancens PAIN seccnnmeneamewnexencnatl COUMUY s.c0-<nseseeavesamanneae
Rs.1500 (36 Issues 3 years) Tel. No. : LLTTTTLTTI TI ETS rescore senseceensceermracnemeenenmernenenene
Manufacturer [_] Broker =] Trader O
You can deposit in your Town also Indentor [1 Importer [J Machinery
BANK OF BARODA Enclosed Herewith Is Cheque / DD NO. ...........ssseeseseseseeeeseseseeteeeeeeeeneee OTS ie renceoceensenn
sees
AIC. 04150200000909, MUMBAI Towards Above Marked Subscription In Favor of MAZADA PUBLICATIONS
Payable In Mumbai. (Please Pay Rs.30/- Extra In Case Of Outstation Cheques)
azada
PUBLICATIONS Signature of Subscriber Date.
Eubllahers. Of Magazines, Directories CD'S Please Send The Complete Form With Cheque / DD To Subscription Department
Gala No. 1 A, Sharma Compund, Old Nagardas Road, Andheri (E), Mumbai -400 069
Mob: 8108049982 / 9860066753 / 9004528972 +« E-mail : chemicalsourcingguide@gmail.com + Website : https://joom.ag/ITNa
Email ID : Email ID :
Email ID : Email ID :
Tel.:91 731 6446888 Mobile :9862386980 Tel.:91 731 5069559 Mobile :9826027027
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Tel.: 022 28303617 Mobile :9324229509 Tel.: 91 251 6446591 Mobile :9890502886
Tel.: 91 265 2359976 Mobile :98252 03550 Tel.: 91 26 92260013 Mobile :7623003656
Tel.: 79 274 32241 Mobile :91 79 403 90451 Tel.: 079-26919309 Mobile :9375808707
Tel.: 91 79 40080800 Mobile :8046052549 Tel.: 2717 297822 Mobile :91 2717 617800
Tel.: 91 (79) 26402695 Mobile :91 (79) 26402695 Tel.: Mobile :9925206364
Tel.: 91 269 8285573 Mobile :8238086725 Tel.: 91 2767 220441 Mobile :91 2767 220768,
Tel.: 91 2717 612000 Mobile :91 2717 91 2717 Tel.: 91 79 26407300 Mobile :9825016301
Contact Person :KAMLESH LALITKUMAR UDANI Contact Person : Shiny Ansa Philip
Designation : Director Designation : Director
Address : 4 Dipali Society Kundan , Bharuch-, Gujarat, Address : Second Floor Shetal 16/17 Lalbaug
India Shopping Cen Manjalpur Naka Manjalpur, Vadodara-
390011, Gujarat, India
Tel.: 91 80 27724235 Mobile :91 80 42113536 Tel.: Mobile :91 79489 57877
Tel.: 1 6096 320 320 Mobile :9825097879 Tel.: 91 281 6641284 Mobile :9586566075
Contact Person : Resonant Pharmaceuticals Private Contact Person : Mr. P.K. PATEL
Designation : Director Designation : President
Address : : A-904 Signature-2 Sarkhej Circle Sarkhej Address : 2 Mahashakti Industrial Estate Anil Starch
Sanand Road, Ahmedabad-382210, Gujarat, India eae B/H Sonia Ceramic, Anmedabad-380025, Gujarat,
Tel.: 079 6617 0054 Mobile :91 96388 16323 Tel.: Mobile :9726809222
Tel.: 91 265 2438918 / Mobile : Tel.: 91 79 26462688 Mobile :91 90235 07060
Tel.: 91 265 2427010 Mobile :91 9687941995 Tel.: 91 265 242 7010 Mobile :91 8401715001
Tel.: 0265-2419119 /0265-2412821 Mobile : Tel.: 91 265 3060300 Mobile :91 265 2476317
Tel.: 91 261 2538898 Mobile :9033941541 Tel.: 91-99988 75033 Mobile :9998975033
Contact Person : Kedar Nath Verma/Manoj Kumar Contact Person : Milan C Shah
Designation : Director Designation : Director
Address : Ff-23 Sitaram Complex Near Chhani Canal , Address : Plot No 804 Satkar Building Near Swagat
Vadodara-390002, Gujarat, India Building C G Road , Anmedabad-380006, Gujarat, India
Tel.: 91 794 006 2405 Mobile :9409419673 Tel.: 91 265 6645531 Mobile :
Tel.: 91 79 48916511 Mobile :91 79 48916511 Tel.: 91 260 2994016 Mobile :9825112732
Email ID :herbal@usquare.
biz Email ID : ultracare.international@yahoo.com
Contact Person : Prem Lata Gupta Contact Person : Manish Bansal/mukesh Sood
Designation : Director Designation : Director/Marketing Manager
Address : Plot No 463 Pace City II Sector-37 , Gurgaon- Address : Plot No 400 Industrial Area Phase 1,
122001, Haryana, India Panchkula-134113, Haryana, India
HIMACHAL PRADESH
Aliance Foumulations Alisha & Isha Pharmaceuticals
Tel.: 91 172 2790782 Mobile :91 172 2790838, Tel.: 998 71 235- 34- 72 Mobile :
Tel.: 91 8046 009 527 Mobile :9886068550 Tel.: 91 8026742928 Mobile :9900927000
Spr Oncocare (P) Limited Srk Life Sciences & Research (India)
Tel.: 91-80- 654 4588 Mobile :9845070020 Tel.: 91 80 26751693 Mobile :9632288566
Trigenesis Life Science Private Limited Trust Chemists And Druggists Limited
Tel.: 91 487 2361135 Mobile :0091-9847466475 Tel.: 91 471 2326022 Mobile :0471 232 8306
Tel.: 91 4822 225426 Mobile :9645991940 Tel.: 91 471 4097000 Mobile :91 98959 42100
Tel.: 91 478 2593160 Mobile :94447036402 Tel.:91 484 6492385 Mobile :9847180444
MADHYA PRADESH
Bright Star Trading Cito-Chem Industries Private Limited
Tel.: 91 0731 2422881 Mobile :(91 22) 2596 0320 Tel.: 022 2351 5011. Mobile :
Contact Person : Harish Amar Nath Guliani Contact Person : Deepak Arya
Designation : Director Designation : Director
Address : 402 B-Wing M K Plaza Near Hypercity Mall Address : Unit No 1 Building No 3 Manish Compound
Ghodbunder Road Thane (W), Thane-400607, Anjur Phata Rehnal Vill Bhiwandi, Thane-421302,
Maharashtra, India Maharashtra, India
Aceto Pharma (I) Private Limited Acg Associated Capsules Private Limited
Tel.: 022 2899 4397 Mobile : Tel.: +91(22) 26354800 Mobile :98676 88506
Tel.: +91-22-2430 6504 Mobile :9819006504 Tel.: [+91] 22 2661 3759 Mobile :9821251397
Contact Person : ARCHANA ALOK PANDEY Contact Person :MR. AMMIN RAJQOTWALA
Designation : director Designation : Managing Director
Address : 5, KENORA CHS LTD., HIRANANDANI Address : 607 -B , Kanakia Wall Street, Andheri - Kurla
ESTATE, OFF GHODBUNDER ROAD, THANE (WEST), Rd, Chakala, Andheri East, Mumbai, Maharashtra
Mumbai, Maharashtra 400607 400093
Tel.: 022 2530 7996 Mobile : Tel.: +91 22 48887171 Mobile :9820438128
Contact Person : Mr. Bharat Mehta Contact Person : Mr. Bharat Mehta
Designation : Founder Designation : Founder
Address : 1208-1211 Universal Majestic (Mighty) P L Address : C-2/304, ACC Nagar, Chedda Nagar,
Lokhande Marg B/H R B K School Govandi, Mumbai- Mumbai, Maharashtra 400043
400043, Maharashtra, India
Tel.: +91-22-6665 1700 Mobile :9821086425 Tel.: 91 22 25327440 Mobile :099209 48088
Contact Person : Santosh Francis Dsouza Contact Person : UMESH KRISHNA JOSHI
Designation : direcctor Designation : dirctor
Address : 317a, Mahatma Gandhi Rd, near Address : 2007 Sadashiv Peth Tilak Road , Pune-
Omkareshwar Temple, Sukarwadi, Borivali East, 411030, Maharashtra, India
Mumbai, Maharashtra 400066
Tel.: 8916214, 8951663 Mobile: Tel.: 022 2206 1274 Mobile :8048611151
Contact Person : Tejas H Batavia Contact Person : MANOJ KUMAR SATISH SAXENA
Designation : Partner Designation : DIRECTOR
Address : Off No 5-6 Commerce Ave Paud Road S No Address : Central Ave Hiranandani Estate Thane (W),
127-24 Mahaganesh Col Kothrud, Pune-411029, Mumbai-400607, Maharashtra, India
Maharashtra, India
Tel.: 022 2623 2016 Mobile : Tel.: 022 4006 0301 Mobile :
Contact Person : Pooja Vikash Shukla Contact Person : MANOJ UPADHYAY HAUSHILA
Designation : Partner Designation : DIRECTOR
Address : Office no. 2, 2nd Floor, 7/10 Botawala bldg,, Address : 502, Tanishka Commercial Premises Chs.
Horniman Circle, Fort, Mumbai, Maharashtra 400023 Ltd. Akurli Road, Kandivali(East), Mumbai, Maharashtra
400101
Tel.: 022 2270 0387 Mobile :9930300027 Tel.: 91 22 28461246 Mobile :097698 77107
Tel.: 022 4215 1100 Mobile :+91 8452001010 Tel.: 91 22 66739974 Mobile :+91 8080604600
Tel.: Mobile :0712 222 4344 Tel.: 022 2240 6612 Mobile :
Tel.: Mobile :9320192846 Tel.: +91 (22) 4216 0000 Mobile :802495109
Caddiline Exports Private Limited Cameo Health Care (I) Private Limited
Contact Person : Sujit Ishwarlal Gulalkari Contact Person : Bhaskar Ramchandra Bhatade
Designation : Director Designation : Director
Address : S-1 B R Complex Tawakkal Layout Wadi, Address : Office No 02 Ganpat Bhuwan Anand Bharti
Nagpur-440023, Maharashtra, India Road Chandani, Thane-400602, Maharashtra, India
Tel.: 91 712 6050777 Mobile :8237090777 Tel.: 22 2532 6282, 22 2532 6943 Mobile :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Contact Person : Prasad Madhukar Chodankar Contact Person : Ashutosh Hanumanthrao Palep
Designation : Director Designation : Director
Address : : C-158 Amar Gyan Industrial Estate Khopat , Address : 19/1 Mahalaxmi Industrial Estate D S Road
Thane-400601, Maharashtra, India Gandhi Nagar Lower Parel (W), Mumbai-400013,
Maharashtra, India
Tel.: 2265018321
,22 65018321Mobile : Tel.: Mobile :77450 85588 /
Email ID : Email ID :
Contact Person : dr. kaushik barot Contact Person :LATHA JAYESH CHAUDHARY
Designation : Director Designation : Director
Address : 112 V Mall Off Western Express Highway Address : 203 Morya Landmark 1 Off New Link Road
Thakur Complex Kandivali (E), Mumbai-400101, Andheri (W), Mumbai-400053, Maharashtra, India
Maharashtra, India
Euradite Consumer Health And Life Care Eureka Global Healthcare Private
Email ID : Email ID :
Contact Person : Rajendra Dahyabhai Patel Contact Person : Bijaykumar Bankebihari Gupta
Designation : Director Designation : Director
Address : 3 & 4 The Gorai Indraprastha Chsl Gorai-2 Address : Diwan And Sons Udyog Ngar Plot No 11
Gillary Gunj Rsc-37 Plot No 90 Borivali (W), Mumbai- Palghar, Thane-, Maharashtra, India
400092, Maharashtra, India
Contact Person : Meghal Mehta Contact Person : Mr. Mohan Anand Chandavarkar
Designation : Partner Designation : Director
Address : Lg 113/A Xth Central Mall 90 Feet Road Next Address : B-8 Midc Area Waluj , Aurangabad-431136,
To D Mart Mahavir Nagar Kandivali (W), Mumbai- Maharashtra, India
400067, Maharashtra, India
Tel.: 22 2778 1651 /2/3/4 Mobile: Tel.: 91-265-2281074 Mobile :096655 80672
Contact Person : Jigar Pankaj Shah Contact Person : Nariman Bamansha Medhora
Designation : Director Designation : Director
Address : Plot No 118-120 Mastermind 4 Near Hotel Address : Manoj Industrial Premises G D Ambekar
Royal Palms Aarey Colony Goregaon (E), Mumbai- Marg Wadala, Mumbai-400031, Maharashtra, India
400065, Maharashtra, India
Contact Person : Jay Narendra Mehta Contact Person :Naz Shamim Bari
Designation : Director Designation : Director
Address : Samrudhi Ventrure Park Andheri East Central Address : Basera 503/A 3rd Cross Lane Lokhandwala
Midc Road Near Tunga Hotel, Mumbai-400093, Complex Andheri (W), Mumbai-400053, Maharashtra,
Maharashtra, India India
Tel.: 022 3511 1040 Mobile :8652561080 Tel.: 91 22 40056381 Mobile :7387558383
Tel.: 91 804 513 6816 Mobile :7506506197 Tel.: 91 22 45044444 Mobile :9819994077
Contact Person : Rahul Kundanmal Darda Contact Person : Prabhat Shripal Saxena
Designation : Director Designation : Director
Address : No-722/B Amir Chambers Nana Peth , Pune- Address : G-4, Krishna Comm Centre, Wing 4, Near
411030, Maharashtra, India Liliya Nagar, Goregaon (West) Mumbai Mumbai City MH
400062 IN .
Contact Person : Monica Nelson Fernandes Contact Person : Malay Kumar Biswas
Designation : Director Designation : Director
Address : 714 Dalamal Tower Opp Vidhan Bhavan Address : 207-208 Crescent Tower Off New Link Road
Road 211 Nariman Point, Mumbai-400021, Andheri (W), Mumbai-400053, Maharashtra, India
Maharashtra, India
Contact Person :BHARAT ZAVERCHAND KHUTHIA Contact Person : Eric Kersi Tangri
Designation : Director Designation : Director
Address : 112 Matruchhya Shri Krishna Nagar Borivali Address : Shivam Chambers 106/108 1st Floor Sv
(E), Mumbai-400066, Maharashtra, India Road Goregaon (W), Mumbai-, Maharashtra, India
Email ID : Email ID :
Tel.: 022 6101 2101 Mobile : Tel.: 91 33 2484 0590 Mobile :9198300 89751
Email ID : Email ID :
Contact Person : Gaurav Satish Shah Contact Person : Bahauddi and Mohd Jamil
Designation : Director Designation : Director
Address : : A-3 Shivsagar Est North Wing Dr Annie Address : Plot No C/203 Pranay Nagar Wazira Naka
Besant Road Worli, Mumbai-400018, Maharashtra, India Borivali (W), Mumbai-, Maharashtra, India
Contact Person :DR. OMPRAKASH JAGNANI Contact Person : Piyush Girishchandra Hindia
Designation : Director Designation : Director
Address : 806 / 206, Unique Tower, Gaiwadi Industrial Address : PLOT NO C/4/10/B/2ND FLOOR ADARSH
Estate, Off. S. V. Road, Goregaon (West), Mumbai- 400 INDUSTRIAL COMPLEX OPP:S B | ANKLESHWAER
062. INDIA. BHARUCH GJ 393002 IN .
M J Lifescience M S Pharma
Contact Person : MR. MARK SALDANHA Contact Person : Umar Mujtaba Khan Shervani
Designation : Promoter and Managing Director Designation : Director
Address : 1st Floor, Bharat Tin Works Building, Address : B 610, Knox Plaza, Mindspace, Malad (W)
Opp. Vasant Oasis, Makwana Road, Near Keys Mumbai, Maharastra 400064, India
Hotel,Marol, Andheri (East), Mumbai — 400059
Email ID : Email ID :
Contact Person : Mr. Amal K Naj Contact Person : Akshay Girjashankar Mehta
Designation : Director Designation : Director
Address : || Floor, Medreich House, No.12 Saraswathi Address : 54-B Drug Houseprocter Road , Mumbai-
Ammal Street, Maruthi Seva Nagar, Bangalore KA 400007, Maharashtra, India
560033 IN .
Tel.: 022 6131 2000 Mobile : Tel.: 91 22 40390400 Mobile :91 70390 24932
Contact Person : Hasumati Amarendra Rahalkar Contact Person : SMITA PRADIP BHATIA
Designation : Director Designation : Director
Address : 1306 Mayuresh Chambers Sector-11 Central Address : Kakad Chambers 132 Dr Annie Besant Road
Buss Dist Belapur, Navi Mumbai-400614, Maharashtra, Worli, Mumbai-400018, Maharashtra, India
India
Mulji Mehta & Sons (P) Limited Murli Krishna Exports Private Limited
Contact Person :Nimesh Bharat Shah Contact Person : Jayant Shantilal Mirani
Designation : Director Designation : Director
Address : 3 Botawala Building Nyayamurti G N Vaidya Address : 510 Keshava Building Bandara Kurla
Marg Bank Street B/H State Bank Fort, Mumbai-400023, Complex Bandra (E), Mumbai-400051, Maharashtra,
Maharashtra, India India
Tel.: 22-22634
14 1/2/3/4 Mobile: Tel.: 22 6783 5800 / 801 Mobile :
Contact Person : Gautam Chandrakumar Shah Contact Person : Mr. Pramod Saraf
Designation : Director Designation : Chief Executive
Address : Plot No B/1 Shankar Smruti Apartment Sir Address : 17-A Shreenath Industrial Estate Mahakali
Bhalchandra Road B/H Midtown Pritem Hotel Dadar (E), Caves Road Andheri (E), Mumbai-400093, Maharashtra,
Mumbai-400014, Maharashtra, India India
Contact Person : MR. PARUL PAREKH Contact Person :Dr. Ravindra Bhavsar
Designation : Director Designation : Director
Address : A-305 Krishna Regency Datta Mandir Road Address : Electronic Zone Midc Industrial Area Mahape
pelle Santacruz (E), Mumbai-400055, Maharashtra, , Navi Mumbai-400705, Maharashtra, India
Tel.: 2238023083 Mobile : Tel.: 22-67035555 / 22- Mobile :1800 103 1299
Contact Person : Mrs. Priyanka Prasad Contact Person : Pradip Kumar Shah
Designation : Director Designation : Proprietor
Address : Off 207 Emerald Plaza Block 4 Hiranandani Address : 701 Arun Chambers 80 Tardeo Road Tardeo,
Powai Meadows Off Pokhran Road No 2, Thane-, Mumbai-400034, Maharashtra, India
Maharashtra, India
Tel.: +91 22 32712333 Mobile :9930569562 Tel.: +91 22 61471800 Mobile :91)022-20871945
Tel.: 0712 2765057 Mobile :9405971891 Tel.: 094371 08742 Mobile :9763444944
Tel.: +91 22 6692130 Mobile :9821270098 Tel.: +91 22 25796999 Mobile :9869193811
Tel.: +91 22 29451346 Mobile :9892642843 Tel.: +91 22 26778000 Mobile :9820936030
Tel.: +91 22 2810016 Mobile :9819079995 Tel.: +91 22 28504513 Mobile :9771418457
Contact Person :NIRMAL LALCHAND JAIN Contact Person : Ronak Sanjeev Agrawal.
Designation : Director Designation : Director
Address : 135/137 Zaveri Bazar Sonawala Building 2nd Address : Off No 401 4th Floor Rimsan Estate Mind
FI, Mumbai-400002, Maharashtra, India Space Off Link Road Malad (W), Mumbai-400064,
Maharashtra, India
Tel.: 022 26600290 Mobile :91-9820540059 Tel.: +91 22 65560111 Mobile :8655338268
Tel.: 022 2456 2985 Mobile : Tel.: +91 22 25228181 Mobile :9819103565
Tel.: +91 22 26101320 Mobile :8097921207 Tel.: +91 22 23888936 Mobile :9833163339
Tel.: +91 22 22056776 Mobile :9820931879 Tel.: +91 22 25789800 Mobile :9819633302
Roop Rasayan Industries Private Limited Rosetta Life Care Private Limited
Tel.: +91 22 22004057 Mobile :8048077446 Tel.: (0251)2621721 Mobile :91 22 61414000
Email ID : Email ID :
Tel.: +91 25 22276414 Mobile :982007 1997 Tel.: +91 22 28256895 Mobile :9320089686
Tel.: 22 4973 3812 Mobile :9867728601 Tel.: 22-2270 3431 / 2266 Mobile :
Email ID : Email ID :
Tel.: +91 22 2883 2394 Mobile :8879785563 Tel.: 020 2553 0292 Mobile :
Tel.: (22)-62599800 Mobile :9323286677 Tel.: 22-2500 6907 Mobile :98211 11045
Contact Person : VIRENDRA BABULAL SHAH Contact Person :DEEPAK BHAILAL SHAH
Designation : director Designation : director
Address : 102 Titan House 60Ft Road Opp Bank Of Address : 210 Kanara Business Center (Kbc) 2nd Floor
Maharashtra Ghatkopar (E), Mumbai-400077, A Wing B/H Everest Garden Off Ghatkopar Andheri Link
Maharashtra, India Road, Mumbai-400075, Maharashtra, India
Contact Person : Anand Satishchandra Soshte Contact Person : JAYESH PANNALAL CHOKSI
Designation : director Designation : director
Address : 6th Floor Sapphire Building Opp-Icici Bank L Address : 105 1st Floor Anand Bhuvan 17 Babu Genu
K Road Santacruz (W), Mumbai-400064, Maharashtra, Road Princess Street Lohar Chawl, Mumbai-400002,
India Maharashtra, India
Tel.: 22-25274438 Mobile :9820512897 Tel.: 22 6700 4932 Mobile :99200 54290
Contact Person : Raj Mohan Appalacharya Nallan Contact Person : Mr. Mehul J. Parekh
Designation : director Designation : Managing Director
Address : 207 2nd Floor Popatlal Chambers 4th Cross Address : 501/E-Wing Skypark Chs Ltd Oshiwara
Clive Road Danabunder Masjid (E), Mumbai-400009, Garden Road Next To Hdfc House Off S V Road
Maharashtra, India Goregaon (W), Mumbai-400104, Maharashtra, India
Contact Person : Mr. Ashok Saroha Contact Person : Mr Vimal Pratap Jaswa
Designation : Vice President Designation : Director
Address : 503/504 5th Floor Hubtown Solaris N S Address : Jet Prime Office No 103 39-B Suren Road
Phadke Marg Andheri (E), Mumbai-400069, Near Western Exp Metro Station Opp Residency Hotel
Maharashtra, India Andheri (E), Mumbai-400093, Maharashtra, India
Tel.: +91 22 2430 6780 Mobile : Tel.: +91 2525 645171 Mobile :9890693768
Tel.: 022 2418 4222 Mobile : Tel.: 022 43441234 Mobile :7738369521
Email ID : Email ID :
Tel.: +91 22 66950648 Mobile : Tel.: +91 22 61322609 Mobile :+91 22 61322629
Contact Person : Mr.Rakesh Bindra Contact Person : Manoj Khanna and Mukesh Khanna
Designation : Designation : Director
Address : 27/14 Malaygiri Navare Nagar B Cabin Road Address : VIJAY EXPORTS ‘st floor Fida Hussain
Ambernath (E), Thane-, Maharashtra, India Compound, Western Express Highway opp. Thakur Mall,
near Lodha Aqua Complex, Mira Road, Mumbai
Maharashtra - 401104
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
ee BN)
Kenosis Biotech India Limited Keva Industries
Tel.: +91 171 2650396 Mobile :98965 - 50396 Tel.: +91 22-26395907 Mobile :
Tel.: +91 44 22321982 Mobile :9600081165 Tel.: +91 44 2496 8000 Mobile :
Tel.: +91 44 23782072 Mobile :9500277777 Tel.: 022 2612 1393 Mobile :
Tel.: +91 44 6613 2500 Mobile :9600829229 Tel.: +91 44 2254 0138 Mobile :
Hems & Nephews Exports Private Hepta Kings Impex Private Limited
Icarus Health Care Private Limited Indus Life Sciences Private Limited
Tel.: +91 804 2756132 Mobile :8903252275 Tel.: +91 11 22322006 Mobile :9841094753
Email ID : Email ID :
Email ID : Email ID :
Tel.: +91 4562 274608 Mobile : Tel.: +91 456 3230890 Mobile :9994454145
Tel.: +91 40 23742821 Mobile :8125586570 Tel.: +91 40 23750124 Mobile :040-23750124
Future Life Sciences Private Limited Galt Pharma Exports Private Limited
Tel.: +91 40 23752315 Mobile :9949902056 Tel.: 040 4002 1757 Mobile :
Contact Person : Davinder Singh Brar Contact Person : Talluri Prasanna Kumar
Designation : Chairman Designation : Managing Partner
Address : Plot No 28A Ida Nacharam , Hyderabad- Address : BACKSIDE METRO CASHCARRYNEAR
500076, Telangana, India SAI BABA TEMPLEKUKATPALLY MAITRINAGAR,
Prashanti Industrial Area, Hyderabad-500072,
Telangana, India
Tel.: 040 2371 3879 Mobile :9849166278 Tel.: 0808 239 8944 Mobile :9963977163
Contact Person :Sreerama Koteswara Rao Contact Person : Sanjay Kumar Kedia
Designation : Chairman Designation : Director
Address : Plot No. 1&2, Sai Krupa Enclave, Near Lanco Address : Raj Towers Main Road Bakaram
Hills Golconda Post, Hyderabad 500 008 Telangana, Musheerabad Near Spencers Hyper Market, Hyderabad-
India. 500020, Telangana, India
Contact Person : Shri Yelamanchi Rama Mohan Rao Contact Person : Sandhya Kumari
Designation : Cahirman and Managing Director Designation : Account Executive
Address : Business Development Manager Address : Address : 302 Bhavya Santastika Road No 12 Banjara
No 302 Bhavyaa S Fantastika Road No 12 Banjara Hills, Hills , Hyderabad-500034, Telangana, India
Hyderabad-500034, Telangana, India
Tel.: +91 40 23221147 Mobile : Tel.: (+91) 4027112379 Mobile :(+91) 9000012739
Tel.: +91 40 27842549 Mobile :+91 — 78933 Tel.: +91 40 2339 6784 Mobile :
Contact Person : Jagan Mohan Perumahanti Contact Person : VIDYA DEVI YALAMANCHILI
Designation : Senior Executive Marketing Designation : Managing Director
Address : No 89/A 2nd Floor Aishwarya Street No 8 Address : Plot No-167 Road No-13A Jubilee Hills,
Sagar Society Road No 2 Banjara Hills, Hyderabad- Hyderabad-500033, Telangana, India
500034, Telangana, India
Tel.: 040 66662400 Mobile :040 2341 1035 Tel.: 40 23544875 Mobile :91-23544875
Ocean Health & Medical Private Limited Panaaya Pharma Private Limited
Spectrum Life Science Private Limited Sprout Life Sciences India Private
Contact Person : CHIVUKULA GOPALA KRISHNA Contact Person : VARUN DASARI REDDY
Designation : Director Designation : Director
Address : C-4 Idnl Area Uppal , Hyderabad-500039, Address :Plot No 3-6-504/A/1 Street 6 Himayatnagar ,
Telangana, India Hyderabad-500029, Telangana, India
Contact Person : Mr. Nav Rattan Munjal Contact Person :Kulbhushan Sharma
Designation : Director Designation : Director
Address : Sco 850 Shivalik Enclave Nac Manimajra , Address : No 66 Industrial Area Phase-| , Chandigarh-
Chandigarh-160101, Uttarakhand, India 160002, Uttarakhand, India
Tel.: +91 172 2730503 Mobile : Tel.: +91 11 815080587 Mobile :9814011675
Tel.: +91 154 2460779 Mobile :9049877222 Tel.: 092165 32801 Mobile :
UTTAR PRADESH
Cemex Pharma Ciel Pharma Private Limited
Kansas Drugs & Pharmaceuticals Private Knight Medicare & Knight Trading Co
Tel.: +91- 0265- 2973973 Mobile :+91- 7043471700 Tel.: Mobile :9932076071
Tel.: 91 98744 02779 Mobile :98306 91197 Tel.: Mobile :70429 61616,
Tel.: +91 1681 225092 Mobile :9215344775 Tel.: Mobile :91 - 40 - 3921
Contact Person : Anant Dattatray Barbadikar Contact Person : Veera Venkata Siva Kumar Reddy
Designation : Director Designation : Director
Address : Plot No 115 Parawada Jawaharial Nehru Address : Plot No 60-C Ramky Pharma City (I) Ltd
Pharma City , Visakhapatnam, 531021, Andhra Parwada Mandal, Visakhapatnam, 531019, Andhra
Pradesh, India Pradesh, India
Contact Person : DAYA RAM Contact Person : Dr. Krishna Prasad Chigurupati
Designation : Director Designation : MANAGING DIRECTOR
Address : D No 24-25-60 Brts Road B/S Sri Chaitanya Address :Flat No 121 & 122 Ramky Pharma City
School Durgapuram, Vijayawada, 520003, Andhra porauaee , Visakhapatnam, 531019, Andhra Pradesh,
Pradesh, India
Tel.: 040 6662 4864 Mobile :9246353746 Tel.: 70938 71666 Mobile :
Tel.: +91 8579 259205 Mobile :9347383024 Tel.: +91 864 7222633 Mobile :
Email ID : Email ID :
Tel.: Mobile :8556297466 Tel.: 1800 425 1925 Mobile :628 145 7109
Pure And Cure Healthcare Private Reckitt Benckiser (India) Private Limited
Tel.: 91 11 27023256 Mobile :9999012080 Tel.: Mobile :91 124 402 8000
Tel.: +91 11 66300100 Mobile :91 124 4518100 Tel.: +91 11 27761196 Mobile:
Tel.: +91 11 26814056 Mobile :9811154802 Tel.: +91 11 27853873 Mobile :9811570009
Tel.: +91 11 28316116 Mobile :9810021264 Tel.: +91 11 41011656 Mobile :91-11-23315861
Contact Person : Sarada Kalyani Bhagawati Contact Person : Vikram Andrew Naharwar
Designation : Director Designation : Director
Address : Plot No. 564/A/22, Road No. 92, Jubilee Address : S 12 Colvale Industrial Estate Colvale ,
Hills, Hyderabad Hyderabad TG 500096 IN Bardez, 403513, Goa, India
Tel.: Mobile :0832 239 5526 Tel.: +91 832 6450266 Mobile :9326117756
Tel.: +91 266 7671301 Mobile :7405958187 Tel.: 91 22 61505200 Mobile :9925299239
Tel.: Mobile :91-79-26563331 Tel.: 91 2717 667000 Mobile :79 6621 6000
Tel.: 02668 671 300 Mobile : Tel.: +91 265 2323046 Mobile :
Tel.: 91 260 2408 000 Mobile : Tel.: 91 260 2408 000 Mobile :
Tel.: +91 260 3052100 Mobile : Tel.: +91 260 3052 100 Mobile :
Tel.: +91 265 2359662 Mobile :9687744555 Tel.: Mobile :91 891 3081555
Tel.: +91 265 2251362 Mobile :91 9773267280 Tel.: 91 20 6818 1200 Mobile :9099937735
Contact Person : Rishad Kairus Dadachanji Contact Person : Mr. Deepak Kulabkar
Designation : Director Designation : Chairman & Managing Director
Address : Survey No 46/1-4 Village Kadaiya Nani Address : 105 Aatish Annexe Opp C G Road Gulbai
Daman , Vapi, 396210, Gujarat, India Trekra , Ahmedabad, 380006, Gujarat, India
Contact Person : Gokul Mrugesh Jaykrishna Contact Person : Niraj Jagdish Thakkar
Designation : Director Designation : Director
Address : 2nd Floor Shiromani Complex Satellite Road Address : 2nd Floor Shiromani Complex Satellite
, Ahmedabad, 380015, Gujarat, India Landmark Near Spips School, Ahmedabad, 380015,
Gujarat, India
Tel.: +91 2762 253121 Mobile :9825022910 Tel.: 98250 10637 Mobile :
Tel.: 0265 242 5413 Mobile : Tel.: 079 2545 1379 Mobile :9099033844
Tel.: 090990 99245 Mobile :9327679900 Tel.: 079 2583 1668 Mobile :
Tel.: 02827 253 690 Mobile : Tel.: 097234 17771 Mobile :9824030957
Tel.: 0265 288 0146 Mobile : Tel.: 080 4603 3025 Mobile :
Tel.: 0261 239 8058 Mobile :9029532346 Tel.: 080 6821 1446 Mobile :
Tel.: 02846 222 522 Mobile : Tel.: 02717 284 368 Mobile :
Contact Person : Manas Anilkumar Jhajharia Contact Person :Amritbhai Purshottamdas Prajapati
Designation : Director Designation : Director
Address : 128 GI D C INDUSTRIAL ESTATEKALOL Address : Door No 301/304 Akash Road Opp National
MEHSANA GJ 382725 Handloom Corp Low Garden C G Road, Ahmedabad,
380009, Gujarat, India
Tel.: 079 2685 2181 Mobile : Tel.: 079 4893 3701 Mobile :
Tel.: 02646 221 189 Mobile :8037400132 Tel.: 096011 17188 Mobile :
Tel.: 079 2658 7210 Mobile :9825006747 Tel.: +91 2752 241554 Mobile :
Tel.: +91 2692 238849 Mobile :9426517320 Tel.: 085111 49413 Mobile :
Tel.: 080 4856 8833 Mobile : Tel.: 079 2646 8353 Mobile :
Hes NOK
Email ID :kbhpolymers@gmail.com
PUBLICATIONS
Publishers Of Magazines, Directories & CD’S
Tel.: +91 78 17824051 Mobile :7819824051
SUBSCRIPTION FORM
Rs. 1500 (2 4 Issues 1 Yea ) Hy risrerossetrsinan STANG eisssscrrotssrenevierco FEET i asnssteswntioere COUNTY siecresinsrsscvsoron
AIC. 041 50200000909, MUMBAI Towards Above Marked Subscription In Favor of MAZADA PUBLICATIONS
Payable In Mumbai, (Please Pay Rs.30/- Extra In Case Of Outstation Cheques)
azada
PUBLICATIONS Signature of Subscriber ————
maha ace Please Send The Complete Form With Cheque / DD To Subscription Department
Gala No. 1A, Sharma Compund, Old Nagardas Road, Andheri (E), Mumbai -400 069
Mob; 8108049982 / 9860066753 / 9004528972 + E-mail ; mazdapharmaguide@gmail.com » Website : http://issuu.com/themazdapharmaguide
Address : G V Chamber, 7-2-C8 & C8/2,IE Sanath Address :Plot No 21 Jawaharlal Nehru Pharma City
Nagar, Hyderabad - 500 018. Telangana. India. Parawada , Visakhapatnam, 531021, Andhra Pradesh,
India
MAZDA PUBLICATIONSPresents
GUJARAT ZONE
43th, i |
NORTH
CPHI*:
ZONE
-""-
}
&
AMPTECH INDIA
INDORE PHARMA
india AND LAB EXPO
LOTS EGS
E - ASIA LABEX 2
Or AaGVEe = = »jele £ a
~ - 7 A - = - . ° 6 ° ° °
e . . YooUUbG =y-}@ . . _
e e e186 t . Ai sf
Contact Person : Anant Dattatray Barbadikar Contact Person : Veera Venkata Siva Kumar Reddy
Designation : Director Designation : Director
Address : Plot No 115 Parawada Jawaharial Nehru Address : Plot No 60-C Ramky Pharma City (I) Ltd
Pharma City , Visakhapatnam, 531021, Andhra Parwada Mandal, Visakhapatnam, 531019, Andhra
Pradesh, India Pradesh, India
Contact Person : DAYA RAM Contact Person : Dr. Krishna Prasad Chigurupati
Designation : Director Designation : MANAGING DIRECTOR
Address : D No 24-25-60 Brts Road B/S Sri Chaitanya Address : Flat No 121 & 122 Ramky Pharma City
School Durgapuram, Vijayawada, 520003, Andhra poreuaee , Visakhapatnam, 531019, Andhra Pradesh,
Pradesh, India
Tel.: 040 6662 4864 Mobile :9246353746 Tel.: 70938 71666 Mobile :
Tel.: +91 8579 259205 Mobile :9347383024 Tel.: +91 864 7222633 Mobile :
Email ID : Email ID :
Tel.: Mobile :8556297466 Tel.: 1800 425 1925 Mobile :628 145 7109
Tel.: +91 11 43845500 Mobile: Tel.: 91 (11) 4352 8248 Mobile :9650436669
Tel.: +91 11 41616377 Mobile :9718508195 Tel.: +91 11 45549213 Mobile :9811101164
Pure And Cure Healthcare Private Reckitt Benckiser (India) Private Limited
Tel.: 91 11 27023256 Mobile :9999012080 Tel.: Mobile :91 124 402 8000
Tel.: +91 11 66300100 Mobile :91 124 4518100 Tel.: +91 11 27761196 Mobile:
Tel.: 011 26221811 Mobile :91-11-47589500 Tel.: +91 011 27430249 Mobile:
Tel.: +91 11 26814056 Mobile :9811154802 Tel.: +91 11 27853873 Mobile :9811570009
Contact Person : Sarada Kalyani Bhagawati Contact Person : Vikram Andrew Naharwar
Designation : Director Designation : Director
Address : Plot No. 564/A/22, Road No. 92, Jubilee Address : S 12 Colvale Industrial Estate Colvale ,
Hills, Hyderabad Hyderabad TG 500096 IN Bardez, 403513, Goa, India
Tel.: Mobile :0832 239 5526 Tel.: +91 832 6450266 Mobile :9326117756
Tel.: +91 266 7671301 Mobile :7405958187 Tel.: 91 22 61505200 Mobile :9925299239
Tel.: Mobile :91-79-26563331 Tel.: 91 2717 667000 Mobile :79 6621 6000
Tel.: 02668 671 300 Mobile : Tel.: +91 265 2323046 Mobile :
Tel.: 91 260 2408 000 Mobile : Tel.: 91 260 2408 000 Mobile :
Tel.: +91 260 3052100 Mobile : Tel.: +91 260 3052 100 Mobile :
Tel.: +91 265 2359662 Mobile :9687744555 Tel.: Mobile :91 891 3081555
Tel.: +91 265 2251362 Mobile :91 9773267280 Tel.: 91 20 6818 1200 Mobile :9099937735
Tel.: 0281 238 8477 Mobile :9426165747 Tel.: 75748 78021 Mobile :
Tel.: 099099 28332 Mobile :9909928332 Tel.: +91 79 66823000 Mobile :8511109687
Tel.: 0265 263 3314 Mobile :9825413813 Tel.: 079 2583 6467 Mobile :
Tel.: 079 4023 3000 Mobile : Tel.: +91 265 2321674 Mobile :
Contact Person : Dr. Jitendra Dobaria Contact Person : Shailendra Maneklal Sharma
Designation : Director Designation : Director
Address : Plot No: 3609, Ankleshwar GIDC, Address : Plot No 115 & 115/1, New GIDC, Dhamdachi,
Ankleshwar, Gujarat 393002 Gundlav, 396035
Tel.: 090990 99245 Mobile :9327679900 Tel.: 079 2583 1668 Mobile :
Tel.: 02827 253 690 Mobile : Tel.: 097234 17771 Mobile :9824030957
Tel.: 0265 288 0146 Mobile : Tel.: 080 4603 3025 Mobile :
Tel.: 0265 284 0376 Mobile : Tel.: 0268 255 8217 Mobile :9825342642
Tel.: 02646 221 189 Mobile :8037400132 Tel.: 096011 17188 Mobile :
Tel.: 079 2658 7210 Mobile :9825006747 Tel.: +91 2752 241554 Mobile :
Tel.: +91 2692 238849 Mobile :9426517320 Tel.: 085111 49413 Mobile :
Tel.: 080 4856 8833 Mobile : Tel.: 079 2646 8353 Mobile :
Tel.: 098252 44883 Mobile : Tel.: 079 2583 5515 Mobile :9825044031
Tel.: +91 79 26440558 Mobile :9825321583 Tel.: +91 2742 257730 Mobile :
Tel.: 0265 284 6794 Mobile :9979036953 Tel.: +91 2767 282448 Mobile :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Tel.: +91 2767 220150 Mobile :9825433442 Tel.: 91 2662 — 244077 Mobile :9909966408
Tel.: 91 (02764 ) 292675 Mobile :91-9727163938 Tel.: 88660 50898 Mobile :91 90330 50853
Tel.: 91 281 2635137 Mobile :9586050004 Tel.: 91 263 4262377 Mobile :9426111364
Tel.: 91 02698 222425 Mobile :9825328551 Tel.: 91 2697 244051 Mobile :91 2697 245550
Tel.: Mobile :079-22821740 Tel.: 91 261 2411220 Mobile :91 99099 52404
Tel.: 91 278 2445267 Mobile :91 94081 09060 Tel.: +91 2646 222825 Mobile : 91 98252 05460
Tel.: 2764 233651 Mobile : Tel.: (265) 2281 631 Mobile :9.19E+11
Tel.: 079 — 27498515 Mobile :9099946396 Tel.: Mobile :1800 121 7585
Tel.: 2662 244100 Mobile: Tel.: 2662 244100 Mobile :94291 57577
Tel.: 0265 2330545 Mobile :98984 84534 / Tel.: 2762 282351 Mobile :79 26568319
Tel.: 02646-226676 Mobile :8037528808 Tel.: 2584 0869 Mobile :79 2630 4045
Tel.: 91 264 6252211 Mobile :83547465000 Tel.: 288 288 5502 Mobile :9904041155
Contact Person :Asit Patel Contact Person : Umalaxmi Organics Private Limited
Designation : President Designation : Umalaxmi Organics Private Limited
Address : 201 Toran Vikas Nagar Old Padra Main Road Address : Umalaxmi Organics Private Limited
, Vadodara, 390007, Gujarat, India
Contact Person : Mayank Patel/jitendra Panchal Contact Person : Jashodaben Shambhubhai Patel
Designation : Managing Director/ General Manager Designation : Director
Address : Khali Char Rasta State Highway , Siddhpur, Address : State Highway Khali Char Rasta Khali,
384151, Gujarat, India Siddhpur, 384151, Gujarat, India
Tel.: 2767 282395 Mobile :98250 69590 Tel.: 91 2767 282390 Mobile :9825069590
Tel.: 2646 - 272289 Mobile :98241 11879 Tel.: 2284 4992 Mobile :79-2284 4991
Contact Person : Mr. Shoeb A Chhavnivala Contact Person : Nikhilbhai Mohanlal Majithia.
Designation : ceo Designation : Director
Address : 79/1 MA Chhavniwala Compound Address : 8th Floor The Chambers Opp New
Habibbhai's Chawl Near Chepirog Hospital Behrampura, Gurudwara Gandhinagar-Sarkhej Highway, Ahmedabad,
Ahmedabad, , Gujarat, India 380054, Gujarat, India
Tel.: 91-172-2565161 ,91- Mobile :9216769566/ 91- Tel.: 9.14E+11 Mobile :9908162949/
Tel.: 0172 — 2556660 Mobile :9816666205 Tel.: 91 130 2484108 Mobile :8059208786
Tel.: 022 6663 8000 Mobile : Tel.: +91 129 4181500 Mobile :
God Gift Laboratory Private Limited llife Medical Devices Private Limited
Tel.:91 1795 308000 Mobile :9805067735 Tel.: 91-11-47057611, 91-11- Mobile :9899011777
Tel.: +91 6283491835 Mobile :+91 9218502690 Tel.: 1800212441 Mobile :9218593186
Contact Person :Dr dan singh Contact Person :Dr dan singh
Designation : CEO Designation : CEO
Address : Mouza-Meerpur Gurudwara Kala-Amb , Address : Moginand Kala-Amb Nahan Road Kala-Amb
Sirmour, 173030, Himachal Pradesh, India , Sirmour, , Himachal Pradesh, India
Tel.: 8110 — 415539 Mobile :9019317788 Tel.: 80- 67397266 Mobile :9900030271
Anglo French Drugs & Industries Limited Apotex Pharmachem India Private
Contact Person : Girija Subramanian Contact Person : YOGANJANEYA REDDY PANEM
Designation : Director Designation : Director
Address : No 41 3rd Cross 5th Block Rajajinagar , Address : Site No-1A Bommasandra Industrial Area 4th
Bangalore, 560010, Karnataka, India Phase Jigani Link Road , Bangalore, 560099,
Karnataka, India
Tel.: +(91)-(80)-2315 6722 Mobile :9009599950 Tel.: 080 2289 1014 Mobile :
Tel.: 1800 425 6939 Mobile :080 2663 5653 Tel.: 080-23571590 Mobile :7309222556
Contact Person : Siva Kumar Bheeman Contact Person : Kalak Abdul Hafeez
Designation : Senior Manager Designation : Managing Director
Address : 34 Kilometer Thumkode Road Illamangala, Address : Flat No 1st Fr 15-A The Presidency St Marks
Channapatna, 562123, Karnataka, India Road, Bangalore, 560035, Karnataka, India
Tel.: 0836 225 2007 Mobile : Tel.: 080 2843 7115 Mobile :
Tel.: +91 80 27971445 Mobile : Tel.: 516-292-7400 Mobile :080 4211 1309
Contact Person : ALUR DRONACHALA SETTY Contact Person : Dr. Sonali Sarnobat
Designation : Director Designation : Managing Director
Address : 86/C2, 3rd Main, 3rd A Cross, Industrial Address : Plot No 166 Auto Nagar , Belgaum, 590016,
Suburb, 2nd Stage, Yesvantpur Industrial Suburb, Karnataka, India
Yeswanthpur, Bengaluru, Karnataka 560022
Email ID : Email ID :
Tel.: 2836 2672 Mobile :+91 80 4127 2737 Tel.: 22210036 Mobile :8026640036
Contact Person : ASHOK ANNARAO HUBLIKA Contact Person : VINAYAK GANESH HEGDE
Designation : Director Designation : Director
Address : Plot No 19-B Kiadb Industrial Area Hoskote , Address : N-12 Industrial Estate , Hubli, 580030,
Bangalore, 562114, Karnataka, India Karnataka, India
Tel.: 91 80 22586567 Mobile :91 80-22586567 Tel.: +91 80 2656 1562 Mobile :+91 80 2656 1581
Tel.: 91 80 23417788 Mobile :9845211481 Tel.: +91 80 42113536 Mobile :+91 8884 110011
Tel.: +91 250 2338315 Mobile :+91 250 2344639 Tel.: +91 - 11 45390146 Mobile :
Tel.: +91 80 41536143 Mobile :+91 98 8072 3272 Tel.: 9448014541 Mobile :
Tel.: 076767 59999 Mobile : Tel.: +91 8027630180 Mobile :+91 8027624540
Shree Anand Life Sciences Limitede Somu Organo Chem Private Limited
Contact Person : Dr. Panniyampally Madhavankutty Contact Person : Shri Ashish Srivastava IAS
Designation : Managing Trustee Designation : Official Director
Address : Vaidyaratnam P S Varier's Arya Vaidya Sala Address : Mahilamandiran Road Poojappura ,
Kottakkal Po, Malappuram, 676503, Kerala, India Thiruvananthapuram, 695012, Kerala, India
Tel.: 91 496 252506 Mobile :9497754109 Tel.: +91 484 2867000 Mobile :8943817000
Tel.: 91 484 4080400 Mobile: Tel.: +91 467 2240 571 Mobile :+91 9895224580
Tel.: +91 484 2454820 Mobile : Tel.: 91 484 2768321 Mobile :+91 9447008830
Tel.: 491 2524822 Mobile :+91 944 727 7418 Tel.: 91 484 2476301 Mobile :
Tel.: 0491 2970087 Mobile :9037 113339 Tel.: 91 484 4080422 Mobile :
Neogen Food And Animal Security New Udaya Pharmacy & Ayurvedic
Tel.: +91 471 2490293 Mobile :9846194949 Tel.: +91 944 772 1140 Mobile :+91 811 391 1999
Sitaram Ayur Veda Pharmacy Limited Systa Pharma Labs (P) Limited
Tel.: 91 487 2432700 Mobile: Tel.: +91 484 - 2559187 Mobile :+91 9820069819
MADHYA PRADESH
Vysali Pharmaceuticals Limited Fortcaps Healthcare Limited
Tel.: 91 484 2410256 Mobile :+91 9447023591 Tel.: -25774132 Mobile :9303396549
Tel.: 91 755 4235734 Mobile :9303696512 Tel.: Mobile :+91 731 2529751
Tel.: Mobile :731 230 7099 Tel.: 91-731- 3249059 Mobile :731 404 7547
Raj Pioneer Laboratories India Private Rini Life Science Private Limited
Contact Person : Virendra Kumar Jain Contact Person :MR ANIL SATWANI
Designation : Director Designation : Managing Director
Address : 165 Ravindra Nath Tagore Marg Opp Chetak Address : Corporate office and Unit — | (Rau, Indore
Centre , Indore, 452001, Madhya Pradesh, India 385, Pigdamber, Rau, Indore, Madhya Pradesh 453331
Tel.: Mobile :91 731 3069100 Tel.: Mobile :731 420 0052
Tel.: Mobile :+91 73 14047518 Tel.: 91 7492 223994 Mobile :94254 29994
Tel.: 022 2760 7954 Mobile : Tel.: 91 22 66485216 Mobile :93170 48600
Tel.: +91 22 2778 1651/2/3/4 Mobile : Tel.: [+91] (022) 66478484 Mobile :
Contact Person : ROY CHAUDHURY SNIGDHENDU Contact Person : Mary Neelima Kerketta
Designation : Director Designation : Director
Address : No 3 Laxmi Industrial Estate Pokhran Road Address : Acharya Donde Marg Parel , Mumbai, ,
No 1 Pokhran Upvan Shivaji Nagar Thane (W), Thane, Maharashtra, India
400606, Maharashtra, India
Punjab Chemicals And Crop Protection Raptakos Brett & Company Limited
Contact Person : Vinay Arvind Ranade Contact Person : Dwarika Prasad Agrawal
Designation : Director Designation : Director
Address : Thaen Belapur Road In Front Rabale Address : 301 Evershine Mall Off Malad Link Road
Railway Station Rabale , Navi Mumbai, 400701, Malad (W), Mumbai, 400064, Maharashtra, India
Maharashtra, India
Contact Person : Vijay Shankarlal Bankda Contact Person : Dr. Sachin Dinesh Patel
Designation : managing director Designation : ceo
Address : 7 Niraj Industrial Estate Off Mahakali Caves Address : 11/12 Udyog NagarV S Road Goregaon (W)
Road Andheri (E), Mumbai, 400093, Maharashtra, India , Mumbai, 400104, Maharashtra, India
Contact Person : Banda Balaji Rao Contact Person : Pallavi Prakash Shedge
Designation : Director Designation : Director
Address : S No 114/A/2 Venkaeshwara House Pune Address : Bsel Techpark B Wing 10th Floor Sector-30A
Singhad Road , Pune, 411030, Maharashtra, India Opp Vashi Railway Station Vashi, Navi Mumbai,
400703, Maharashtra, India
Contact Person : SANJAY RAJANIKANT MEHTA Contact Person : Ganesh Narayan Nayak
Designation : Director Designation : Director
Address : Off No 5119 5th Floor D Wing Oberoi Garden Address : C-4 Midc Ttc Industrial Area Village Pawne
Estate Chandivali Andheri (E), Mumbai, 400072, Thane Belapur Road, Navi Mumbai, 400705,
Maharashtra, India Maharashtra, India
Contact Person :AMIT ARUN GORE Contact Person :RAVINDRA VISHNU JAGTAP
Designation : Director Designation : Director
Address : Plot No 8C Survey No 288 Raisoni Industrial Address : 247-248 Udyog Bhavan Sonawala Lane
Estate Mann Tal Mulshi Hinjewadi , Pune, 411057, Goregaon (E), Mumbai, 400063, Maharashtra, India
Maharashtra, India
Contact Person : MILAN RAMESH THAKKAR Contact Person : Ganpat Mahadev Patil
Designation : Director Designation : Director
Address : 32, Jamuna Building, 2nd Floor, L.T. Address : Number B-15 Kalayn Badlapur Road MID C
Marg,Dhobi Talao, Near Metro Cinema,Mumbai- 400002. Area Ambernath Near Reliance Petrol Pump Ambernath,
Thane, 451501, Maharashtra, India
Tel.: (+91 22) 6600 2313. ~—- Mobile: Tel.: 022-4241 8888 Mobile :
Contact Person : ULHAS RAJARAM PURANIK Contact Person : Dhwanil Durgesh Kapadia
Designation : Director Designation : Director
Address : Cure House C-12/13 Midc Bhosari, Pune, Address : Savita Sadan-3 1st Floor 1st Wing 61-Sahar
411026, Maharashtra, India Road Andheri (E), Mumbai, 400069, Maharashtra, India
Contact Person : Mr. Arun Gupta Contact Person :Bhooshan Madhukar Pai
Designation : Director Designation : Director
Address : 159/6 Mittal Industrial Estate Sir M V Road Address :Plot No A-22 Midc Additional Ambarnath
Andheri (E), Mumbai, 400059, Maharashtra, India Ambarnath (E), Thane, 421506, Maharashtra, India
Contact Person : Murali Krishna Valluri Contact Person :Lalsa Balgovind Yadav
Designation : Director Designation : Director
Address : G 39/5 Midc Waluj , Aurangabad, 431133, Address : 20 Dr E Moses Road Mahalaxmi , Mumbai,
Maharashtra, India 400011, Maharashtra, India
Tel.: 22 2838 7538/22 2839 Mobile : Tel.: +91 22 61289200 Mobile :9619450566
Contact Person : Mukund Prataprai Mehta Contact Person : Pinky Rishabh Desai,
Designation : Director Designation : Director
Address : 902/B Godrej Cloiseum B/H Everad Nagar Address : F-11 Nand-Jyot Industrial Premises Andheri
Near Priyadarshani Circle Sion (E), Mumbai, 400022, Kurla Road Safed Pool Sakinaka Andheri (E), Mumbai,
Maharashtra, India 400072, Maharashtra, India
Contact Person : Abhijeet Prabhakar Konduskar Contact Person : Gagan Harsh Sharma,
Designation : Director Designation : Director
Address : Plot No 312 Building No 221 2nd Floor Address : B-8 Aditional Ambernath Midc Opp Anand
Pashan , Pune, 411021, Maharashtra, India Nagar Near Police Chowky Ambernath (E), Thane,
421506, Maharashtra, India
Contact Person : Shailesh Ishwarlal Patel Contact Person :Lalsa Balgovind Yadav
Designation : Director Designation : Director
Address : Sunshine Tower 26th Floor Senapati Bapat Address : 20 Haines Road , Mumbai, 400011,
Marg Dadar (W), Mumbai, 400013, Maharashtra, India Maharashtra, India
Tel.: 91 721 2520302 Mobile :9370153672 Tel.: 91 724 2258393 Mobile :9604004299
Email ID : Email ID :
Contact Person : JAl RAM SINGH Contact Person : Kostuv Purushottam Kejriwal
Designation : Director Designation : Director
Address : 201 Adhyaru Industrial Estate Lower Parel , Address : Shop No 76 Whispering Palm Shopping
Mumbai, 400013, Maharashtra, India Centre Lokhandwala Complex Kandivali (E), Mumbai,
400101, Maharashtra, India
Contact Person : NIKHIL JITENDRA SHAH Contact Person : Pradeep Ramwilas Rathi,
Designation : Director Designation : Director
Address : 251/8 Alankar 2nd Floor Sion (W) , Mumbai, Address : 2 Shilp Nagar Station Road , Aurangabad,
400022, Maharashtra, India 431005, Maharashtra, India
Tel.: 91 2525 661297 Mobile :9320009240 Tel.: 91 712 2765296 Mobile :91 9028049946
Email ID : Email ID :
Tel.: 91 712 2640062 Mobile :9561088057 Tel.: 91 250 2390002 Mobile :9892842150
Paras Organics Private Limited Pell Tech Health Care Private Limited
Email ID : Email ID :
Contact Person :Sunanda Vaman Mutkule, Contact Person : Sapphire Lifesciences Private
Designation : Director Designation : Director
Address : Shop No 81 Stice Musalgaon Tal Sinnar Main Address :Plot No 44/45 Palghar Taluka Industrial Co
Road , Nashik, 422112, Maharashtra, India Op Estate Ltd Boisar Road, Palghar, 401404,
Maharashtra, India
Tel.: +91 2551 240266 Mobile :9028168412 Tel.: 2525 256170 Mobile :
Contact Person : Satyanarayana Rao Penchala Contact Person : Hema Suresh Bhatwadekar
Designation : Director Designation : Director
Address : B-307 Sarita Building Prabhat Industrial Address : E-35 Palghar (Tal) Boisar Midc , Tarapur,
Estate Dahidar (E), Mumbai, 400088, Maharashtra, 401506, Maharashtra, India
India
Contact Person : Veerdhawal Jawahirlal Gandhi Contact Person : Nitin Ramdas Gavande
Designation : Director Designation : Proprietor
Address : Gat No 5 Gevrai Tanda Paithan Road, Address : B-23 Midc Ajntha Road , Jalgaon, 425003,
Aurangabad, 431002, Maharashtra, India Maharashtra, India
Tel.: +91 240 2694466 Mobile :9822794364 Tel.: +91 257 3296354 Mobile :9423186790
Sna Health Care Private Limited Snehal Pharma & Surgicals Private
Contact Person : ANKUR KHEM RAJ TODI Contact Person : Sudhir R. Deulgaonkar
Designation : Director Designation : Director
Address : 127 Gundecha Industrial Complex Address : 103, Renuka Enclave,Keshav Niwara,
Patankar Wadi Akurli Road Kandivali (E), Mumbai, Renuka Layout, Yashoda Nagar, Hingna Road,
400101, Maharashtra, India Nagpur-441108.
Tel.: +91 22 28465006 Mobile :8983933632 Tel.: 0712 - 2221331 Mobile :91 7796615904
Contact Person : Dr. V. S. Gandhi Contact Person : Dr. Sachin Dinesh Patel
Designation : Director Designation : Managing Director & CEO
Address : 11/11B Ganshyam Industrial Estate Off Address : 11/12, Udyog Nagar,S. V. Road, Goregaon
Veera Desai Road B/H Fun Republic Andheri (W), (W),Mumbai — 400104,Maharashtra , India.
Mumbai, 400053, Maharashtra, India
Ven Petrochem & Pharma (India) Private Vetbiochem India Private Limited
Tel.: +91 2525 655360 Mobile :9561074929 Tel.: +91 22 22067376 Mobile :9321475594
Tel.: +91 22 22068585 Mobile :9324658585 Tel.: Mobile :91 983 312 4983
Tel.: Mobile :098145 32990 Tel.: +91 1493 222278 Mobile :9828206001
RAJASTHAN
Sunil Healthcare Limited Barsana Hychem Industries
Contact Person : Sanjay Kumar Kaushik Contact Person : Amit Agarwal
Designation : Director Designation : Chief Executive Officer
Address : 17/18 Old Industrial Area , Alwar,300001, Address : No 42 Scheme No 8 Main Road ,
Rajasthan, India Alwar,301001, Rajasthan, India
Tel.: +91 29 42453067 Mobile :9928094608 Tel.: 0291 298 0406 Mobile :
Tel.: +91 149 3222123 Mobile :074120 58413 Tel.: Mobile :8048371538
Tel.: +91 129 42584811 Mobile :072968 66111 Tel.: Mobile :8048964067
Tel.: +91 291 5131666 Mobile :9928841166 Tel.: +91 141 4107694 Mobile :
Tel.: +91 294 2561378 Mobile : Tel.: +91 294 2427529 Mobile :9983516661
Tel.: 91 452 4368132 Mobile : Tel.: +91 44 23860190 Mobile :096000 66626
Contact Person :R. Krishna Kumar Contact Person : Sabarish Mohan Kumar
Designation : Director Designation : Joint Managing Director
Address : Plot No 51 Slem Co Op Industrial Estate Address : D No 1/2 Arjunan Street Rajiv Gandhi
Udayapatty, Salem, 636140, Tamilnadu, India Nagar Nesapakkam West K K Nagar,
Chennai,600078, Tamilnadu, India
Tel.: +91 424 2230519 Mobile : Tel.: +91 80 43043177 Mobile :9943037117
Tel.: +91 44 2491 1355 Mobile :9229424965 Tel.: 99655 50092 Mobile :9443344056
Tel.: +91 44 4205 0000 Mobile : Tel.: +91 44 23820269 Mobile :9962501641
Tel.: +91 40 2344 5961 Mobile :9849052235 Tel.: +91 40 30866666 Mobile :
Contact Person : Chandra Reddy Tirumalareddy, Contact Person : Mudiraj Saritha Rani,
Designation : Director Designation : Director
Address : Plot No-2 Maitri Vihar Ameerpet Address : Plot No 2 Maitrivihar Ameerpet
,Hyderabad, 500038, Telangana, India sHyderabad, 500038, Telangana, India
Tel.: +91 40 23404438 Mobile: Tel.: +91 40 2778 4084 Mobile :91 40 2348 0567
Brilliant Bio Pharma Private Limited Deys Medical Stores Mfg Limited
Tel.: +91 40 23786300 Mobile :91 (40) 2378 6460 Tel.: +91 40 49002900 Mobile :
Contact Person : Mr Ghanshyam Jaju Contact Person : Dr. K.V.S. Ram Rao
Designation : Designation : ceo
Address : 1st Floor Mayfair Sardar Patel Road Address : 2nd Floor 3rd Block My Home Hub
,Secunderabad, 500003, Telangana, India Madhapur, Hyderabad, 500081, Telangana, India
Contact Person : Bhaskar Vemban lyer Contact Person : Surya Venkata Narasimha Sastry
Designation : Director Designation : Director
Address : Plot No 26 & 27 Techno Industrial Estate Address : Plot No 151 S V Co-Operative Industrial
Balanagar, Hyderabad, 500037, Telangana, India Estate Village Road Ida Bollaram , Medak, 502325,
Telangana, India
Tel.: 40 6608 6608 Mobile : Tel.: 040 - 2525 9999 Mobile :7032807337
Tel.: 0172 5085736 2653974 Mobile : Tel.: 91 413 2661103 Mobile :9486748343
Tel.: 91 172 5005000 Mobile :9935210013 Tel.: 91 172 5070472 Mobile :9814813536
Tel.: 91 172 4642918 Mobile :9418052341 Tel.: 91 172 2585481 Mobile :9316316312
Tel.: 91 260 3267764 Mobile :8141718755 Tel.: 91 172 5081122 Mobile :9855569999
Tel.: 91 413 2677060 Mobile :9750977218 Tel.: Mobile :0172 223 6009
Email ID : Email ID :
Contact Person : Chandra Sekhar Tumuluru, Contact Person : Sankara Venkata Krishna Prasad
Designation : Director Designation : Director
Address : 8-3-166/7/1 Hetero House Erragadda , Address : Lakshmi Nilayam 2-2-18/32/B G-10 Dd
Hyderabad, 500018, Telangana, India Colony Bagh Amberpet, Hyderabad, 500013,
Telangana, India
Tel.: 9052779505 Mobile :91 9052779505 Tel.: +91 40 23715528 Mobile :91 - 40-23701738
Credo Life Sciences Private Limited Cyma Life Sciences Private Limited
Contact Person :Kandru Madhavarao, Contact Person : SUDHA BALUSU
Designation : Director Designation : Director
Address : #102 Aditya Trade Center Ameerpet , Address : : 8-4-376/14 New Sastry Nagar Sanath
Hyderabad, 500038, Telangana, India Nagar , Hyderabad, 500018, Telangana, India
Email ID : Email ID :
Integrin Life Sciences Private Limited Inter Labs (India) Private Limited
Maithili Life Sciences Private Limited Mars Therapeutics & Chemicals Limited
Email ID : Email ID :
Tel.: +91 5947 275279 Mobile :9219050929 Tel.: 91 1334 239155 Mobile :9897054150
Tel.: 91 1334 239794 Mobile :8859004189 Tel.: 91 1332 235117 Mobile :91 91577 03835
Tel.: 9810513826 Mobile : Tel.: 91 133 2232793 Mobile :91 133 2232 793
Tel.: +91 135 2699037 Mobile :7500175922 Tel.: 01334 239 987 Mobile :9759491300
Tel.: 91 135 2698706 Mobile :8192960154 Tel.: 91 1334 265155 Mobile :9720450451
Tel.: 91 260 5546565 Mobile : Tel.: 91 172 4237709 Mobile :98157 77744
Tel.: 91 413 2272213 Mobile :9942796401 Tel.: 91 1332 234041 Mobile :9319690011
UTTAR PRADESH
Ayurvet Limited Surya Herbal Limited
Contact Person : Anup Kalra Contact Person : VISHWANATHAN SWAMINATHAN
Designation : Director Designation : Director
Address : Unit No 101 103 1st Floor Km Trade Tower Address : : C-33 Sector-59 , Noida, 201301, Uttar
Plot No H3 Sector-14 Kaushambi, Ghaziabad, Pradesh, India
201010, Uttar Pradesh, India
Contact Person : Uma Shanker Sharma Contact Person : Prabhat Shanker Pandey
Designation : Director Designation : Director
Address : Panchvati Madhavpuri , Kasganj, 207123, Address : B-1/84 P Ravindrapuri Extension Gangotri
Uttar Pradesh, India , Varanasi, 221005, Uttar Pradesh, India
Tel.: 5744 244 563 Mobile : Tel.: 91 542 2314541 Mobile :99367 34440
Tel.: 91 595 2350829 Mobile :9837022285 Tel.: 91 585 2222444 Mobile :9415175899
Tel. 91 121 2532108 Mobile :8191801831 Tel.: 91 120 4376436 Mobile :9312221199
Tel.: 91 120 4919100 Mobile :9990990099 Tel.: 91 512 2563930 Mobile :7388233330
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
Email ID : Email ID :
azda
Contact Person :
Designation :
Address : -505, Saraswati Apts., 5th Floor,Chhatrapati
Meherest PUBLICATIONS
Shivaji Road No. 4, Dahisar(E), Mumbai - 400 068.
Presents
o%
(\
PHARMA = an *2"Ye2 Anacon analytica Anacon India
“PHEX >)
)
éS/NDIALABEXPoO
\ 2023 Rerunaa | 2023 ASIA
mone LABEX ~
| MUMBAI | |MUMBA!|
< hpci , A 8” dition
mn HR OuTH
or INDIA
W
.
Size Rate Dimensions =
| Front Page Solace Color 30,000/- 18cm X 14cm
| Half Page Color 20,000/- 16cm X 23cm
= | Quarter Page Color 10,000/- 46cm X 11cm 7
. 2 « 4 eile ‘° : ° 3 ° ° °
a s U YOOUUOG wy.le . s s
e e ete ( ; Af
xX
* ALOE-EMODIN * DICLOXACILLIN SOD STERILE OXACILLIN SOD. STERILE
x
*
* ALPHA LIPOIC ACID USP/EP * DILOXANIDE FUROATE «+ PACLITAXEL IP/USP
** AMOXICILLIN SODIUM STERILE “> DOCETAXEL “> PIPERACILLIN+TAZOBACTUM (8:1)
** AMOXICILLN TRI COMP/POWDER > FAMOTIDINE * PREGABALINE
+ AMPICILLIN TRI COMP/POWDER * FAROPENEM PROMETHAZINE HCL / THEO
* AMPICILLIN + CLOXACILLIN 1:1
«+ FERROUS ASCORBATE POW/DC “+ PROPRANOLOL HCL
“> AMPICILLIN +*SULBACTAM 2:1
“> FLUCLOXACILLIN SODIUM PVPK-30/60/90
"~
* AVIBACTAM
“> HABAPENTIN * SUCRALOSE FCC/ USP/NF / EP
* AZITHROMYCIN IP/USP
*
* CLOXACILLIN SODIUM STERILE “> METHYLDOPA IP/BP/USP VITAMIN C PLAIN & COATED
307, Exim Link, Near Nahur Station, Mulund Goregaon Link Road,
Nahur (W), Mumbai - 400078. Maharashtra, India.
Tel: 022-40628300